TW200927790A - Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display - Google Patents
Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display Download PDFInfo
- Publication number
- TW200927790A TW200927790A TW097143519A TW97143519A TW200927790A TW 200927790 A TW200927790 A TW 200927790A TW 097143519 A TW097143519 A TW 097143519A TW 97143519 A TW97143519 A TW 97143519A TW 200927790 A TW200927790 A TW 200927790A
- Authority
- TW
- Taiwan
- Prior art keywords
- liquid crystal
- formula
- crystal alignment
- group
- structural formula
- Prior art date
Links
- 239000004973 liquid crystal related substance Substances 0.000 title claims abstract description 383
- 239000003795 chemical substances by application Substances 0.000 title claims abstract description 212
- 150000004985 diamines Chemical class 0.000 claims abstract description 117
- GTDPSWPPOUPBNX-UHFFFAOYSA-N ac1mqpva Chemical compound CC12C(=O)OC(=O)C1(C)C1(C)C2(C)C(=O)OC1=O GTDPSWPPOUPBNX-UHFFFAOYSA-N 0.000 claims abstract description 43
- 125000006158 tetracarboxylic acid group Chemical group 0.000 claims abstract description 32
- 229920005575 poly(amic acid) Polymers 0.000 claims abstract description 21
- 239000007795 chemical reaction product Substances 0.000 claims abstract description 4
- 150000001875 compounds Chemical class 0.000 claims description 202
- -1 R6 represents -Η Chemical group 0.000 claims description 158
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 claims description 86
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 79
- 229910052799 carbon Inorganic materials 0.000 claims description 79
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 69
- 125000000217 alkyl group Chemical group 0.000 claims description 63
- 239000004593 Epoxy Substances 0.000 claims description 53
- 239000002253 acid Substances 0.000 claims description 46
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 40
- 125000004432 carbon atom Chemical group C* 0.000 claims description 40
- 239000000126 substance Substances 0.000 claims description 29
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 28
- 239000000758 substrate Substances 0.000 claims description 28
- 150000001412 amines Chemical class 0.000 claims description 21
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 claims description 20
- 125000003545 alkoxy group Chemical group 0.000 claims description 18
- 238000000576 coating method Methods 0.000 claims description 18
- 229920000768 polyamine Polymers 0.000 claims description 17
- 239000000052 vinegar Substances 0.000 claims description 16
- 235000021419 vinegar Nutrition 0.000 claims description 16
- 239000011248 coating agent Substances 0.000 claims description 15
- 150000002466 imines Chemical class 0.000 claims description 15
- 125000003277 amino group Chemical group 0.000 claims description 14
- MWPLVEDNUUSJAV-UHFFFAOYSA-N anthracene Chemical compound C1=CC=CC2=CC3=CC=CC=C3C=C21 MWPLVEDNUUSJAV-UHFFFAOYSA-N 0.000 claims description 14
- 125000001931 aliphatic group Chemical group 0.000 claims description 13
- 125000003118 aryl group Chemical group 0.000 claims description 13
- 125000002947 alkylene group Chemical group 0.000 claims description 12
- 125000000962 organic group Chemical group 0.000 claims description 12
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 claims description 11
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Natural products C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 claims description 11
- 150000003254 radicals Chemical class 0.000 claims description 11
- 229910052707 ruthenium Inorganic materials 0.000 claims description 11
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 claims description 10
- 239000001257 hydrogen Substances 0.000 claims description 10
- 229910052739 hydrogen Inorganic materials 0.000 claims description 10
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 claims description 10
- 239000001294 propane Substances 0.000 claims description 10
- 125000002723 alicyclic group Chemical group 0.000 claims description 9
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 9
- 238000010438 heat treatment Methods 0.000 claims description 9
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 9
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 claims description 8
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims description 8
- NIHNNTQXNPWCJQ-UHFFFAOYSA-N o-biphenylenemethane Natural products C1=CC=C2CC3=CC=CC=C3C2=C1 NIHNNTQXNPWCJQ-UHFFFAOYSA-N 0.000 claims description 8
- BCHZICNRHXRCHY-UHFFFAOYSA-N 2h-oxazine Chemical compound N1OC=CC=C1 BCHZICNRHXRCHY-UHFFFAOYSA-N 0.000 claims description 6
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 claims description 6
- 125000003342 alkenyl group Chemical group 0.000 claims description 6
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 6
- 239000007789 gas Substances 0.000 claims description 6
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 claims description 6
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 claims description 6
- 125000004955 1,4-cyclohexylene group Chemical group [H]C1([H])C([H])([H])C([H])([*:1])C([H])([H])C([H])([H])C1([H])[*:2] 0.000 claims description 5
- 125000001140 1,4-phenylene group Chemical group [H]C1=C([H])C([*:2])=C([H])C([H])=C1[*:1] 0.000 claims description 5
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 5
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 5
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 5
- 229910052731 fluorine Inorganic materials 0.000 claims description 5
- DIIIISSCIXVANO-UHFFFAOYSA-N 1,2-Dimethylhydrazine Chemical compound CNNC DIIIISSCIXVANO-UHFFFAOYSA-N 0.000 claims description 3
- KUDUQBURMYMBIJ-UHFFFAOYSA-N 2-prop-2-enoyloxyethyl prop-2-enoate Chemical compound C=CC(=O)OCCOC(=O)C=C KUDUQBURMYMBIJ-UHFFFAOYSA-N 0.000 claims description 3
- 101100459319 Arabidopsis thaliana VIII-2 gene Proteins 0.000 claims description 3
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 3
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 3
- 229910052797 bismuth Inorganic materials 0.000 claims description 3
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 3
- 229910052794 bromium Inorganic materials 0.000 claims description 3
- 239000011737 fluorine Substances 0.000 claims description 3
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 claims description 2
- 239000013078 crystal Substances 0.000 claims description 2
- 125000004122 cyclic group Chemical group 0.000 claims description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 2
- ZCXVJRGWDAFVTK-UHFFFAOYSA-N 2,3-dihydroxyocta-2,6-dienediamide Chemical compound NC(=O)C=CCCC(O)=C(O)C(N)=O ZCXVJRGWDAFVTK-UHFFFAOYSA-N 0.000 claims 1
- KKKKCPPTESQGQH-UHFFFAOYSA-N 2-(4,5-dihydro-1,3-oxazol-2-yl)-4,5-dihydro-1,3-oxazole Chemical compound O1CCN=C1C1=NCCO1 KKKKCPPTESQGQH-UHFFFAOYSA-N 0.000 claims 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-N Caprylic acid Natural products CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims 1
- MUFACMKPLYKKBU-UHFFFAOYSA-N N1C(=O)NC=2N=CNC2C1=O.N1C(=O)NC=2N=CNC2C1=O.C(CCCCCCCCCCCCC)(=O)O Chemical compound N1C(=O)NC=2N=CNC2C1=O.N1C(=O)NC=2N=CNC2C1=O.C(CCCCCCCCCCCCC)(=O)O MUFACMKPLYKKBU-UHFFFAOYSA-N 0.000 claims 1
- 239000005864 Sulphur Substances 0.000 claims 1
- 150000001408 amides Chemical class 0.000 claims 1
- GONOPSZTUGRENK-UHFFFAOYSA-N benzyl(trichloro)silane Chemical compound Cl[Si](Cl)(Cl)CC1=CC=CC=C1 GONOPSZTUGRENK-UHFFFAOYSA-N 0.000 claims 1
- 238000007334 copolymerization reaction Methods 0.000 claims 1
- RMBPEFMHABBEKP-UHFFFAOYSA-N fluorene Chemical compound C1=CC=C2C3=C[CH]C=CC3=CC2=C1 RMBPEFMHABBEKP-UHFFFAOYSA-N 0.000 claims 1
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 claims 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N n-hexanoic acid Natural products CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 claims 1
- 125000002328 sterol group Chemical group 0.000 claims 1
- 230000007774 longterm Effects 0.000 abstract description 11
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 abstract description 6
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 abstract description 5
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 71
- 230000015572 biosynthetic process Effects 0.000 description 54
- 238000003786 synthesis reaction Methods 0.000 description 54
- 239000000243 solution Substances 0.000 description 50
- 238000000034 method Methods 0.000 description 41
- 239000012046 mixed solvent Substances 0.000 description 40
- 108010094020 polyglycine Proteins 0.000 description 40
- 229920000232 polyglycine polymer Polymers 0.000 description 40
- 229910052757 nitrogen Inorganic materials 0.000 description 36
- ANSXAPJVJOKRDJ-UHFFFAOYSA-N furo[3,4-f][2]benzofuran-1,3,5,7-tetrone Chemical compound C1=C2C(=O)OC(=O)C2=CC2=C1C(=O)OC2=O ANSXAPJVJOKRDJ-UHFFFAOYSA-N 0.000 description 32
- 229920000642 polymer Polymers 0.000 description 31
- 239000002904 solvent Substances 0.000 description 29
- WVOLTBSCXRRQFR-SJORKVTESA-N Cannabidiolic acid Natural products OC1=C(C(O)=O)C(CCCCC)=CC(O)=C1[C@@H]1[C@@H](C(C)=C)CCC(C)=C1 WVOLTBSCXRRQFR-SJORKVTESA-N 0.000 description 27
- WVOLTBSCXRRQFR-DLBZAZTESA-N cannabidiolic acid Chemical compound OC1=C(C(O)=O)C(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)=C)CCC(C)=C1 WVOLTBSCXRRQFR-DLBZAZTESA-N 0.000 description 27
- 239000000203 mixture Substances 0.000 description 25
- 150000002500 ions Chemical class 0.000 description 23
- 229920001577 copolymer Polymers 0.000 description 21
- 239000000178 monomer Substances 0.000 description 21
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 19
- 108010039918 Polylysine Proteins 0.000 description 13
- 239000002585 base Substances 0.000 description 13
- 229920000656 polylysine Polymers 0.000 description 13
- 238000006243 chemical reaction Methods 0.000 description 12
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 12
- FVCSARBUZVPSQF-UHFFFAOYSA-N 5-(2,4-dioxooxolan-3-yl)-7-methyl-3a,4,5,7a-tetrahydro-2-benzofuran-1,3-dione Chemical compound C1C(C(OC2=O)=O)C2C(C)=CC1C1C(=O)COC1=O FVCSARBUZVPSQF-UHFFFAOYSA-N 0.000 description 11
- 229920000647 polyepoxide Polymers 0.000 description 11
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 11
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 10
- 230000000052 comparative effect Effects 0.000 description 10
- 230000000694 effects Effects 0.000 description 10
- 229910000071 diazene Inorganic materials 0.000 description 9
- 125000003700 epoxy group Chemical group 0.000 description 9
- 239000003822 epoxy resin Substances 0.000 description 9
- 239000007788 liquid Substances 0.000 description 9
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- 238000004140 cleaning Methods 0.000 description 8
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 8
- 125000003504 2-oxazolinyl group Chemical group O1C(=NCC1)* 0.000 description 7
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 7
- CTKINSOISVBQLD-UHFFFAOYSA-N Glycidol Chemical compound OCC1CO1 CTKINSOISVBQLD-UHFFFAOYSA-N 0.000 description 7
- 230000005684 electric field Effects 0.000 description 7
- 108010026466 polyproline Proteins 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 125000002572 propoxy group Chemical group [*]OC([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 7
- HIXDQWDOVZUNNA-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-hydroxy-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 HIXDQWDOVZUNNA-UHFFFAOYSA-N 0.000 description 6
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 6
- YEJRWHAVMIAJKC-UHFFFAOYSA-N 4-Butyrolactone Chemical compound O=C1CCCO1 YEJRWHAVMIAJKC-UHFFFAOYSA-N 0.000 description 6
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 6
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 6
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical class CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 6
- 238000001354 calcination Methods 0.000 description 6
- RAABOESOVLLHRU-UHFFFAOYSA-N diazene Chemical compound N=N RAABOESOVLLHRU-UHFFFAOYSA-N 0.000 description 6
- DIOQZVSQGTUSAI-UHFFFAOYSA-N n-butylhexane Natural products CCCCCCCCCC DIOQZVSQGTUSAI-UHFFFAOYSA-N 0.000 description 6
- 150000002923 oximes Chemical class 0.000 description 6
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 5
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 5
- 125000003983 fluorenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 description 5
- 239000011521 glass Substances 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 125000001424 substituent group Chemical group 0.000 description 5
- 150000000000 tetracarboxylic acids Chemical class 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 4
- 229920002125 Sokalan® Polymers 0.000 description 4
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 4
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 4
- 150000008065 acid anhydrides Chemical class 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 4
- 239000000460 chlorine Substances 0.000 description 4
- 230000018044 dehydration Effects 0.000 description 4
- 238000006297 dehydration reaction Methods 0.000 description 4
- 230000001747 exhibiting effect Effects 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 4
- AWJUIBRHMBBTKR-UHFFFAOYSA-N isoquinoline Chemical class C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- AFEQENGXSMURHA-UHFFFAOYSA-N oxiran-2-ylmethanamine Chemical compound NCC1CO1 AFEQENGXSMURHA-UHFFFAOYSA-N 0.000 description 4
- 150000002927 oxygen compounds Chemical class 0.000 description 4
- 239000004584 polyacrylic acid Substances 0.000 description 4
- 229920002959 polymer blend Polymers 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 238000007363 ring formation reaction Methods 0.000 description 4
- BGKZULDOBMANRY-UHFFFAOYSA-N sulfanyl prop-2-enoate Chemical compound SOC(=O)C=C BGKZULDOBMANRY-UHFFFAOYSA-N 0.000 description 4
- 229910021653 sulphate ion Inorganic materials 0.000 description 4
- TUNFSRHWOTWDNC-UHFFFAOYSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 4
- XQUPVDVFXZDTLT-UHFFFAOYSA-N 1-[4-[[4-(2,5-dioxopyrrol-1-yl)phenyl]methyl]phenyl]pyrrole-2,5-dione Chemical compound O=C1C=CC(=O)N1C(C=C1)=CC=C1CC1=CC=C(N2C(C=CC2=O)=O)C=C1 XQUPVDVFXZDTLT-UHFFFAOYSA-N 0.000 description 3
- AIACLXROWHONEE-UHFFFAOYSA-N 2,3-dimethylcyclohexa-2,5-diene-1,4-dione Chemical compound CC1=C(C)C(=O)C=CC1=O AIACLXROWHONEE-UHFFFAOYSA-N 0.000 description 3
- HMOZDINWBHMBSQ-UHFFFAOYSA-N 2-[3-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]-4,5-dihydro-1,3-oxazole Chemical compound O1CCN=C1C1=CC=CC(C=2OCCN=2)=C1 HMOZDINWBHMBSQ-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 229940123208 Biguanide Drugs 0.000 description 3
- VPLKXGORNUYFBO-UHFFFAOYSA-N C1(CC2C(CC1)O2)CCC(C(OC)(OC)OC)CCCCCCCC Chemical compound C1(CC2C(CC1)O2)CCC(C(OC)(OC)OC)CCCCCCCC VPLKXGORNUYFBO-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 3
- 229920000954 Polyglycolide Polymers 0.000 description 3
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- IISBACLAFKSPIT-UHFFFAOYSA-N bisphenol A Chemical compound C=1C=C(O)C=CC=1C(C)(C)C1=CC=C(O)C=C1 IISBACLAFKSPIT-UHFFFAOYSA-N 0.000 description 3
- 239000003054 catalyst Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000007822 coupling agent Substances 0.000 description 3
- UKJLNMAFNRKWGR-UHFFFAOYSA-N cyclohexatrienamine Chemical group NC1=CC=C=C[CH]1 UKJLNMAFNRKWGR-UHFFFAOYSA-N 0.000 description 3
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 3
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 229940093476 ethylene glycol Drugs 0.000 description 3
- 238000005227 gel permeation chromatography Methods 0.000 description 3
- 229920001519 homopolymer Polymers 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Chemical class C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 125000001841 imino group Chemical group [H]N=* 0.000 description 3
- ZFSLODLOARCGLH-UHFFFAOYSA-N isocyanuric acid Chemical compound OC1=NC(O)=NC(O)=N1 ZFSLODLOARCGLH-UHFFFAOYSA-N 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- ZGEGCLOFRBLKSE-UHFFFAOYSA-N methylene hexane Natural products CCCCCC=C ZGEGCLOFRBLKSE-UHFFFAOYSA-N 0.000 description 3
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 3
- AFFLGGQVNFXPEV-UHFFFAOYSA-N n-decene Natural products CCCCCCCCC=C AFFLGGQVNFXPEV-UHFFFAOYSA-N 0.000 description 3
- XNGIFLGASWRNHJ-UHFFFAOYSA-N o-dicarboxybenzene Natural products OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 229910052762 osmium Inorganic materials 0.000 description 3
- SYQBFIAQOQZEGI-UHFFFAOYSA-N osmium atom Chemical compound [Os] SYQBFIAQOQZEGI-UHFFFAOYSA-N 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- AZQWKYJCGOJGHM-UHFFFAOYSA-N para-benzoquinone Natural products O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 3
- 239000004633 polyglycolic acid Substances 0.000 description 3
- 238000006116 polymerization reaction Methods 0.000 description 3
- 238000007639 printing Methods 0.000 description 3
- 150000004060 quinone imines Chemical class 0.000 description 3
- 239000002689 soil Substances 0.000 description 3
- 238000004528 spin coating Methods 0.000 description 3
- 125000002345 steroid group Chemical group 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- KATAXDCYPGGJNJ-UHFFFAOYSA-N 1,3-bis(oxiran-2-ylmethoxy)propan-2-ol Chemical compound C1OC1COCC(O)COCC1CO1 KATAXDCYPGGJNJ-UHFFFAOYSA-N 0.000 description 2
- 125000001989 1,3-phenylene group Chemical group [H]C1=C([H])C([*:1])=C([H])C([*:2])=C1[H] 0.000 description 2
- UWFRVQVNYNPBEF-UHFFFAOYSA-N 1-(2,4-dimethylphenyl)propan-1-one Chemical compound CCC(=O)C1=CC=C(C)C=C1C UWFRVQVNYNPBEF-UHFFFAOYSA-N 0.000 description 2
- KMBSSXSNDSJXCG-UHFFFAOYSA-N 1-[2-(2-hydroxyundecylamino)ethylamino]undecan-2-ol Chemical compound CCCCCCCCCC(O)CNCCNCC(O)CCCCCCCCC KMBSSXSNDSJXCG-UHFFFAOYSA-N 0.000 description 2
- RWNUSVWFHDHRCJ-UHFFFAOYSA-N 1-butoxypropan-2-ol Chemical compound CCCCOCC(C)O RWNUSVWFHDHRCJ-UHFFFAOYSA-N 0.000 description 2
- HIDBROSJWZYGSZ-UHFFFAOYSA-N 1-phenylpyrrole-2,5-dione Chemical compound O=C1C=CC(=O)N1C1=CC=CC=C1 HIDBROSJWZYGSZ-UHFFFAOYSA-N 0.000 description 2
- KGRVJHAUYBGFFP-UHFFFAOYSA-N 2,2'-Methylenebis(4-methyl-6-tert-butylphenol) Chemical compound CC(C)(C)C1=CC(C)=CC(CC=2C(=C(C=C(C)C=2)C(C)(C)C)O)=C1O KGRVJHAUYBGFFP-UHFFFAOYSA-N 0.000 description 2
- CFGGNXFNDNQZKD-UHFFFAOYSA-N 2-(9H-fluoren-1-yl)prop-2-enoic acid Chemical compound C1C2=CC=CC=C2C2=C1C(C(=C)C(=O)O)=CC=C2 CFGGNXFNDNQZKD-UHFFFAOYSA-N 0.000 description 2
- HDPLHDGYGLENEI-UHFFFAOYSA-N 2-[1-(oxiran-2-ylmethoxy)propan-2-yloxymethyl]oxirane Chemical compound C1OC1COC(C)COCC1CO1 HDPLHDGYGLENEI-UHFFFAOYSA-N 0.000 description 2
- AOBIOSPNXBMOAT-UHFFFAOYSA-N 2-[2-(oxiran-2-ylmethoxy)ethoxymethyl]oxirane Chemical compound C1OC1COCCOCC1CO1 AOBIOSPNXBMOAT-UHFFFAOYSA-N 0.000 description 2
- POAOYUHQDCAZBD-UHFFFAOYSA-N 2-butoxyethanol Chemical compound CCCCOCCO POAOYUHQDCAZBD-UHFFFAOYSA-N 0.000 description 2
- UUODQIKUTGWMPT-UHFFFAOYSA-N 2-fluoro-5-(trifluoromethyl)pyridine Chemical compound FC1=CC=C(C(F)(F)F)C=N1 UUODQIKUTGWMPT-UHFFFAOYSA-N 0.000 description 2
- HLYCTXRRGDDBOW-UHFFFAOYSA-N 2-methylpiperazine-1-carbodithioic acid Chemical compound CC1CNCCN1C(S)=S HLYCTXRRGDDBOW-UHFFFAOYSA-N 0.000 description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 2
- 101100132433 Arabidopsis thaliana VIII-1 gene Proteins 0.000 description 2
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 2
- 235000017491 Bambusa tulda Nutrition 0.000 description 2
- 241001330002 Bambuseae Species 0.000 description 2
- XNCOSPRUTUOJCJ-UHFFFAOYSA-N Biguanide Chemical compound NC(N)=NC(N)=N XNCOSPRUTUOJCJ-UHFFFAOYSA-N 0.000 description 2
- 229930185605 Bisphenol Natural products 0.000 description 2
- KAKZBPTYRLMSJV-UHFFFAOYSA-N Butadiene Chemical compound C=CC=C KAKZBPTYRLMSJV-UHFFFAOYSA-N 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- MHZGKXUYDGKKIU-UHFFFAOYSA-N Decylamine Chemical compound CCCCCCCCCCN MHZGKXUYDGKKIU-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 2
- 239000005977 Ethylene Substances 0.000 description 2
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical group C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- 238000004566 IR spectroscopy Methods 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- UHFHEWLHJIWDGK-UHFFFAOYSA-N O1C(=NCC1)C1=CC(=CC=C1)C=1OCCN1.C1=CC=CC=C1 Chemical compound O1C(=NCC1)C1=CC(=CC=C1)C=1OCCN1.C1=CC=CC=C1 UHFHEWLHJIWDGK-UHFFFAOYSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 101000701286 Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1) Alkanesulfonate monooxygenase Proteins 0.000 description 2
- 101000983349 Solanum commersonii Osmotin-like protein OSML13 Proteins 0.000 description 2
- 101000983338 Solanum commersonii Osmotin-like protein OSML15 Proteins 0.000 description 2
- PJANXHGTPQOBST-VAWYXSNFSA-N Stilbene Natural products C=1C=CC=CC=1/C=C/C1=CC=CC=C1 PJANXHGTPQOBST-VAWYXSNFSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 150000001335 aliphatic alkanes Chemical class 0.000 description 2
- 150000001336 alkenes Chemical class 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000011425 bamboo Substances 0.000 description 2
- 125000002619 bicyclic group Chemical group 0.000 description 2
- 239000001273 butane Substances 0.000 description 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 2
- 239000003610 charcoal Substances 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 125000004956 cyclohexylene group Chemical group 0.000 description 2
- MWKFXSUHUHTGQN-UHFFFAOYSA-N decan-1-ol Chemical compound CCCCCCCCCCO MWKFXSUHUHTGQN-UHFFFAOYSA-N 0.000 description 2
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- GGSUCNLOZRCGPQ-UHFFFAOYSA-N diethylaniline Chemical compound CCN(CC)C1=CC=CC=C1 GGSUCNLOZRCGPQ-UHFFFAOYSA-N 0.000 description 2
- JRBPAEWTRLWTQC-UHFFFAOYSA-N dodecylamine Chemical compound CCCCCCCCCCCCN JRBPAEWTRLWTQC-UHFFFAOYSA-N 0.000 description 2
- 150000002118 epoxides Chemical class 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- SBRXLTRZCJVAPH-UHFFFAOYSA-N ethyl(trimethoxy)silane Chemical compound CC[Si](OC)(OC)OC SBRXLTRZCJVAPH-UHFFFAOYSA-N 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 238000004817 gas chromatography Methods 0.000 description 2
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 2
- NDJKXXJCMXVBJW-UHFFFAOYSA-N heptadecane Chemical compound CCCCCCCCCCCCCCCCC NDJKXXJCMXVBJW-UHFFFAOYSA-N 0.000 description 2
- NAQMVNRVTILPCV-UHFFFAOYSA-N hexane-1,6-diamine Chemical compound NCCCCCCN NAQMVNRVTILPCV-UHFFFAOYSA-N 0.000 description 2
- 150000002430 hydrocarbons Chemical group 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- HJOVHMDZYOCNQW-UHFFFAOYSA-N isophorone Chemical compound CC1=CC(=O)CC(C)(C)C1 HJOVHMDZYOCNQW-UHFFFAOYSA-N 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- IVSZLXZYQVIEFR-UHFFFAOYSA-N m-xylene Chemical group CC1=CC=CC(C)=C1 IVSZLXZYQVIEFR-UHFFFAOYSA-N 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 229930003658 monoterpene Natural products 0.000 description 2
- 235000002577 monoterpenes Nutrition 0.000 description 2
- JAYXSROKFZAHRQ-UHFFFAOYSA-N n,n-bis(oxiran-2-ylmethyl)aniline Chemical compound C1OC1CN(C=1C=CC=CC=1)CC1CO1 JAYXSROKFZAHRQ-UHFFFAOYSA-N 0.000 description 2
- KPEKHIHQXHOSRM-UHFFFAOYSA-N n-(oxolan-2-ylmethyl)prop-2-enamide Chemical compound C=CC(=O)NCC1CCCO1 KPEKHIHQXHOSRM-UHFFFAOYSA-N 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical group CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- OLAPPGSPBNVTRF-UHFFFAOYSA-N naphthalene-1,4,5,8-tetracarboxylic acid Chemical compound C1=CC(C(O)=O)=C2C(C(=O)O)=CC=C(C(O)=O)C2=C1C(O)=O OLAPPGSPBNVTRF-UHFFFAOYSA-N 0.000 description 2
- 125000001624 naphthyl group Chemical group 0.000 description 2
- 229920003986 novolac Polymers 0.000 description 2
- RNVCVTLRINQCPJ-UHFFFAOYSA-N o-toluidine Chemical compound CC1=CC=CC=C1N RNVCVTLRINQCPJ-UHFFFAOYSA-N 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- FDPIMTJIUBPUKL-UHFFFAOYSA-N pentan-3-one Chemical compound CCC(=O)CC FDPIMTJIUBPUKL-UHFFFAOYSA-N 0.000 description 2
- 229960003742 phenol Drugs 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 229920003192 poly(bis maleimide) Polymers 0.000 description 2
- 229920000058 polyacrylate Polymers 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 229920005906 polyester polyol Polymers 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920002098 polyfluorene Polymers 0.000 description 2
- 229920001451 polypropylene glycol Polymers 0.000 description 2
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 2
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 2
- PBMFSQRYOILNGV-UHFFFAOYSA-N pyridazine Chemical compound C1=CC=NN=C1 PBMFSQRYOILNGV-UHFFFAOYSA-N 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 230000000087 stabilizing effect Effects 0.000 description 2
- PJANXHGTPQOBST-UHFFFAOYSA-N stilbene Chemical compound C=1C=CC=CC=1C=CC1=CC=CC=C1 PJANXHGTPQOBST-UHFFFAOYSA-N 0.000 description 2
- 235000021286 stilbenes Nutrition 0.000 description 2
- 239000004575 stone Substances 0.000 description 2
- ABVVEAHYODGCLZ-UHFFFAOYSA-N tridecan-1-amine Chemical compound CCCCCCCCCCCCCN ABVVEAHYODGCLZ-UHFFFAOYSA-N 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical group C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- VZXTWGWHSMCWGA-UHFFFAOYSA-N 1,3,5-triazine-2,4-diamine Chemical compound NC1=NC=NC(N)=N1 VZXTWGWHSMCWGA-UHFFFAOYSA-N 0.000 description 1
- OUPZKGBUJRBPGC-UHFFFAOYSA-N 1,3,5-tris(oxiran-2-ylmethyl)-1,3,5-triazinane-2,4,6-trione Chemical compound O=C1N(CC2OC2)C(=O)N(CC2OC2)C(=O)N1CC1CO1 OUPZKGBUJRBPGC-UHFFFAOYSA-N 0.000 description 1
- CYSGHNMQYZDMIA-UHFFFAOYSA-N 1,3-Dimethyl-2-imidazolidinon Chemical compound CN1CCN(C)C1=O CYSGHNMQYZDMIA-UHFFFAOYSA-N 0.000 description 1
- FJLUATLTXUNBOT-UHFFFAOYSA-N 1-Hexadecylamine Chemical compound CCCCCCCCCCCCCCCCN FJLUATLTXUNBOT-UHFFFAOYSA-N 0.000 description 1
- DMYOHQBLOZMDLP-UHFFFAOYSA-N 1-[2-(2-hydroxy-3-piperidin-1-ylpropoxy)phenyl]-3-phenylpropan-1-one Chemical compound C1CCCCN1CC(O)COC1=CC=CC=C1C(=O)CCC1=CC=CC=C1 DMYOHQBLOZMDLP-UHFFFAOYSA-N 0.000 description 1
- IPJGAEWUPXWFPL-UHFFFAOYSA-N 1-[3-(2,5-dioxopyrrol-1-yl)phenyl]pyrrole-2,5-dione Chemical compound O=C1C=CC(=O)N1C1=CC=CC(N2C(C=CC2=O)=O)=C1 IPJGAEWUPXWFPL-UHFFFAOYSA-N 0.000 description 1
- JPZYXGPCHFZBHO-UHFFFAOYSA-N 1-aminopentadecane Chemical compound CCCCCCCCCCCCCCCN JPZYXGPCHFZBHO-UHFFFAOYSA-N 0.000 description 1
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 1
- VLDPXPPHXDGHEW-UHFFFAOYSA-N 1-chloro-2-dichlorophosphoryloxybenzene Chemical compound ClC1=CC=CC=C1OP(Cl)(Cl)=O VLDPXPPHXDGHEW-UHFFFAOYSA-N 0.000 description 1
- BQTPKSBXMONSJI-UHFFFAOYSA-N 1-cyclohexylpyrrole-2,5-dione Chemical compound O=C1C=CC(=O)N1C1CCCCC1 BQTPKSBXMONSJI-UHFFFAOYSA-N 0.000 description 1
- BQCCJWMQESHLIT-UHFFFAOYSA-N 1-propylsulfinylpropane Chemical compound CCCS(=O)CCC BQCCJWMQESHLIT-UHFFFAOYSA-N 0.000 description 1
- LTMRRSWNXVJMBA-UHFFFAOYSA-L 2,2-diethylpropanedioate Chemical compound CCC(CC)(C([O-])=O)C([O-])=O LTMRRSWNXVJMBA-UHFFFAOYSA-L 0.000 description 1
- IVIDDMGBRCPGLJ-UHFFFAOYSA-N 2,3-bis(oxiran-2-ylmethoxy)propan-1-ol Chemical compound C1OC1COC(CO)COCC1CO1 IVIDDMGBRCPGLJ-UHFFFAOYSA-N 0.000 description 1
- NRMFZALSFCIANK-UHFFFAOYSA-N 2,3-dipropylbicyclo[2.2.1]hept-2-ene Chemical compound C(CC)C1=C(C2CCC1C2)CCC NRMFZALSFCIANK-UHFFFAOYSA-N 0.000 description 1
- ZVDSMYGTJDFNHN-UHFFFAOYSA-N 2,4,6-trimethylbenzene-1,3-diamine Chemical compound CC1=CC(C)=C(N)C(C)=C1N ZVDSMYGTJDFNHN-UHFFFAOYSA-N 0.000 description 1
- KMHXAJUDYPONES-UHFFFAOYSA-N 2-(1,1,2,2,2-pentafluoroethoxymethyl)oxirane Chemical compound FC(F)(F)C(F)(F)OCC1CO1 KMHXAJUDYPONES-UHFFFAOYSA-N 0.000 description 1
- NJWAYDPFSGPKLL-UHFFFAOYSA-N 2-(2-hydroxyethoxy)ethanol;dihydrate Chemical compound O.O.OCCOCCO NJWAYDPFSGPKLL-UHFFFAOYSA-N 0.000 description 1
- JAHNSTQSQJOJLO-UHFFFAOYSA-N 2-(3-fluorophenyl)-1h-imidazole Chemical compound FC1=CC=CC(C=2NC=CN=2)=C1 JAHNSTQSQJOJLO-UHFFFAOYSA-N 0.000 description 1
- KUBDPQJOLOUJRM-UHFFFAOYSA-N 2-(chloromethyl)oxirane;4-[2-(4-hydroxyphenyl)propan-2-yl]phenol Chemical compound ClCC1CO1.C=1C=C(O)C=CC=1C(C)(C)C1=CC=C(O)C=C1 KUBDPQJOLOUJRM-UHFFFAOYSA-N 0.000 description 1
- BXGYYDRIMBPOMN-UHFFFAOYSA-N 2-(hydroxymethoxy)ethoxymethanol Chemical compound OCOCCOCO BXGYYDRIMBPOMN-UHFFFAOYSA-N 0.000 description 1
- IMSODMZESSGVBE-UHFFFAOYSA-N 2-Oxazoline Chemical compound C1CN=CO1 IMSODMZESSGVBE-UHFFFAOYSA-N 0.000 description 1
- FCSSPCOFDUKHPV-UHFFFAOYSA-N 2-Propenyl propyl disulfide Chemical compound CCCSSCC=C FCSSPCOFDUKHPV-UHFFFAOYSA-N 0.000 description 1
- HSDVRWZKEDRBAG-UHFFFAOYSA-N 2-[1-(oxiran-2-ylmethoxy)hexoxymethyl]oxirane Chemical compound C1OC1COC(CCCCC)OCC1CO1 HSDVRWZKEDRBAG-UHFFFAOYSA-N 0.000 description 1
- FVCHRIQAIOHAIC-UHFFFAOYSA-N 2-[1-[1-[1-(oxiran-2-ylmethoxy)propan-2-yloxy]propan-2-yloxy]propan-2-yloxymethyl]oxirane Chemical compound C1OC1COC(C)COC(C)COC(C)COCC1CO1 FVCHRIQAIOHAIC-UHFFFAOYSA-N 0.000 description 1
- LCZVSXRMYJUNFX-UHFFFAOYSA-N 2-[2-(2-hydroxypropoxy)propoxy]propan-1-ol Chemical compound CC(O)COC(C)COC(C)CO LCZVSXRMYJUNFX-UHFFFAOYSA-N 0.000 description 1
- VOGDKZZTBPDRBD-UHFFFAOYSA-N 2-[2-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]-4,5-dihydro-1,3-oxazole Chemical compound O1CCN=C1C1=CC=CC=C1C1=NCCO1 VOGDKZZTBPDRBD-UHFFFAOYSA-N 0.000 description 1
- PRJQBLZFLQSJOM-UHFFFAOYSA-N 2-[[1,3-dibromo-2,2-dimethyl-3-(oxiran-2-ylmethoxy)propoxy]methyl]oxirane Chemical compound C(C1CO1)OC(C(C)(C(OCC1CO1)Br)C)Br PRJQBLZFLQSJOM-UHFFFAOYSA-N 0.000 description 1
- XOSCKTQMAZSFBZ-UHFFFAOYSA-N 2-[[1-[[2,7-bis(oxiran-2-ylmethoxy)naphthalen-1-yl]methyl]-7-(oxiran-2-ylmethoxy)naphthalen-2-yl]oxymethyl]oxirane Chemical compound C1OC1COC(C=C1C=2CC=3C4=CC(OCC5OC5)=CC=C4C=CC=3OCC3OC3)=CC=C1C=CC=2OCC1CO1 XOSCKTQMAZSFBZ-UHFFFAOYSA-N 0.000 description 1
- NKANYVMWDXJHLE-UHFFFAOYSA-N 2-[[2-(oxiran-2-ylmethoxy)phenoxy]methyl]oxirane Chemical compound C1OC1COC1=CC=CC=C1OCC1CO1 NKANYVMWDXJHLE-UHFFFAOYSA-N 0.000 description 1
- FSYPIGPPWAJCJG-UHFFFAOYSA-N 2-[[4-(oxiran-2-ylmethoxy)phenoxy]methyl]oxirane Chemical compound C1OC1COC(C=C1)=CC=C1OCC1CO1 FSYPIGPPWAJCJG-UHFFFAOYSA-N 0.000 description 1
- CDAWCLOXVUBKRW-UHFFFAOYSA-N 2-aminophenol Chemical compound NC1=CC=CC=C1O CDAWCLOXVUBKRW-UHFFFAOYSA-N 0.000 description 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
- OMIGHNLMNHATMP-UHFFFAOYSA-N 2-hydroxyethyl prop-2-enoate Chemical compound OCCOC(=O)C=C OMIGHNLMNHATMP-UHFFFAOYSA-N 0.000 description 1
- OVEUFHOBGCSKSH-UHFFFAOYSA-N 2-methyl-n,n-bis(oxiran-2-ylmethyl)aniline Chemical compound CC1=CC=CC=C1N(CC1OC1)CC1OC1 OVEUFHOBGCSKSH-UHFFFAOYSA-N 0.000 description 1
- IJSVVICYGLOZHA-UHFFFAOYSA-N 2-methyl-n-phenylprop-2-enamide Chemical compound CC(=C)C(=O)NC1=CC=CC=C1 IJSVVICYGLOZHA-UHFFFAOYSA-N 0.000 description 1
- YQIGLEFUZMIVHU-UHFFFAOYSA-N 2-methyl-n-propan-2-ylprop-2-enamide Chemical compound CC(C)NC(=O)C(C)=C YQIGLEFUZMIVHU-UHFFFAOYSA-N 0.000 description 1
- QTWJRLJHJPIABL-UHFFFAOYSA-N 2-methylphenol;3-methylphenol;4-methylphenol Chemical compound CC1=CC=C(O)C=C1.CC1=CC=CC(O)=C1.CC1=CC=CC=C1O QTWJRLJHJPIABL-UHFFFAOYSA-N 0.000 description 1
- YOHKNKVVNFWDKI-UHFFFAOYSA-N 2-n,4-n,4-n-trimethyl-2-n-propyl-1,3,5-triazine-2,4,6-triamine Chemical compound CCCN(C)C1=NC(N)=NC(N(C)C)=N1 YOHKNKVVNFWDKI-UHFFFAOYSA-N 0.000 description 1
- DAWJJMYZJQJLPZ-UHFFFAOYSA-N 2-sulfanylprop-2-enoic acid Chemical class OC(=O)C(S)=C DAWJJMYZJQJLPZ-UHFFFAOYSA-N 0.000 description 1
- CMLFRMDBDNHMRA-UHFFFAOYSA-N 2h-1,2-benzoxazine Chemical compound C1=CC=C2C=CNOC2=C1 CMLFRMDBDNHMRA-UHFFFAOYSA-N 0.000 description 1
- AGUZIPIUVSGKPT-UHFFFAOYSA-N 3-[2-(3-aminopropyl)-1H-pyridazin-5-yl]propan-1-amine Chemical compound NCCCN1NC=C(C=C1)CCCN AGUZIPIUVSGKPT-UHFFFAOYSA-N 0.000 description 1
- KLJZSHGQOMNMAC-UHFFFAOYSA-N 3-[2-oxo-2-[2-(2,3,5-tricarboxycyclopentyl)acetyl]oxyethyl]cyclopentane-1,2,4-tricarboxylic acid Chemical compound OC(=O)C1CC(C(O)=O)C(C(O)=O)C1CC(=O)OC(=O)CC1C(C(O)=O)C(C(O)=O)CC1C(O)=O KLJZSHGQOMNMAC-UHFFFAOYSA-N 0.000 description 1
- GPXCORHXFPYJEH-UHFFFAOYSA-N 3-[[3-aminopropyl(dimethyl)silyl]oxy-dimethylsilyl]propan-1-amine Chemical compound NCCC[Si](C)(C)O[Si](C)(C)CCCN GPXCORHXFPYJEH-UHFFFAOYSA-N 0.000 description 1
- KFFUEVDMVNIOHA-UHFFFAOYSA-N 3-aminobenzenethiol Chemical compound NC1=CC=CC(S)=C1 KFFUEVDMVNIOHA-UHFFFAOYSA-N 0.000 description 1
- CWLKGDAVCFYWJK-UHFFFAOYSA-N 3-aminophenol Chemical compound NC1=CC=CC(O)=C1 CWLKGDAVCFYWJK-UHFFFAOYSA-N 0.000 description 1
- 229940018563 3-aminophenol Drugs 0.000 description 1
- JFUOAGBSDGCVES-UHFFFAOYSA-N 3-but-2-enyl-4-methylpyrrolidine-2,5-dione Chemical compound CC=CCC1C(C)C(=O)NC1=O JFUOAGBSDGCVES-UHFFFAOYSA-N 0.000 description 1
- KJZBSJXXYPVALB-UHFFFAOYSA-N 3-methoxy-3-sulfanylbutan-1-ol Chemical compound SC(CCO)(C)OC KJZBSJXXYPVALB-UHFFFAOYSA-N 0.000 description 1
- RCSBZARYQGKGAA-UHFFFAOYSA-N 3-methyl-n,n-bis(oxiran-2-ylmethyl)aniline Chemical compound CC1=CC=CC(N(CC2OC2)CC2OC2)=C1 RCSBZARYQGKGAA-UHFFFAOYSA-N 0.000 description 1
- QJLNIQUNKIFOHT-UHFFFAOYSA-N 3-propylbicyclo[2.2.1]hept-3-ene Chemical compound C1CC2CC(CCC)=C1C2 QJLNIQUNKIFOHT-UHFFFAOYSA-N 0.000 description 1
- GRFNBEZIAWKNCO-UHFFFAOYSA-N 3-pyridinol Chemical compound OC1=CC=CN=C1 GRFNBEZIAWKNCO-UHFFFAOYSA-N 0.000 description 1
- YBRVSVVVWCFQMG-UHFFFAOYSA-N 4,4'-diaminodiphenylmethane Chemical compound C1=CC(N)=CC=C1CC1=CC=C(N)C=C1 YBRVSVVVWCFQMG-UHFFFAOYSA-N 0.000 description 1
- UHNUHZHQLCGZDA-UHFFFAOYSA-N 4-[2-(4-aminophenyl)ethyl]aniline Chemical compound C1=CC(N)=CC=C1CCC1=CC=C(N)C=C1 UHNUHZHQLCGZDA-UHFFFAOYSA-N 0.000 description 1
- NRHZAVJNUJCQRL-UHFFFAOYSA-N 4-[4-(4-aminophenyl)piperazin-1-yl]aniline Chemical compound C1=CC(N)=CC=C1N1CCN(C=2C=CC(N)=CC=2)CC1 NRHZAVJNUJCQRL-UHFFFAOYSA-N 0.000 description 1
- ZHVBBDVBERFGCH-UHFFFAOYSA-N 4-[[4-[1-[4-[(4-aminophenyl)methyl]phenyl]-4-heptylcyclohexyl]phenyl]methyl]aniline Chemical compound C1CC(CCCCCCC)CCC1(C=1C=CC(CC=2C=CC(N)=CC=2)=CC=1)C(C=C1)=CC=C1CC1=CC=C(N)C=C1 ZHVBBDVBERFGCH-UHFFFAOYSA-N 0.000 description 1
- PLIKAWJENQZMHA-UHFFFAOYSA-N 4-aminophenol Chemical compound NC1=CC=C(O)C=C1 PLIKAWJENQZMHA-UHFFFAOYSA-N 0.000 description 1
- HCFAJYNVAYBARA-UHFFFAOYSA-N 4-heptanone Chemical compound CCCC(=O)CCC HCFAJYNVAYBARA-UHFFFAOYSA-N 0.000 description 1
- DBTPMQIQJZFVAB-UHFFFAOYSA-N 4-phenyl-4,5-dihydro-1,3-oxazole Chemical compound C1OC=NC1C1=CC=CC=C1 DBTPMQIQJZFVAB-UHFFFAOYSA-N 0.000 description 1
- QEMGMKHRBKOVHA-UHFFFAOYSA-N 4-tert-butyl-4,5-dihydro-1,3-oxazole Chemical compound CC(C)(C)C1COC=N1 QEMGMKHRBKOVHA-UHFFFAOYSA-N 0.000 description 1
- YGYCECQIOXZODZ-UHFFFAOYSA-N 4415-87-6 Chemical compound O=C1OC(=O)C2C1C1C(=O)OC(=O)C12 YGYCECQIOXZODZ-UHFFFAOYSA-N 0.000 description 1
- HBZVNWNSRNTWPS-UHFFFAOYSA-N 6-amino-4-hydroxynaphthalene-2-sulfonic acid Chemical compound C1=C(S(O)(=O)=O)C=C(O)C2=CC(N)=CC=C21 HBZVNWNSRNTWPS-UHFFFAOYSA-N 0.000 description 1
- RBHIUNHSNSQJNG-UHFFFAOYSA-N 6-methyl-3-(2-methyloxiran-2-yl)-7-oxabicyclo[4.1.0]heptane Chemical compound C1CC2(C)OC2CC1C1(C)CO1 RBHIUNHSNSQJNG-UHFFFAOYSA-N 0.000 description 1
- FIHBHSQYSYVZQE-UHFFFAOYSA-N 6-prop-2-enoyloxyhexyl prop-2-enoate Chemical compound C=CC(=O)OCCCCCCOC(=O)C=C FIHBHSQYSYVZQE-UHFFFAOYSA-N 0.000 description 1
- VAYCBEIMJNGBGH-UHFFFAOYSA-N 7-oxabicyclo[4.1.0]heptan-4-yl prop-2-enoate Chemical compound C1C(OC(=O)C=C)CCC2OC21 VAYCBEIMJNGBGH-UHFFFAOYSA-N 0.000 description 1
- UJOBWOGCFQCDNV-UHFFFAOYSA-N 9H-carbazole Chemical compound C1=CC=C2C3=CC=CC=C3NC2=C1 UJOBWOGCFQCDNV-UHFFFAOYSA-N 0.000 description 1
- YCZUWQOJQGCZKG-UHFFFAOYSA-N 9h-carbazole-3,6-diamine Chemical compound C1=C(N)C=C2C3=CC(N)=CC=C3NC2=C1 YCZUWQOJQGCZKG-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 1
- 239000004229 Alkannin Substances 0.000 description 1
- 101001053395 Arabidopsis thaliana Acid beta-fructofuranosidase 4, vacuolar Proteins 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- NOWKCMXCCJGMRR-UHFFFAOYSA-N Aziridine Chemical compound C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 description 1
- 101500000959 Bacillus anthracis Protective antigen PA-20 Proteins 0.000 description 1
- ITFSDBWDHFGXCT-UHFFFAOYSA-N C(C1CO1)OC1=CC=C(C=C1)C(CCCCCCCCC)(C1=CC=C(C=C1)OCC1CO1)C1=CC=C(C=C1)OCC1CO1 Chemical compound C(C1CO1)OC1=CC=C(C=C1)C(CCCCCCCCC)(C1=CC=C(C=C1)OCC1CO1)C1=CC=C(C=C1)OCC1CO1 ITFSDBWDHFGXCT-UHFFFAOYSA-N 0.000 description 1
- SBFKAMKZJRKSIQ-UHFFFAOYSA-N C(C=C)(=O)N(C1=CC=C(C=C1)O)CCCCCCCCCC Chemical compound C(C=C)(=O)N(C1=CC=C(C=C1)O)CCCCCCCCCC SBFKAMKZJRKSIQ-UHFFFAOYSA-N 0.000 description 1
- OJWQXWAPVGZJNT-UHFFFAOYSA-N C(C=C)(=O)N(C1CC1)CCCCCCCCCC Chemical compound C(C=C)(=O)N(C1CC1)CCCCCCCCCC OJWQXWAPVGZJNT-UHFFFAOYSA-N 0.000 description 1
- UXLXXAFNZWYMLX-UHFFFAOYSA-N C(C=C)(=O)N(CCCC)CCCCCCCCCC Chemical compound C(C=C)(=O)N(CCCC)CCCCCCCCCC UXLXXAFNZWYMLX-UHFFFAOYSA-N 0.000 description 1
- KRUDPDKCXHGYLP-UHFFFAOYSA-N C(C=C)(=O)N(CCOCC)CCCCCCCCCC Chemical compound C(C=C)(=O)N(CCOCC)CCCCCCCCCC KRUDPDKCXHGYLP-UHFFFAOYSA-N 0.000 description 1
- XUTQLMKDSUFGIQ-JCNLHEQBSA-N C(CCCC)[C@@H]1CC[C@H](CC1)C1CCCCC1 Chemical compound C(CCCC)[C@@H]1CC[C@H](CC1)C1CCCCC1 XUTQLMKDSUFGIQ-JCNLHEQBSA-N 0.000 description 1
- PGFDFNHMVWFPGY-UHFFFAOYSA-N C1(CCCCC1)C=1C(=O)NC(C1)=O.C1=CC=CC=2C3=CC=CC=C3CC12 Chemical compound C1(CCCCC1)C=1C(=O)NC(C1)=O.C1=CC=CC=2C3=CC=CC=C3CC12 PGFDFNHMVWFPGY-UHFFFAOYSA-N 0.000 description 1
- IUBGUGQLSQMRLX-UHFFFAOYSA-N C12=CC=C(N1)C=C1C=CC(=N1)C=C1C=CC(N1)=CC=1C=CC(N1)=C2.C(C=2C(C(=O)O)=CC=CC2)(=O)O Chemical compound C12=CC=C(N1)C=C1C=CC(=N1)C=C1C=CC(N1)=CC=1C=CC(N1)=C2.C(C=2C(C(=O)O)=CC=CC2)(=O)O IUBGUGQLSQMRLX-UHFFFAOYSA-N 0.000 description 1
- QWOJMRHUQHTCJG-UHFFFAOYSA-N CC([CH2-])=O Chemical class CC([CH2-])=O QWOJMRHUQHTCJG-UHFFFAOYSA-N 0.000 description 1
- KSSJBGNOJJETTC-UHFFFAOYSA-N COC1=C(C=CC=C1)N(C1=CC=2C3(C4=CC(=CC=C4C=2C=C1)N(C1=CC=C(C=C1)OC)C1=C(C=CC=C1)OC)C1=CC(=CC=C1C=1C=CC(=CC=13)N(C1=CC=C(C=C1)OC)C1=C(C=CC=C1)OC)N(C1=CC=C(C=C1)OC)C1=C(C=CC=C1)OC)C1=CC=C(C=C1)OC Chemical compound COC1=C(C=CC=C1)N(C1=CC=2C3(C4=CC(=CC=C4C=2C=C1)N(C1=CC=C(C=C1)OC)C1=C(C=CC=C1)OC)C1=CC(=CC=C1C=1C=CC(=CC=13)N(C1=CC=C(C=C1)OC)C1=C(C=CC=C1)OC)N(C1=CC=C(C=C1)OC)C1=C(C=CC=C1)OC)C1=CC=C(C=C1)OC KSSJBGNOJJETTC-UHFFFAOYSA-N 0.000 description 1
- 101100452593 Caenorhabditis elegans ina-1 gene Proteins 0.000 description 1
- COVDQHMMLLDQKU-UHFFFAOYSA-N ClCCCCCCCCCCC=CC1=CC=CC=C1 Chemical compound ClCCCCCCCCCCC=CC1=CC=CC=C1 COVDQHMMLLDQKU-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- QMMFVYPAHWMCMS-UHFFFAOYSA-N Dimethyl sulfide Chemical compound CSC QMMFVYPAHWMCMS-UHFFFAOYSA-N 0.000 description 1
- GDFCSMCGLZFNFY-UHFFFAOYSA-N Dimethylaminopropyl Methacrylamide Chemical compound CN(C)CCCNC(=O)C(C)=C GDFCSMCGLZFNFY-UHFFFAOYSA-N 0.000 description 1
- BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- 239000004214 Fast Green FCF Substances 0.000 description 1
- 239000004230 Fast Yellow AB Substances 0.000 description 1
- BDAGIHXWWSANSR-UHFFFAOYSA-N Formic acid Chemical compound OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 1
- AEMRFAOFKBGASW-UHFFFAOYSA-M Glycolate Chemical compound OCC([O-])=O AEMRFAOFKBGASW-UHFFFAOYSA-M 0.000 description 1
- WJYIASZWHGOTOU-UHFFFAOYSA-N Heptylamine Chemical compound CCCCCCCN WJYIASZWHGOTOU-UHFFFAOYSA-N 0.000 description 1
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 description 1
- 239000004233 Indanthrene blue RS Substances 0.000 description 1
- RRHGJUQNOFWUDK-UHFFFAOYSA-N Isoprene Chemical compound CC(=C)C=C RRHGJUQNOFWUDK-UHFFFAOYSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- RJUFJBKOKNCXHH-UHFFFAOYSA-N Methyl propionate Chemical group CCC(=O)OC RJUFJBKOKNCXHH-UHFFFAOYSA-N 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- SUAKHGWARZSWIH-UHFFFAOYSA-N N,N‐diethylformamide Chemical compound CCN(CC)C=O SUAKHGWARZSWIH-UHFFFAOYSA-N 0.000 description 1
- ZWXPDGCFMMFNRW-UHFFFAOYSA-N N-methylcaprolactam Chemical compound CN1CCCCCC1=O ZWXPDGCFMMFNRW-UHFFFAOYSA-N 0.000 description 1
- HTHFYFAMKGNFSF-UHFFFAOYSA-N NC1=CC=CC=C1.C(C=C)(=O)O.OC=CO.NN Chemical compound NC1=CC=CC=C1.C(C=C)(=O)O.OC=CO.NN HTHFYFAMKGNFSF-UHFFFAOYSA-N 0.000 description 1
- XGCBMSGQBNGRTA-UHFFFAOYSA-N NCCCC(CCCCCCCCC)C Chemical compound NCCCC(CCCCCCCCC)C XGCBMSGQBNGRTA-UHFFFAOYSA-N 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- QRIWJDPIRRCSOZ-UHFFFAOYSA-N OCC(O)CO.[Bi] Chemical compound OCC(O)CO.[Bi] QRIWJDPIRRCSOZ-UHFFFAOYSA-N 0.000 description 1
- PCKPVGOLPKLUHR-UHFFFAOYSA-N OH-Indolxyl Natural products C1=CC=C2C(O)=CNC2=C1 PCKPVGOLPKLUHR-UHFFFAOYSA-N 0.000 description 1
- REYJJPSVUYRZGE-UHFFFAOYSA-N Octadecylamine Chemical compound CCCCCCCCCCCCCCCCCCN REYJJPSVUYRZGE-UHFFFAOYSA-N 0.000 description 1
- 239000004235 Orange GGN Substances 0.000 description 1
- FQYUMYWMJTYZTK-UHFFFAOYSA-N Phenyl glycidyl ether Chemical compound C1OC1COC1=CC=CC=C1 FQYUMYWMJTYZTK-UHFFFAOYSA-N 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000005062 Polybutadiene Substances 0.000 description 1
- 239000004642 Polyimide Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 229920002396 Polyurea Polymers 0.000 description 1
- 239000004237 Ponceau 6R Substances 0.000 description 1
- 239000004236 Ponceau SX Substances 0.000 description 1
- GSHNLOOPJNOXSB-UHFFFAOYSA-N SC(C(=O)O)=C.C(C(=C)C)(=O)OCC1=CC=CC=C1 Chemical compound SC(C(=O)O)=C.C(C(=C)C)(=O)OCC1=CC=CC=C1 GSHNLOOPJNOXSB-UHFFFAOYSA-N 0.000 description 1
- 241000272171 Scolopacidae Species 0.000 description 1
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 1
- WKDDRNSBRWANNC-UHFFFAOYSA-N Thienamycin Natural products C1C(SCCN)=C(C(O)=O)N2C(=O)C(C(O)C)C21 WKDDRNSBRWANNC-UHFFFAOYSA-N 0.000 description 1
- 229920001079 Thiokol (polymer) Polymers 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- MWBPRDONLNQCFV-UHFFFAOYSA-N Tri-allate Chemical group CC(C)N(C(C)C)C(=O)SCC(Cl)=C(Cl)Cl MWBPRDONLNQCFV-UHFFFAOYSA-N 0.000 description 1
- DAKWPKUUDNSNPN-UHFFFAOYSA-N Trimethylolpropane triacrylate Chemical compound C=CC(=O)OCC(CC)(COC(=O)C=C)COC(=O)C=C DAKWPKUUDNSNPN-UHFFFAOYSA-N 0.000 description 1
- 229910052770 Uranium Inorganic materials 0.000 description 1
- 206010047571 Visual impairment Diseases 0.000 description 1
- VCFFZAQQHCLMNH-UHFFFAOYSA-N [3-(6-prop-2-enoyloxyhexanoyloxy)-2-[[3-(6-prop-2-enoyloxyhexanoyloxy)-2,2-bis(6-prop-2-enoyloxyhexanoyloxymethyl)propoxy]methyl]-2-(6-prop-2-enoyloxyhexanoyloxymethyl)propyl] 6-prop-2-enoyloxyhexanoate Chemical compound C=CC(=O)OCCCCCC(=O)OCC(COC(=O)CCCCCOC(=O)C=C)(COC(=O)CCCCCOC(=O)C=C)COCC(COC(=O)CCCCCOC(=O)C=C)(COC(=O)CCCCCOC(=O)C=C)COC(=O)CCCCCOC(=O)C=C VCFFZAQQHCLMNH-UHFFFAOYSA-N 0.000 description 1
- FDLQZKYLHJJBHD-UHFFFAOYSA-N [3-(aminomethyl)phenyl]methanamine Chemical compound NCC1=CC=CC(CN)=C1 FDLQZKYLHJJBHD-UHFFFAOYSA-N 0.000 description 1
- HTMMMSIQFWMMIJ-UHFFFAOYSA-N [3-[2,2-dimethyl-3-(6-prop-2-enoyloxyhexanoyloxy)propanoyl]oxy-2,2-dimethylpropyl] 6-prop-2-enoyloxyhexanoate Chemical compound C=CC(=O)OCCCCCC(=O)OCC(C)(C)COC(=O)C(C)(C)COC(=O)CCCCCOC(=O)C=C HTMMMSIQFWMMIJ-UHFFFAOYSA-N 0.000 description 1
- YNTQTLGBCMXNFX-UHFFFAOYSA-N [5-ethyl-2-(2-methyl-1-prop-2-enoyloxypropan-2-yl)-1,3-dioxan-5-yl]methyl prop-2-enoate Chemical compound C=CC(=O)OCC1(CC)COC(C(C)(C)COC(=O)C=C)OC1 YNTQTLGBCMXNFX-UHFFFAOYSA-N 0.000 description 1
- IPBVNPXQWQGGJP-UHFFFAOYSA-N acetic acid phenyl ester Natural products CC(=O)OC1=CC=CC=C1 IPBVNPXQWQGGJP-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 150000003926 acrylamides Chemical class 0.000 description 1
- 125000002015 acyclic group Chemical group 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 125000003158 alcohol group Chemical group 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 150000001334 alicyclic compounds Chemical group 0.000 description 1
- 239000004844 aliphatic epoxy resin Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 125000004450 alkenylene group Chemical group 0.000 description 1
- 239000004191 allura red AC Substances 0.000 description 1
- 235000012741 allura red AC Nutrition 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 239000004178 amaranth Substances 0.000 description 1
- 235000012735 amaranth Nutrition 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 125000004653 anthracenylene group Chemical group 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- RJGDLRCDCYRQOQ-UHFFFAOYSA-N anthrone Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3CC2=C1 RJGDLRCDCYRQOQ-UHFFFAOYSA-N 0.000 description 1
- 239000002216 antistatic agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 238000000149 argon plasma sintering Methods 0.000 description 1
- 150000001491 aromatic compounds Chemical class 0.000 description 1
- 150000004984 aromatic diamines Chemical class 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 125000000732 arylene group Chemical group 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 150000001540 azides Chemical class 0.000 description 1
- 239000004176 azorubin Substances 0.000 description 1
- 235000012733 azorubine Nutrition 0.000 description 1
- KCXMKQUNVWSEMD-UHFFFAOYSA-N benzyl chloride Chemical compound ClCC1=CC=CC=C1 KCXMKQUNVWSEMD-UHFFFAOYSA-N 0.000 description 1
- 125000000649 benzylidene group Chemical group [H]C(=[*])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 239000004305 biphenyl Substances 0.000 description 1
- 125000000319 biphenyl-4-yl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 description 1
- NEPKLUNSRVEBIX-UHFFFAOYSA-N bis(oxiran-2-ylmethyl) benzene-1,4-dicarboxylate Chemical compound C=1C=C(C(=O)OCC2OC2)C=CC=1C(=O)OCC1CO1 NEPKLUNSRVEBIX-UHFFFAOYSA-N 0.000 description 1
- 150000001622 bismuth compounds Chemical class 0.000 description 1
- ZFVMWEVVKGLCIJ-UHFFFAOYSA-N bisphenol AF Chemical compound C1=CC(O)=CC=C1C(C(F)(F)F)(C(F)(F)F)C1=CC=C(O)C=C1 ZFVMWEVVKGLCIJ-UHFFFAOYSA-N 0.000 description 1
- 239000004161 brilliant blue FCF Substances 0.000 description 1
- 235000012745 brilliant blue FCF Nutrition 0.000 description 1
- RDHPKYGYEGBMSE-UHFFFAOYSA-N bromoethane Chemical compound CCBr RDHPKYGYEGBMSE-UHFFFAOYSA-N 0.000 description 1
- 239000004109 brown FK Substances 0.000 description 1
- 239000001678 brown HT Substances 0.000 description 1
- 235000012670 brown HT Nutrition 0.000 description 1
- 230000001680 brushing effect Effects 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 235000013877 carbamide Nutrition 0.000 description 1
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 1
- 150000001244 carboxylic acid anhydrides Chemical class 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 239000001679 citrus red 2 Substances 0.000 description 1
- 235000013986 citrus red 2 Nutrition 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 238000006482 condensation reaction Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 229930003836 cresol Natural products 0.000 description 1
- 238000001723 curing Methods 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- 125000002993 cycloalkylene group Chemical group 0.000 description 1
- NZNMSOFKMUBTKW-UHFFFAOYSA-N cyclohexanecarboxylic acid Chemical compound OC(=O)C1CCCCC1 NZNMSOFKMUBTKW-UHFFFAOYSA-N 0.000 description 1
- KBLWLMPSVYBVDK-UHFFFAOYSA-N cyclohexyl prop-2-enoate Chemical compound C=CC(=O)OC1CCCCC1 KBLWLMPSVYBVDK-UHFFFAOYSA-N 0.000 description 1
- NWWQJUISNMIVLJ-UHFFFAOYSA-N cyclotetrasulfur Chemical compound S1SSS1 NWWQJUISNMIVLJ-UHFFFAOYSA-N 0.000 description 1
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 1
- FWLDHHJLVGRRHD-UHFFFAOYSA-N decyl prop-2-enoate Chemical compound CCCCCCCCCCOC(=O)C=C FWLDHHJLVGRRHD-UHFFFAOYSA-N 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 125000001142 dicarboxylic acid group Chemical group 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 description 1
- 229940075557 diethylene glycol monoethyl ether Drugs 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- GYZLOYUZLJXAJU-UHFFFAOYSA-N diglycidyl ether Chemical group C1OC1COCC1CO1 GYZLOYUZLJXAJU-UHFFFAOYSA-N 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N dodecane Chemical group CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- GKIPXFAANLTWBM-UHFFFAOYSA-N epibromohydrin Chemical compound BrCC1CO1 GKIPXFAANLTWBM-UHFFFAOYSA-N 0.000 description 1
- XSQNOFMFKVYSNL-UHFFFAOYSA-N ethene;toluene Chemical group C=C.CC1=CC=CC=C1 XSQNOFMFKVYSNL-UHFFFAOYSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 235000019240 fast green FCF Nutrition 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- VOZRXNHHFUQHIL-UHFFFAOYSA-N glycidyl methacrylate Chemical compound CC(=C)C(=O)OCC1CO1 VOZRXNHHFUQHIL-UHFFFAOYSA-N 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- OTTZHAVKAVGASB-UHFFFAOYSA-N hept-2-ene Chemical compound CCCCC=CC OTTZHAVKAVGASB-UHFFFAOYSA-N 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- PGFXOWRDDHCDTE-UHFFFAOYSA-N hexafluoropropylene oxide Chemical compound FC(F)(F)C1(F)OC1(F)F PGFXOWRDDHCDTE-UHFFFAOYSA-N 0.000 description 1
- XXMIOPMDWAUFGU-UHFFFAOYSA-N hexane-1,6-diol Chemical compound OCCCCCCO XXMIOPMDWAUFGU-UHFFFAOYSA-N 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 101150027973 hira gene Proteins 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 150000003949 imides Chemical class 0.000 description 1
- 229960002182 imipenem Drugs 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000005470 impregnation Methods 0.000 description 1
- 239000004179 indigotine Substances 0.000 description 1
- 235000012738 indigotine Nutrition 0.000 description 1
- AMGQUBHHOARCQH-UHFFFAOYSA-N indium;oxotin Chemical compound [In].[Sn]=O AMGQUBHHOARCQH-UHFFFAOYSA-N 0.000 description 1
- JYGFTBXVXVMTGB-UHFFFAOYSA-N indolin-2-one Chemical compound C1=CC=C2NC(=O)CC2=C1 JYGFTBXVXVMTGB-UHFFFAOYSA-N 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910052741 iridium Inorganic materials 0.000 description 1
- GKOZUEZYRPOHIO-UHFFFAOYSA-N iridium atom Chemical compound [Ir] GKOZUEZYRPOHIO-UHFFFAOYSA-N 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 239000012948 isocyanate Substances 0.000 description 1
- 150000002513 isocyanates Chemical class 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 229940018564 m-phenylenediamine Drugs 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 125000005395 methacrylic acid group Chemical group 0.000 description 1
- 125000005394 methallyl group Chemical group 0.000 description 1
- MATGUKMMZXEOOY-UHFFFAOYSA-N methanesulfonic acid propane-1,2-diol Chemical compound C(C(C)O)O.S(C)(=O)(=O)O MATGUKMMZXEOOY-UHFFFAOYSA-N 0.000 description 1
- LVHBHZANLOWSRM-UHFFFAOYSA-N methylenebutanedioic acid Natural products OC(=O)CC(=C)C(O)=O LVHBHZANLOWSRM-UHFFFAOYSA-N 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 1
- ZIUHHBKFKCYYJD-UHFFFAOYSA-N n,n'-methylenebisacrylamide Chemical compound C=CC(=O)NCNC(=O)C=C ZIUHHBKFKCYYJD-UHFFFAOYSA-N 0.000 description 1
- FXJADUPVIYKCMH-UHFFFAOYSA-N n,n-bis(sulfanyl)aniline Chemical compound SN(S)C1=CC=CC=C1 FXJADUPVIYKCMH-UHFFFAOYSA-N 0.000 description 1
- AJFDBNQQDYLMJN-UHFFFAOYSA-N n,n-diethylacetamide Chemical compound CCN(CC)C(C)=O AJFDBNQQDYLMJN-UHFFFAOYSA-N 0.000 description 1
- OVHHHVAVHBHXAK-UHFFFAOYSA-N n,n-diethylprop-2-enamide Chemical compound CCN(CC)C(=O)C=C OVHHHVAVHBHXAK-UHFFFAOYSA-N 0.000 description 1
- YWWNNLPSZSEZNZ-UHFFFAOYSA-N n,n-dimethyldecan-1-amine Chemical compound CCCCCCCCCCN(C)C YWWNNLPSZSEZNZ-UHFFFAOYSA-N 0.000 description 1
- YLQHOUDDHYMERA-UHFFFAOYSA-N n-(2-ethoxyethyl)prop-2-enamide Chemical compound CCOCCNC(=O)C=C YLQHOUDDHYMERA-UHFFFAOYSA-N 0.000 description 1
- DPDRYRZTJZXUBH-UHFFFAOYSA-N n-(decoxymethyl)-2-methylprop-2-enamide Chemical compound CCCCCCCCCCOCNC(=O)C(C)=C DPDRYRZTJZXUBH-UHFFFAOYSA-N 0.000 description 1
- AYGYHGXUJBFUJU-UHFFFAOYSA-N n-[2-(prop-2-enoylamino)ethyl]prop-2-enamide Chemical compound C=CC(=O)NCCNC(=O)C=C AYGYHGXUJBFUJU-UHFFFAOYSA-N 0.000 description 1
- LCXIFAOALNZGDO-UHFFFAOYSA-N n-cyclopropylprop-2-enamide Chemical compound C=CC(=O)NC1CC1 LCXIFAOALNZGDO-UHFFFAOYSA-N 0.000 description 1
- SWPMNMYLORDLJE-UHFFFAOYSA-N n-ethylprop-2-enamide Chemical compound CCNC(=O)C=C SWPMNMYLORDLJE-UHFFFAOYSA-N 0.000 description 1
- COYVWKMZTCAFHO-UHFFFAOYSA-N n-methyl-n-propan-2-ylprop-2-enamide Chemical compound CC(C)N(C)C(=O)C=C COYVWKMZTCAFHO-UHFFFAOYSA-N 0.000 description 1
- RGNKVBUBMHKKJP-UHFFFAOYSA-N n-methyl-n-propylprop-2-enamide Chemical compound CCCN(C)C(=O)C=C RGNKVBUBMHKKJP-UHFFFAOYSA-N 0.000 description 1
- QJQAMHYHNCADNR-UHFFFAOYSA-N n-methylpropanamide Chemical compound CCC(=O)NC QJQAMHYHNCADNR-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- QNILTEGFHQSKFF-UHFFFAOYSA-N n-propan-2-ylprop-2-enamide Chemical compound CC(C)NC(=O)C=C QNILTEGFHQSKFF-UHFFFAOYSA-N 0.000 description 1
- WDFKEEALECCKTJ-UHFFFAOYSA-N n-propylprop-2-enamide Chemical compound CCCNC(=O)C=C WDFKEEALECCKTJ-UHFFFAOYSA-N 0.000 description 1
- BHYJMUFNVQBDRC-UHFFFAOYSA-N n-sulfanylprop-2-enamide Chemical compound SNC(=O)C=C BHYJMUFNVQBDRC-UHFFFAOYSA-N 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- BEJBETAAAVFGOR-UHFFFAOYSA-N nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1.[O-][N+](=O)C1=CC=CC=C1 BEJBETAAAVFGOR-UHFFFAOYSA-N 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- JFNLZVQOOSMTJK-UHFFFAOYSA-N norbornene Chemical compound C1C2CCC1C=C2 JFNLZVQOOSMTJK-UHFFFAOYSA-N 0.000 description 1
- IOQPZZOEVPZRBK-UHFFFAOYSA-N octan-1-amine Chemical compound CCCCCCCCN IOQPZZOEVPZRBK-UHFFFAOYSA-N 0.000 description 1
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 1
- ZDHCZVWCTKTBRY-UHFFFAOYSA-N omega-Hydroxydodecanoic acid Natural products OCCCCCCCCCCCC(O)=O ZDHCZVWCTKTBRY-UHFFFAOYSA-N 0.000 description 1
- 230000005693 optoelectronics Effects 0.000 description 1
- 150000002918 oxazolines Chemical class 0.000 description 1
- 125000002971 oxazolyl group Chemical group 0.000 description 1
- RPQRDASANLAFCM-UHFFFAOYSA-N oxiran-2-ylmethyl prop-2-enoate Chemical compound C=CC(=O)OCC1CO1 RPQRDASANLAFCM-UHFFFAOYSA-N 0.000 description 1
- 125000000466 oxiranyl group Chemical group 0.000 description 1
- 125000005702 oxyalkylene group Chemical group 0.000 description 1
- 229960005489 paracetamol Drugs 0.000 description 1
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 1
- PNJWIWWMYCMZRO-UHFFFAOYSA-N pent‐4‐en‐2‐one Natural products CC(=O)CC=C PNJWIWWMYCMZRO-UHFFFAOYSA-N 0.000 description 1
- QQBPIHBUCMDKFG-UHFFFAOYSA-N phenazopyridine hydrochloride Chemical group Cl.NC1=NC(N)=CC=C1N=NC1=CC=CC=C1 QQBPIHBUCMDKFG-UHFFFAOYSA-N 0.000 description 1
- DGTNSSLYPYDJGL-UHFFFAOYSA-N phenyl isocyanate Chemical compound O=C=NC1=CC=CC=C1 DGTNSSLYPYDJGL-UHFFFAOYSA-N 0.000 description 1
- UZILCZKGXMQEQR-UHFFFAOYSA-N phenyl-n-decane Natural products CCCCCCCCCCC1=CC=CC=C1 UZILCZKGXMQEQR-UHFFFAOYSA-N 0.000 description 1
- 229940049953 phenylacetate Drugs 0.000 description 1
- WLJVXDMOQOGPHL-UHFFFAOYSA-N phenylacetic acid Chemical compound OC(=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-UHFFFAOYSA-N 0.000 description 1
- 238000000016 photochemical curing Methods 0.000 description 1
- XNGIFLGASWRNHJ-UHFFFAOYSA-L phthalate(2-) Chemical compound [O-]C(=O)C1=CC=CC=C1C([O-])=O XNGIFLGASWRNHJ-UHFFFAOYSA-L 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000003495 polar organic solvent Substances 0.000 description 1
- 229920002454 poly(glycidyl methacrylate) polymer Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920002857 polybutadiene Polymers 0.000 description 1
- 238000006068 polycondensation reaction Methods 0.000 description 1
- 229920002557 polyglycidol polymer Polymers 0.000 description 1
- 229920001721 polyimide Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920001021 polysulfide Polymers 0.000 description 1
- 239000005077 polysulfide Substances 0.000 description 1
- 150000008117 polysulfides Polymers 0.000 description 1
- 239000004175 ponceau 4R Substances 0.000 description 1
- 235000012731 ponceau 4R Nutrition 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- ZTILHLWDFSMCLZ-UHFFFAOYSA-N prop-2-enylhydrazine Chemical compound NNCC=C ZTILHLWDFSMCLZ-UHFFFAOYSA-N 0.000 description 1
- 150000003151 propanoic acid esters Chemical class 0.000 description 1
- AOHJOMMDDJHIJH-UHFFFAOYSA-N propylenediamine Chemical compound CC(N)CN AOHJOMMDDJHIJH-UHFFFAOYSA-N 0.000 description 1
- OSFBJERFMQCEQY-UHFFFAOYSA-N propylidene Chemical group [CH]CC OSFBJERFMQCEQY-UHFFFAOYSA-N 0.000 description 1
- KIDHWZJUCRJVML-UHFFFAOYSA-N putrescine Chemical compound NCCCCN KIDHWZJUCRJVML-UHFFFAOYSA-N 0.000 description 1
- 150000003248 quinolines Chemical class 0.000 description 1
- 239000004180 red 2G Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 238000007142 ring opening reaction Methods 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000002893 slag Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000013020 steam cleaning Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 125000005650 substituted phenylene group Chemical group 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 150000003457 sulfones Chemical class 0.000 description 1
- 150000003462 sulfoxides Chemical class 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000004149 tartrazine Substances 0.000 description 1
- 235000012756 tartrazine Nutrition 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000004014 thioethyl group Chemical group [H]SC([H])([H])C([H])([H])* 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- IMFACGCPASFAPR-UHFFFAOYSA-N tributylamine Chemical compound CCCCN(CCCC)CCCC IMFACGCPASFAPR-UHFFFAOYSA-N 0.000 description 1
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 description 1
- 229960001082 trimethoprim Drugs 0.000 description 1
- YFTHZRPMJXBUME-UHFFFAOYSA-N tripropylamine Chemical compound CCCN(CCC)CCC YFTHZRPMJXBUME-UHFFFAOYSA-N 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 238000004506 ultrasonic cleaning Methods 0.000 description 1
- 239000004108 vegetable carbon Substances 0.000 description 1
- 235000012712 vegetable carbon Nutrition 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
- 125000006839 xylylene group Chemical group 0.000 description 1
- PAPBSGBWRJIAAV-UHFFFAOYSA-N ε-Caprolactone Chemical compound O=C1CCCCCO1 PAPBSGBWRJIAAV-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K19/00—Liquid crystal materials
- C09K19/52—Liquid crystal materials characterised by components which are not liquid crystals, e.g. additives with special physical aspect: solvents, solid particles
- C09K19/54—Additives having no specific mesophase characterised by their chemical composition
- C09K19/56—Aligning agents
-
- G—PHYSICS
- G02—OPTICS
- G02F—OPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
- G02F1/00—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
- G02F1/01—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour
- G02F1/13—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour based on liquid crystals, e.g. single liquid crystal display cells
- G02F1/133—Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
- G02F1/1333—Constructional arrangements; Manufacturing methods
- G02F1/1337—Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers
Landscapes
- Physics & Mathematics (AREA)
- Chemical & Material Sciences (AREA)
- Crystallography & Structural Chemistry (AREA)
- Nonlinear Science (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Organic Chemistry (AREA)
- Materials Engineering (AREA)
- Mathematical Physics (AREA)
- Engineering & Computer Science (AREA)
- General Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Liquid Crystal (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Abstract
Description
200927790 六、發明說明: 【發明所屬之技術領域】 本發明有關於一種液晶配向劑、由該液晶配向劑所獲 得的液晶配向膜以及具有該液晶配向膜的液晶顯示元件, 所述液晶配向劑含有使主鍵上具有狐唤(piperazine)的二 胺(diamine)與四羧酸二酐(tetracarboxylic dianhydride)BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a liquid crystal alignment agent, a liquid crystal alignment film obtained from the liquid crystal alignment agent, and a liquid crystal display element having the liquid crystal alignment film, wherein the liquid crystal alignment agent contains A diamine with a piperazine on the primary bond and a tetracarboxylic dianhydride
❹ 反應而獲得的聚酿胺酸(polyamicacid)或者其衍生物。 【先前技術】 液晶顯示元件被用於以筆記型電腦(note pers〇nal computer)或桌上型電腦(desktop pers〇nal c〇mputer)的 監視器(monitor)爲代表的攝像機(vide〇 camera)的取 景器(viewfinder)、投影式顯示器等的各種液晶顯示裝置, 近來也被用於電視。另外,液晶顯示元件也被用於光學打 印頭(optical printer head)、光學傅利葉變換元件(〇ptical Fourier transform device)、光閥(lightvalve)等光電子相 關元件。 液晶顯示元件中已知了各種元件,而液晶顯示元件的 技術發展不僅是通·懷晶赫讀的骑方式或者液晶 顯示元件的結構騎改良來實_,而且是_對液晶顯 示元件所㈣的構成構件進行改良來實_。通常,液晶 顯不凡件具有用來將H巾職晶減物配向在特定方 。液晶配向膜是與液晶顯示元件的顯示 要的要素,液晶配向膜的作用隨著液晶 顯示元件的品質提“逐㈣得重要。用隨輕日日 4 200927790 液晶配向膜是由液晶配向劑所製備的。目义 用的液晶配向劑是將聚醯胺酸或者 =,主要使 (polyimide)溶解在有機溶劑中的溶液广將醯亞胺 =板之後’利用加熱等方法進行成膜, 爲了提尚液晶顯示元件的顯示品皙, 要的重要特性可以列舉離子密度。如果離二膜:: ❹ ❹ «在幢(frame)期間中施加給液晶的電壓會 壳度下降而妨礙正常的灰度顯示。而且 π果 人們嘗試著解决所述關題,例如 酸組成物,其用來形成液晶配向膜,且組合含有物 的兩種或者兩種以上的聚醯胺酸(例如冋Poly Polyamic acid obtained by the reaction or a derivative thereof. [Prior Art] The liquid crystal display element is used as a camera (vide〇camera) represented by a monitor (note pers〇nal computer) or a desktop (desktop pers〇nal c〇mputer) monitor (monitor) Various liquid crystal display devices such as viewfinders and projection displays have recently been used for televisions. Further, the liquid crystal display element is also used for an optoelectronic electronically related element such as an optical printer head, an optical Fourier transform device, or a light valve. Various components are known in the liquid crystal display element, and the technical development of the liquid crystal display element is not only the riding mode of the through-chip reading or the structure riding of the liquid crystal display element, but also the liquid crystal display element (four) The components are improved and implemented. In general, liquid crystal display elements are used to align the H-pads in a particular area. The liquid crystal alignment film is an essential element for display of a liquid crystal display element, and the function of the liquid crystal alignment film is important in accordance with the quality of the liquid crystal display element. The liquid crystal alignment film is prepared by a liquid crystal alignment agent. The liquid crystal alignment agent used in the present invention is a solution in which polylysine or =, mainly polyimide is dissolved in an organic solvent, and the film is formed by heating or the like, in order to improve the film. The display characteristics of the liquid crystal display element, the important characteristics to be mentioned, may be exemplified by the ion density. If the film is separated from the second film: ❹ ❹ «The voltage applied to the liquid crystal during the frame period is lowered to prevent the normal gradation display. Moreover, π fruit people try to solve the problem, such as an acid composition, which is used to form a liquid crystal alignment film, and combines two or more kinds of poly-proline (for example, ruthenium).
平謂345號公報和日本專利特開平 報)。 A 另-方面’用來形成即使在低溫下進行锻燒但 :率的液晶配向劑’已知一種如下的液晶配向 劑.其3有=二胺與讀酸二酐反應而獲得的聚酿胺酸白 所述二胺具有料之_含驗性氮原 (例如參照日本專利特開平9_194725號公報)㈣機基團 另外,已知-種使具有料的芳香族二胺與四竣酸二 酐反應而獲得的聚_ 其麟性(例如倾;嶋^ Polymer Science:Part A:P〇lymer chemistry vol 3〇 5 200927790 ρ1099-1102 (1992))° 的餘地 【發明内容】 這些現有技術中,對於形成要求進一步改良的如今的 液晶配向膜的液晶配向劑而言’在所得液晶配向膜的 性或者用來獲得所需電雜的材料方面尚 究 本發明提供一種表現出所需的離子密度以及實現該離 子密度的長期穩定性的液晶顯示元件、在該液晶顯示元件 中表現出所需的離子密度以及實現該離子密度的長期穩定 ^的液晶配向膜、以及可以形成該液晶配向膜的液晶^向 ❹ 本發明者們發現,將含有以具有呱嗪的芳香族二胺作 爲原料的聚醯胺酸或者其衍生物的組成物用於液晶配向 劑’可以對具有由此所形成的液晶配向膜的液晶顯示元件 賦予良好的離子密度以及長期可靠性’從而完成了本發明。 本發明包括以下構成。 [1]一種液晶配向劑,其含有作爲四羧酸二酐與二胺的 反應產物的聚醯胺酸或者其衍生物,該液晶配向劑的特徵 在於: 所述二胺包含以下述通式(Ν)表示的二胺 ΟIt is said that the 345th bulletin and the Japanese Patent Special Report). A another aspect is a liquid crystal alignment agent which is used to form a liquid crystal alignment agent which is calcined at a low temperature: a liquid crystal alignment agent is known as a polyamine amine obtained by reacting a diamine with a read acid dianhydride. The acid-white diamine has a nitrogen-containing acid (see, for example, Japanese Patent Laid-Open Publication No. Hei 9-194725). (IV) Machine group In addition, it is known that a kind of aromatic diamine and tetradecanoic acid dianhydride are provided. The ligament obtained by the reaction (for example, tilting; 嶋^ Polymer Science: Part A: P〇lymer chemistry vol 3〇5 200927790 ρ1099-1102 (1992)) ° room for the invention [invention] In the prior art, In order to form a liquid crystal alignment agent of a liquid crystal alignment film which is required to be further improved, the present invention provides a desired ion density and realization in terms of the properties of the obtained liquid crystal alignment film or the material for obtaining a desired electrical impurity. a long-term stability liquid crystal display element having an ion density, a liquid crystal alignment film exhibiting a desired ion density in the liquid crystal display element, and a long-term stability of the ion density, and a liquid crystal alignment film can be formed The present inventors have found that a composition containing a polyaminic acid having a polydiamine having a pyridazine as a raw material or a derivative thereof can be used for a liquid crystal alignment agent. The liquid crystal display element of the formed liquid crystal alignment film imparts good ion density and long-term reliability', thereby completing the present invention. The present invention includes the following constitutions. [1] A liquid crystal alignment agent comprising, as a reaction product of a tetracarboxylic dianhydride and a diamine, or a derivative thereof, the liquid crystal alignment agent characterized in that the diamine comprises the following formula ( Diamine
(Ν) 通式(Ν)中,Α1獨立地表示一價有機基團,Α2獨立 地表示一價有機基團,m表示〇〜3的整數,η表示〇〜4 6 200927790 的整數。 [2] 根據[1]所述的液晶配向劑,其特徵在於:a1獨立 地爲?數,1〜10的燒基、石炭數爲卜⑺的烧氧基、乙醯 胺、氟、氯或者溴,A2獨立地爲碳數爲i〜3的烷基。 [3] 根據[1]或者[2]所述的液晶配向劑,其特徵在於: 以通式(N)表示的二胺於兩端的苯基中在對位上具有氨 基。(Ν) In the formula (Ν), Α1 independently represents a monovalent organic group, Α2 independently represents a monovalent organic group, m represents an integer of 〇~3, and η represents an integer of 〇~4 6 200927790. [2] The liquid crystal alignment agent according to [1], wherein a1 is independently a number, a burning base of 1 to 10, a charcoal number of a (7) alkoxy group, acetamide, fluorine, chlorine or Bromine, A2 is independently an alkyl group having a carbon number of i to 3. [3] The liquid crystal alignment agent according to [1] or [2], wherein the diamine represented by the formula (N) has an amino group in the para position in the phenyl group at both ends.
[4] 根據[1]〜[3]中任一項所述的液晶配向劑’其特徵 在於:以通式(N)表示的二胺是選自由以下述結構式(N) —1、結構式(N) — 2、結構式(N) 結構式(N) —7、結構式(N) _9、結構式(N) _1〇、結構式(N) —14、結構式(n) —17、結構式(N) — 18、結構式(N) —21〜結構式(n) —23、結構式(N) — 26以及結構式 (N) —28表示的化合物所組成的族群中的〆種或者一種 以上。[4] The liquid crystal alignment agent according to any one of [1] to [3] wherein the diamine represented by the formula (N) is selected from the group consisting of the following structural formula (N)-1. Formula (N) — 2, Structural Formula (N) Structural Formula (N) — 7, Structural Formula (N) _9, Structural Formula (N) _1 〇, Structural Formula (N) — 14, Structural Formula (n) — 17 , the structural formula (N) - 18, the structural formula (N) - 21 - structural formula (n) - 23, the structural formula (N) - 26 and the structural formula (N) - 28 represent a group of compounds in the group Kind or more.
(Ν)·10 (Ν)-14 7 200927790(Ν)·10 (Ν)-14 7 200927790
(N)-17 h2n(N)-17 h2n
(N)-23 HsCqi^CHa ΗΖΟΟ^ΟΟΗ3 Η2Ν"ν--ν~Ν\_NH2(N)-23 HsCqi^CHa ΗΖΟΟ^ΟΟΗ3 Η2Ν"ν--ν~Ν\_NH2
(N)-22 (N)-26(N)-22 (N)-26
(N)-28 [5]根據[4]所述的液晶配向劑’其特徵在於:以通式 (N)表示的二胺是以所述結構式(N)_1以及結構式(N) —2表示的化合物中的一方或者兩方。 [6]根據[1]〜[5]中任一項所述的液晶配向劑,其特徵 在於:所述二胺進一步包含以下述通式(VIII)以及通式 ❹ (X)〜通式(XIII)表示的具有侧鏈結構的二胺。(N)-28. The liquid crystal alignment agent according to [4], wherein the diamine represented by the formula (N) is the structural formula (N)_1 and the structural formula (N). One or both of the compounds represented by 2. [6] The liquid crystal alignment agent according to any one of [1] to [5] wherein the diamine further comprises the following general formula (VIII) and the general formula (X) to the general formula ( A diamine having a side chain structure represented by XIII).
通式(VIII)中,A3 表示單鍵、-〇_、-COO-、-OCO-、 -CO---C0NH_或者-(CH2)m- (m 表示 1 〜6 的整數),R1 表示具有類固醇(steroid)骨架的基團、以下述通式(IX) 表示的巧團,當苯環上所鍵合的兩個氨基的位置關係爲對 位時,R1進一步包含碳數爲1〜3〇的烷基,當該位置關係 爲間位時’ R1進一步包含碳數爲1〜3〇的烷基或者苯基, 8 200927790 該烷基中’任意的·<:Η2-可以獨立地經-CF2-、-CHF-、_〇-(此處爲非連續)、-CH=CH-或者所取代,-CH3可以 經-CHJ、-CHF2或者_CF3所取代,該苯基的氫可以獨立地 被取代爲_F、-ch3、-〇ch3、-OCH2F、-ochf2 或者-〇cf3。In the formula (VIII), A3 represents a single bond, -〇_, -COO-, -OCO-, -CO---C0NH_ or -(CH2)m- (m represents an integer of 1 to 6), and R1 represents a group having a steroid skeleton and a group represented by the following formula (IX): when the positional relationship of the two amino groups bonded to the benzene ring is para, R1 further contains a carbon number of 1 to 3 The alkyl group of ruthenium, when the positional relationship is meta-R', further includes an alkyl group having a carbon number of 1 to 3 Å or a phenyl group, 8 200927790 'any arbitrary '<: Η2- can be independently -CF2-, -CHF-, _〇-(here is discontinuous), -CH=CH- or substituted, -CH3 may be substituted by -CHJ, -CHF2 or _CF3, the hydrogen of the phenyl group may be independently The ground is replaced by _F, -ch3, -〇ch3, -OCH2F, -ochf2 or -〇cf3.
通式(IX)中,A4以及A5分別獨立地表示單鍵、-〇· (此處爲非連續)、-COO-、-OCO-、-CONH-、 或者碳數爲1〜12的亞烷基,R2以及R3分別獨立地表示_F 或者-CH3,環S獨立地表示1,4-亞苯基、1,4-亞環己基、 1,3-二噁院_2,5_二基(l,3-dioxane-2,5_diyl)、嘧咬-2,5-二基 (pyrimidine-2,5-diyl)、吼啶-2,5-二基(pyridine-2,5-diyl) ' 萘-1,5-二基(naphthalene-l,5-diyl)、萘·2,7-二基或者蒽 -9,10-二基(anthracene-9, l〇-diyl) ’ R4 表示 _h、-F、碳數爲 1〜30的烧基、碳數爲1〜30的氟取代燒基、碳數爲1〜3〇 的烷氧基、-CN、-OCH2:F、-〇CHF2或者_0Cf3,a以及匕 〇 分別表示〇〜4的整數,c、d以及e分別表示〇〜3的整數, f以及g分別獨立地表示0〜2的整數,並且c + d + eg 1。In the formula (IX), A4 and A5 each independently represent a single bond, -〇 (here, discontinuous), -COO-, -OCO-, -CONH-, or an alkylene group having a carbon number of 1 to 12 The bases, R2 and R3 each independently represent _F or -CH3, and the ring S independently represents 1,4-phenylene, 1,4-cyclohexylene, 1,3-dioxin-2,5-diyl (l,3-dioxane-2,5_diyl), pyrimidine-2,5-diyl, pyridine-2,5-diyl Naphthalene-1,5-diyl, naphthalene 2,7-diyl or anthracene-9, l〇-diyl ' R4 represents _h , -F, a carbon group having a carbon number of 1 to 30, a fluorine-substituted alkyl group having 1 to 30 carbon atoms, an alkoxy group having 1 to 3 carbon atoms, -CN, -OCH2:F, -〇CHF2 or _0Cf3, a and 匕〇 respectively represent integers of 〇~4, c, d, and e represent integers of 〇~3, respectively, and f and g each independently represent an integer of 0~2, and c + d + eg 1.
b1 9 200927790B1 9 200927790
6通式(X)以及(XI)中,R5獨立地表示_H或者_CH3, R6。表示-Η或者碳數爲的烷基或烯基,a6獨立地表 示單鍵、-C(=0)-或者-CH2-,通式(XI)中,R7以及r8 分別獨立地表示碳數爲的烷基或者苯基。 R9 plO p11 山通式(XII)以及(XIII)中,a7獨立地表示_〇_或者 碳數爲1〜6的亞烷基,通式(χπ)中,R9表示或者碳 數爲1〜30的烷基,該烷基中,碳數爲2〜3〇的烷基的任 意的-CH2_可以經-〇-(此處爲非連續)、_ch=CH-或者_〇C-所取代,A8表示單鍵或者碳數爲1〜3的亞烷基,環τ表 示1,4-亞苯基或者1,4-亞環己基,h表示〇或者1,通式 (XIII)中,R1G表示碳數爲6〜22的烷基,RU表示碳數 爲1〜22的院基。 [7]根據[6]所述的液晶配向劑,其特徵在於:所述具有 侧鏈結構的二胺是選自以下述通式(VIII —2)、通式(νιπ 200927790 —4)〜通式(VIII —6)、通式(XII —2)、通式(XII-4) 以及通式(XII —6)表示的化合物中的至少一種。In the general formulae (X) and (XI), R5 independently represents _H or _CH3, R6. An alkyl group or an alkenyl group which represents -Η or a carbon number, a6 independently represents a single bond, -C(=0)- or -CH2-, and in the formula (XI), R7 and r8 each independently represent a carbon number of Alkyl or phenyl. R9 plO p11 In the general formula (XII) and (XIII), a7 independently represents _〇_ or an alkylene group having a carbon number of 1 to 6, and in the formula (χπ), R9 represents or the carbon number is 1 to 30. An alkyl group in which any -CH2_ of an alkyl group having a carbon number of 2 to 3 Å may be substituted by -〇- (here, discontinuous), _ch=CH- or _〇C-, A8 represents a single bond or an alkylene group having a carbon number of 1 to 3, a ring τ represents a 1,4-phenylene group or a 1,4-cyclohexylene group, h represents fluorene or 1, and in the formula (XIII), R1G represents The alkyl group has a carbon number of 6 to 22, and RU represents a hospital base having a carbon number of 1 to 22. [7] The liquid crystal alignment agent according to [6], wherein the diamine having a side chain structure is selected from the group consisting of the following general formula (VIII-2) and the general formula (νιπ 200927790-4) At least one of the compounds represented by the formula (VIII-6), the formula (XII-2), the formula (XII-4) and the formula (XII-6).
(VIII-5)(VIII-5)
所述通式中,R23、R29以及R3G分別表示碳數爲1〜30 的烷基或者碳數爲1〜30的烷氧基。 [8]根據[1]〜[7]中任一項所述的液晶配向劑,其特徵 在於:所述二胺進一步包含以下述通式(I)〜通式(VII) 11 200927790 以及通式(xv)表不的不具有側鍵結構的二胺。 H2N—X-NH2 (I) η η2ν^—^νη2In the above formula, R23, R29 and R3G each represent an alkyl group having 1 to 30 carbon atoms or an alkoxy group having 1 to 30 carbon atoms. [8] The liquid crystal alignment agent according to any one of [1] to [7] wherein the diamine further comprises the following general formula (I) to general formula (VII) 11 200927790 and a general formula (xv) a diamine which does not have a side bond structure. H2N—X-NH2 (I) η η2ν^—^νη2
❷ 通式(I)中’ X表示-(CH2)m_ (m表示1〜6的整數), 通式(III)以及通式(V)〜通式(VII)中,Y獨立地表’ In the general formula (I), 'X represents -(CH2)m_ (m represents an integer of 1 to 6), and in the general formula (III) and the general formula (V) to the general formula (VII), Y independently represents
示單鍵、-〇_、_s_、-S-S-、-S02-、-CO-、-CONH-、-NHCO-、 -NH- . -N(CH3)-(CH2)m-N(CH3)- > -C(CH3)2- > -C(CF3)2- ' **(CH2)m-、-O(CH2)m-0_、-S-(CH2)m-S- (m 表示 1 〜6 的整 數)’通式(V)中,z表示單鍵或者不存在,通式(χν) 中,R33以及R34分別獨立地表示碳數爲i〜3的烷基或者 ,基,A3獨立地表示亞曱基、亞苯基或者經烷基取代的亞 笨基。1表示1〜6的整數’m表示1〜10的整數,通式(π) 〜(VII)中,環己烷環或者苯環上所鍵合的氫可以獨立地 被取代爲-F、-CH3、-CF3、-OH、-COOH、-S03H、_Ρ〇3η2, 12 200927790 通式(ιν)中的苯環上所鍵合的氳可以經苄基所取代。 [9]根據[8]所述的液晶配向劑,其特徵在於:所述不具 有侧鏈結構的二胺是選自以下述結構式(IV—1)、結構式 (IV — 2)、結構式(IV—15)〜結構式(IV—17)、結構 式(V—1)〜結構式(V—12)、結構式(V— 33)、結構 式(V —35)〜結構式(V —37)、結構式(VII —2)以及 結構式(XV—1)表示的化合物中的至少一種。Show single key, -〇_, _s_, -SS-, -S02-, -CO-, -CONH-, -NHCO-, -NH- . -N(CH3)-(CH2)mN(CH3)- > -C(CH3)2- > -C(CF3)2- ' **(CH2)m-, -O(CH2)m-0_, -S-(CH2)mS- (m represents an integer from 1 to 6 In the general formula (V), z represents a single bond or does not exist. In the formula (χν), R33 and R34 each independently represent an alkyl group having a carbon number of i 〜3 or a group, and A3 independently represents an anthracene. A phenylene group or a substituted group substituted with an alkyl group. 1 represents an integer of 1 to 6 'm represents an integer of 1 to 10, and in the formula (π) to (VII), a hydrogen bonded to a cyclohexane ring or a benzene ring may be independently substituted with -F, - CH3, -CF3, -OH, -COOH, -S03H, _Ρ〇3η2, 12 200927790 The ruthenium bonded to the benzene ring in the formula (ιν) can be substituted with a benzyl group. [9] The liquid crystal alignment agent according to [8], wherein the diamine having no side chain structure is selected from the group consisting of the following structural formula (IV-1), structural formula (IV-2), and structure Formula (IV-15)~Structure Formula (IV-17), Structural Formula (V-1)~Structure Formula (V-12), Structural Formula (V-33), Structural Formula (V-35)~Structure Formula ( At least one of a compound represented by V-37), structural formula (VII-2), and structural formula (XV-1).
(V-1) (V-2) (V-3)(V-1) (V-2) (V-3)
(V-10)(V-10)
(V-11)(V-11)
(V-12)(V-12)
(V-33) 13 200927790 H2N^Q^nhQ^nh2 (V-35)(V-33) 13 200927790 H2N^Q^nhQ^nh2 (V-35)
(V-37) ch3 ch3 H2N-C3H6_?i~〇-Si-C3H6-NH2 CH3 ch3(V-37) ch3 ch3 H2N-C3H6_?i~〇-Si-C3H6-NH2 CH3 ch3
(VIW) (XV-1)(VIW) (XV-1)
[10] 根據[1]〜[9]中任一項所述的液晶配向劑,其特徵 在於:所述四幾酸二酐包含芳香族四羧酸二酐。 [11] 根據[10]所述的液晶配向劑,其特徵在於:所述芳 香族四羧酸二酐是以下述結構式(丨)、結構式(2)、結構 式(5)〜結構式(7)以及結構式(14)表示的化舍物中[10] The liquid crystal alignment agent according to any one of [1] to [9] wherein the tetraacid dianhydride comprises an aromatic tetracarboxylic dianhydride. [11] The liquid crystal alignment agent according to [10], wherein the aromatic tetracarboxylic dianhydride is a structural formula (丨), a structural formula (2), and a structural formula (5) to a structural formula. (7) and the chemical house represented by the structural formula (14)
香族四羧酸二酐是以所述結構式(1)表示的化合物。主 [13] 根據[1]〜[12]中任一項所述的液晶配向劑,其特 徵在於:所述四羧酸二針包含脂環式四叛酸二酐以及脂肪 族四緩酸J巾的—方或者兩方。 [12] 根據[11]所述的液晶配向劑’其特徵在於:所述方 200927790 [14]根據[13]所述的液晶配向劑,其特徵在於:所述脂 環式四羧酸二酐以及脂肪族四羧酸二酐是以下述結構式 (19)、結構式(23)、結構式(25)、結構式(35)〜結構 式(39)、結構式(44)以及結構式(49)表示的化合物中 的至少一種。The aromatic tetracarboxylic dianhydride is a compound represented by the above structural formula (1). The liquid crystal alignment agent according to any one of [1] to [12] wherein the tetracarboxylic acid two needles comprise an alicyclic tetrahydro acid dianhydride and an aliphatic tetrasulphur acid J The towel - square or both. [12] The liquid crystal alignment agent according to [11], wherein the liquid crystal alignment agent according to [13], characterized in that the alicyclic tetracarboxylic dianhydride And the aliphatic tetracarboxylic dianhydride is represented by the following structural formula (19), structural formula (23), structural formula (25), structural formula (35) to structural formula (39), structural formula (44), and structural formula ( 49) at least one of the compounds indicated.
[15]根據[14]所述的液晶配向劑,其特徵在於:所述脂 環式四羧酸二酐以及脂肪族四羧酸二酐是以所述結構式 (19)、結構式(23)、結構式(37)以及結構式(49)表 示的化合物中的至少一種。 D6]根據[6]〜[15]中任一項所述的液晶配向劑,其特 徵在於:該液晶配向劑含有所述聚醯胺酸或者其衍生物A 以及B,並且所述聚醯胺酸或者其衍生物A包含所述二胺 中的所述具有侧鏈結構的二胺,且所述聚酿胺酸或者其衍 生物A以及B的二胺中的一方或者兩方包含以通式(N) 15 200927790 表示的二胺。 [17] 根據[1]〜[16]中任一項所述的液晶配向劑,其特 徵在於:該液晶配向劑進一步含有選自烯基取代納迪克 (nadic)酿亞胺化合物、具有自由基聚合性不飽和雙鍵的化 合物、噁嗪(oxazine)化合物、噁唑啉(oxaz〇iine)化合 物以及環氧化合物中的一種或者一種以上。 [18] 根據[17]所述的液晶配向劑,其特徵在於:所述烯 基取代納迪克醯亞胺化合物是選自由雙{4-(烯丙基雙環 ® [2.2.1]庚-5-烯-2,3-二甲醯亞胺)苯基}曱烷 ( bis{4-(allylbicyclo[2.2.1] ept-5_ene-2,3-dicarboxyimide)phenyl}methane)、N,N’-間亞 苯基-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二曱醯亞胺)以及 N,M_六亞甲基-雙(烯丙基雙環[2.2.1]庚-5·烯-2,3-二甲醯亞 胺)所組成的族群中的一種或者一種以上。 [19] 根據[18]所述的液晶配向劑,其特徵在於:所述烯 基取代納迪克醯亞胺化合物爲雙{4-(烯丙基雙環[2.2.1]庚 Q -5-烯-2,3-二甲醯亞胺)苯基}甲烷。 [20] 根據[17]所述的液晶配向劑,其特徵在於:所述具 有自由基聚合性不飽和雙鍵的化合物是選自由N,N’-亞曱 基雙丙烯醯胺(N,N'-methylenebisacrylamide)、N,N’-二經 基亞乙基雙丙婦醯胺(Ν,Ν·-dihydroxy ethylene bisacrylamide )、雙丙烯酸乙二酯(ethylene bisacrylate )以 及4,4’-亞甲基雙(N,N-二羥基亞乙基丙烯酸酯苯胺) (4,4’_methylene bis(N,N-dihydroxy ethylene acrylate 16 200927790 aniline))所組成的族群中的一種或者—種以上。 [21]根據[20]所述的液晶配向劑,其特徵在於:所述具 有自由基聚合性不飽和雙鍵的化合物爲-二 基雙丙烯Si胺。 沒㈣乙 [22]根據[17]所述的液晶配向劑,其特徵在於 嗪化合物是選自由以下述式(b—丨)、 Ο 式(d-6)、式(e-3)、式(e —4)以及式 (卜4)表示的化合物所組成的族群中的—種或者 _ 義[15] The liquid crystal alignment agent according to [14], wherein the alicyclic tetracarboxylic dianhydride and the aliphatic tetracarboxylic dianhydride are the structural formula (19), structural formula (23) At least one of the compounds represented by the structural formula (37) and the structural formula (49). The liquid crystal alignment agent according to any one of [6] to [15] wherein the liquid crystal alignment agent contains the polyamic acid or derivatives A and B thereof, and the polyamine The acid or derivative A thereof comprises the diamine having a side chain structure in the diamine, and one or both of the poly-brenamic acid or a derivative thereof and a diamine of B contain a general formula (N) 15 Diamine represented by 200927790. The liquid crystal alignment agent according to any one of [1] to [16] wherein the liquid crystal alignment agent further contains an alkenyl-substituted nadic-based imine compound having a radical One or more of a compound having a polymerizable unsaturated double bond, an oxazine compound, an oxazoxaine compound, and an epoxy compound. [18] The liquid crystal alignment agent according to [17], wherein the alkenyl-substituted nadicilimine compound is selected from the group consisting of bis{4-(allylbicyclo® [2.2.1] g-5 -ene-2,3-dimethylimine imine) phenyl} decane (bis{4-(allylbicyclo[2.2.1] ept-5_ene-2,3-dicarboxyimide)phenyl}methane), N,N'- m-Phenylene-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-diimineimine) and N,M_hexamethylene-bis(allylbicyclo[2.2 .1] one or more of the group consisting of hept-5-ene-2,3-dimethylimine. [19] The liquid crystal alignment agent according to [18], wherein the alkenyl-substituted nadicilide compound is bis{4-(allylbicyclo[2.2.1]hepta-5-ene -2,3-dimethylimine)phenyl}methane. [20] The liquid crystal alignment agent according to [17], wherein the compound having a radical polymerizable unsaturated double bond is selected from N, N'-fluorenylene bis acrylamide (N, N) '-methylenebisacrylamide), N,N'-dihydroxy ethylene bisacrylamide, ethylene bisacrylate, and 4,4'-methylene One or more of the group consisting of 4,4'-methylene bis (N, N-dihydroxy ethylene acrylate 16 200927790 aniline). [21] The liquid crystal alignment agent according to [20], wherein the compound having a radical polymerizable unsaturated double bond is -diylbispropeneSiamine. [4] The liquid crystal alignment agent according to [17], wherein the azine compound is selected from the group consisting of the following formula (b-丨), Ο (d-6), (e-3), (e-4) and the species represented by the compound represented by the formula (Bu 4) or _ meaning
17 20092779017 200927790
[23] 根據[22]所述的液晶配向劑’其特徵在於:所述喔 嗪化合物爲以所述式(c—1)表示的化合物。 [24] 根據[17]所述的液晶配向劑’其特徵在於:所述°惡 唑啉化合物爲2,2,_雙(2_噁唑啉)以及1,3-雙(4,5-二氮-2一鳴 口坐基)苯(l,3-bis(4,5_dihydro-2-oxazolyl)benzene)中的〆 18 200927790 或者兩方。 [25] 根據[24]所述的液晶配向劑,其特徵在於:所述噁 唑啉化合物爲1,3-雙(4,5-二氫-2-噁唑基)苯。 [26] 根據[17]所述的液晶配向劑,其特徵在於:所述環 氧化合物是選自由Ν,Ν,Ν',Ν’-四縮水甘油基-間苯二甲胺 (N,N,N’,N’-tetraglycidyl_m-xylenediamine)、1,3-雙(Ν,Ν- 二縮水甘油基氨基甲基)環己烷、Ν,Ν,Ν,,Ν,-四縮水甘油基 _4,4’-二氨基二苯基甲烷、2-[4-(2,3-環氧丙氧基)苯 基]-2-[4-[1,1-雙[4-([2,3-環氧丙氧基]苯基)]乙基]苯基]丙烷 ( 2-[4-(2,3-epoxy propoxy)phenyl]-2-[4-[l,l-bis[4-([2,3-epoxy propoxy]phenyl)] ethyl] henyl]ropane)、3,4-環氧環己烯基甲 基-3’,4'-環氧環己稀曱酸醋(3,4_epOXy CyCi〇hexenyi methyl-3',4'-epoxy cyclohexene carboxylate)、N-苯基馬來醯 亞胺-曱基丙稀酸縮水甘油酯共聚物 (N-phenylmaleimide-glycidyl methacrylate copolymer)以 ❹ 及2-(3,4-環氧環己基)乙基三曱氧基矽烷(2_(3,4_ep()xy cyclohexyl)ethyl trimethoxy silane )所組成的族群中的一種 或者一種以上。 [27] 根據P6]所述的液晶配向劑,其特徵在於:所述環 氧化合物爲3,4_環氧環己烯基曱基·3’,4,-環氧環己烯甲酸 酯或者2-(3,4-環氧環己基)乙基三曱氧基矽烷。 [28] —種液晶配向膜’其特徵在於:該液晶配向膜是 對根據[1]〜[27]中任一項所述的液晶配向劑的塗膜進行加 19 200927790 熱而形成的。 、[29]—種液晶顯示元件,其具有一對基板、含有液晶 为子且形成在所述一對基板間的液晶層、對液晶層施加電 壓的電極、以及將所述液晶分子配向在預定方向上的液晶 配向膜,此液晶顯示元件的特徵在於:所述液晶配向膜是 根據P8]所述的液晶配向膜。 [發明效果] 根據本發明,可以提供一種離子密度高、與該離子密 ^ ㈣隨時間變動相對應的長期可靠性良好、可應用於各種 驅動方式中的液晶顯示元件。 為讓本發明之上述特徵和優點能更明顯易懂,下文特 舉實施例,並配合所附圖式作詳細說明如下。 【實施方式】 本發明的液晶配向劑含有作爲四羧酸二酐與二胺的反 f產物的聚醯胺酸或者其衍生物。所述聚醯胺酸的衍生物 疋才曰,在製成含有溶劑的後述液晶配向劑時溶解於溶劑中 〇 的成分、且在將該液晶配向劑製成後述液晶配向臈時可以 形成以聚醯亞胺作爲主成分的液晶配向膜的成分。這樣的 聚醯胺酸的衍生物例如可以列舉可溶性聚醯亞胺、聚醯胺 酸酯以及聚醯胺酸醯胺等,更具體而言可以列舉n聚醯 胺酸的所有氨基與羧基進行脫水閉環反應而成的聚醯亞 胺、2)部分地進行脫水閉環反應而成的部分聚醯亞胺、3) 將聚醯胺酸的羧基轉變爲酯而成的聚醯胺酸酯、4)將四羧 酸二酐化合物所含的酸二酐的一部分替換爲有機二羧酸來 20 200927790 進行反應祕得的㈣胺酸·聚賴共聚物’進—步可以列 舉5)使該聚醯胺酸胺共聚物#部分或者全部進行 脫水閉環反應而成的聚0^醢亞胺θ所述聚胺酸或者其 衍生物可以是一種化舍物,也可以疋兩種或者兩種以上的 化合物。 所述二胺包含以下述通式(Ν)表示的二胺。本發明 中使用的二胺可以是〆種化合物’也可以是兩種或者兩種[23] The liquid crystal alignment agent according to [22], wherein the azine compound is a compound represented by the formula (c-1). [24] The liquid crystal alignment agent according to [17] characterized in that the oxazoline compound is 2,2,_bis(2-oxazoline) and 1,3-bis(4,5- 〆18 200927790 or both of the benzene (1,3-bis(4,5-dihydro-2-oxazolyl)benzene). [25] The liquid crystal alignment agent according to [24], wherein the oxazoline compound is 1,3-bis(4,5-dihydro-2-oxazolyl)benzene. [26] The liquid crystal alignment agent according to [17], wherein the epoxy compound is selected from the group consisting of ruthenium, osmium, iridium, Ν'-tetraglycidyl-m-xylylenediamine (N, N) , N', N'-tetraglycidyl_m-xylenediamine), 1,3-bis(indole, Ν-diglycidylaminomethyl)cyclohexane, hydrazine, hydrazine, hydrazine, hydrazine, -tetraglycidyl _4 , 4'-diaminodiphenylmethane, 2-[4-(2,3-epoxypropoxy)phenyl]-2-[4-[1,1-bis[4-([2,3 -Epoxypropoxy]phenyl]]ethyl]phenyl]propane (2-[4-(2,3-epoxy propoxy)phenyl]-2-[4-[l,l-bis[4-( [2,3-epoxy propoxy]phenyl)] ethyl] henyl]ropane), 3,4-epoxycyclohexenylmethyl-3',4'-epoxycyclohexanoic acid vinegar (3,4_epOXy CyCi 〇hexenyi methyl-3',4'-epoxy cyclohexene carboxylate), N-phenylmaleimide-glycidyl methacrylate copolymer with ❹ and 2-( One or more of the groups consisting of 3,4-epoxycyclohexyl)ethyltrimethoxysilane (2_(3,4_ep()xy cyclohexyl)ethyl trimethoxy silane ). [27] The liquid crystal alignment agent according to P6, wherein the epoxy compound is 3,4-epoxycyclohexenyl indenyl 3',4,-epoxycyclohexenecarboxylate Or 2-(3,4-epoxycyclohexyl)ethyltrimethoxy decane. [28] A liquid crystal alignment film, wherein the liquid crystal alignment film is formed by adding heat to a coating film of the liquid crystal alignment agent according to any one of [1] to [27]. [29] A liquid crystal display device having a pair of substrates, a liquid crystal layer containing a liquid crystal and formed between the pair of substrates, an electrode for applying a voltage to the liquid crystal layer, and aligning the liquid crystal molecules at a predetermined A liquid crystal alignment film in a direction, wherein the liquid crystal alignment film is a liquid crystal alignment film according to P8]. [Effect of the Invention] According to the present invention, it is possible to provide a liquid crystal display element which has a high ion density and is excellent in long-term reliability in accordance with the variation of the ion density with time, and can be applied to various driving methods. The above described features and advantages of the present invention will become more apparent from the description of the appended claims. [Embodiment] The liquid crystal alignment agent of the present invention contains polyamic acid or a derivative thereof as an inverse f product of tetracarboxylic dianhydride and diamine. The derivative of the poly-proline is a component which is dissolved in a solvent when the liquid crystal alignment agent described later contains a solvent, and can be formed into a polymer when the liquid crystal alignment agent is formed into a liquid crystal alignment agent. A component of a liquid crystal alignment film containing quinone imine as a main component. Examples of such a derivative of polylysine include soluble polyimine, polyphthalate, and polyamidamine, and more specifically, all of the amino group of the n-polyglycolic acid and the carboxyl group are dehydrated. Polyimine which is formed by ring closure reaction, 2) partial polyimine which is partially subjected to dehydration ring closure reaction, 3) polyphthalate which converts carboxyl group of polylysine into ester, 4) A part of the acid dianhydride contained in the tetracarboxylic dianhydride compound is replaced by an organic dicarboxylic acid. 20 200927790 The reaction of the (tetra) aminic acid/poly lysine copolymer can be enumerated. 5) The polyamine can be used. The acid amine copolymer # may be partially or completely subjected to a dehydration ring-closing reaction. The polyamine or the derivative thereof may be a compound or two or more compounds. The diamine contains a diamine represented by the following formula (Ν). The diamine used in the present invention may be a quinone compound or two or two
以上的化合物。The above compounds.
通式(Ν)中,Α1獨立地表示一價有機基團,Α2獨立 地表示一價有機基團,m表示〇〜3的整數,η表示〇〜4 的整數。另外,在本發明中,鹵素包括在有機基團中。 所述Α〗以及Α2可以分別使用各種一價有機基團。Αι 優選的是獨立地爲碳數爲1〜10的烷基、碳數爲i〜1〇的In the formula (Ν), Α1 independently represents a monovalent organic group, Α2 independently represents a monovalent organic group, m represents an integer of 〇~3, and η represents an integer of 〇~4. Further, in the present invention, halogen is included in the organic group. The oxime and oxime 2 may each use various monovalent organic groups. Αι is preferably an alkyl group having a carbon number of 1 to 10 independently and having a carbon number of i 〜1 〇.
烧氧基、乙醯胺、氟、氯或者溴。A2優選的是獨立地爲石炭 數爲1〜3的烷基。 ’、' 以通式(N)表示的二胺於兩端的苯基上分別具有氨 基。這些氨基驗置可以㈣於斜,獨立地處於鄰位、 f位二對位:的任-位置。從所述二胺的製造比較容易的 觀點考慮’這些氨基的位置優選的是均爲對位。 ’以通式(N)表示的二胺例如可以列舉 在本發明中 以下化合物。 21 200927790 〇Alkoxy, acetamide, fluorine, chlorine or bromine. A2 is preferably an alkyl group independently having a charcoal number of 1 to 3. The diamine represented by the formula (N) has an amino group at each of the phenyl groups at both ends. These amino assays can be (iv) slanted, independently in the ortho position, the equi-position of the two-position of the f-position. From the viewpoint of easy production of the diamine, the positions of these amino groups are preferably all para-position. The diamine represented by the formula (N) is exemplified by the following compounds in the present invention. 21 200927790 〇
(Ν)-3 (Ν)-4(Ν)-3 (Ν)-4
(Ν)-12 (Ν)-11(Ν)-12 (Ν)-11
(Ν)-13 22 200927790(Ν)-13 22 200927790
ΗζΝ~^Ζ^~Ν\_/Ν—ΝΗζ (Ν)-14 ❹ΗζΝ~^Ζ^~Ν\_/Ν—ΝΗζ (Ν)-14 ❹
Η2Ν Ρ〇Η3 H3COΗ2Ν Ρ〇Η3 H3CO
Βγ η2νΒγ η2ν
O^L//^NH2 (Ν)-22 Βγν/Ί^ΝΗ2 (Ν)-24O^L//^NH2 (Ν)-22 Βγν/Ί^ΝΗ2 (Ν)-24
NHCOCH3 NHCOCH3 H2NHWKNCNHVJ^NH2 (Ν)-21 ClNHCOCH3 NHCOCH3 H2NHWKNCNHVJ^NH2 (Ν)-21 Cl
Cl η2νCl η2ν
NV_yNHi /ΓΗΗζ (N)-23 h2nNV_yNHi /ΓΗΗζ (N)-23 h2n
N NN N
/-nh2 (N)-25 h3c h2n ch3 nh2 (N)-27 (N)-26 H3C〇 〇ch3 h3c〇 〇CH3 η2νη0^νΟν vVnh2 (N)-28 以所述通式(N)表示的二胺優選以所述結構式(N) —1、結構式(N) —2、結構式(N) —5〜結構式(N) 23 200927790 —7、結構式(N) —9、結構式(N) 一1〇、結構式(N) -14、結構式(N) -17、結構式(N) —18、結構式(N) -21〜結構式(N) -23、結構式(N) —26以及結構式 (N) -28表示的化合物’更加優選以所述結構式(N) _ 1以及結構式(N) ~~2表示的化合物。 從使液晶顯示元件中表現出所需的離子密度、而且表 現出該離子密度的長期穩定性的觀點考慮,輯述通式 (N)表示的二胺在構成本發明液晶配向劑中的聚酿胺酸 的二胺中,以莫耳比計優選爲含有2〇%〜1〇〇%,更加 爲含有35%〜1〇〇%。 以所述通式(N)表示的二胺可以用衆所周知的方法 來製造。這樣的製造方法例如可以列舉如下方法:如曰本 專利特開昭52-14780號公報所記載的那樣,在使用錫、路 酸等還原劑的普通的還原條件下,將使可以具有對應的ς 代基的硝基苯(Nitrobenzene)或者其衍生物與呱嗪進行加 熱反應所得的化合物的硝基還原爲氨基。 © 所述二胺可以僅包含以所述通式(N)表示的二胺, 也可以進一步包含其他二胺。其他二胺例如可以列舉具有 侧鏈結構的一胺以及不具有侧鍵結構的二胺。這樣的其他 二胺可以是一種化合物,也可以是兩種或者兩種以上的化 合物。 所述具有侧鏈結構的二胺是指具有如下取代基(侧鏈) 的一胺,該取代基在將連結兩個氨基的取代基作爲主鍵時 自主鏈分支,並且可以表現出所需的預傾角(pretm angl)。 24 200927790 具有侧鏈結制二胺巾_鏈只絲據 適當,擇即可,例如,該側鏈可以列舉碳數爲2 = 上的基團。所述具有侧鏈結構的二胺可以列舉以下述二 ⑽广及通式(X)〜通式(腿)絲的化合^通式/-nh2 (N)-25 h3c h2n ch3 nh2 (N)-27 (N)-26 H3C〇〇ch3 h3c〇〇CH3 η2νη0^νΟν vVnh2 (N)-28 The two expressed by the general formula (N) The amine preferably has the structural formula (N)-1, structural formula (N)-2, structural formula (N)-5~ structural formula (N) 23 200927790-7, structural formula (N)-9, structural formula ( N) -1〇, structural formula (N) -14, structural formula (N) -17, structural formula (N) -18, structural formula (N) -21~ structural formula (N) -23, structural formula (N -26 and the compound represented by the structural formula (N)-28 are more preferably a compound represented by the structural formula (N)-1 and the structural formula (N)~~2. From the viewpoint of exhibiting a desired ion density in a liquid crystal display element and exhibiting long-term stability of the ion density, the diamine represented by the general formula (N) is set to form a polystyrene in the liquid crystal alignment agent of the present invention. The diamine of the amine acid preferably contains 2% by weight to 1% by mole based on the molar ratio, and more preferably 35% to 1% by weight. The diamine represented by the above formula (N) can be produced by a known method. For example, as described in JP-A-52-14780, it is possible to have a corresponding enthalpy under ordinary reducing conditions using a reducing agent such as tin or a citric acid. The nitro group of the compound obtained by subjecting the nitrobenzene (Nitrobenzene) or its derivative to the pyridazine reaction reaction is reduced to an amino group. © The diamine may contain only the diamine represented by the above formula (N), and may further contain other diamines. The other diamine may, for example, be a monoamine having a side chain structure and a diamine having no side bond structure. Such other diamine may be one compound or two or more compounds. The diamine having a side chain structure means an amine having a substituent (side chain) which branches autonomously when a substituent linking two amino groups is used as a primary bond, and can exhibit a desired pre Inclination (pretm angl). 24 200927790 A side chain-bound diamine towel _ chain yarn may be selected as appropriate. For example, the side chain may be a group having a carbon number of 2 = . The diamine having a side chain structure may be exemplified by the following two (10) broad and general formula (X) to general formula (leg) filaments.
H2N (VIII) 通式(vm)中,A3表示單鍵、_〇_、_c〇〇_、_〇c〇 ❹-CO·、-CONH_或者_(CH2)m_ (m表示卜6的整數i 表不具有類固醇骨架的基團、以下述通式(IX)表示的武 且’當笨環上所鍵合的兩個氨基的位置關係爲對ς 時,R進二步包含碳數爲U的烧基,當 間位時,R1進一步包含碳數爲Ν30的院基或者苯H 烷基中,任意的-CH2-可以獨立地經_CF2_、_CHF_、_〇 處爲非連續)、-CHKH·或者-〇c_所取代,-CH3可以經 -CH2F、-CHF2或者_Cf3所取代。而且,該苯基的氫可以獨 0 立地絲似_F、·™ΠΗ3、_qch2f、_〇咖2或者 -OCFq。H2N (VIII) In the formula (vm), A3 represents a single bond, _〇_, _c〇〇_, _〇c〇❹-CO·, -CONH_ or _(CH2)m_ (m represents an integer of 6 i is a group having no steroid skeleton, represented by the following formula (IX), and when the positional relationship of the two amino groups bonded to the stupid ring is opposite, R includes two carbon atoms in the second step. The calcining group, when in the meta position, R1 further comprises a decyl group having a carbon number of Ν30 or a benzene H alkyl group, and any -CH2- may be independently discontinuous via _CF2_, _CHF_, _〇), -CHKH· Alternatively, -CH3 may be substituted, and -CH3 may be substituted by -CH2F, -CHF2 or _Cf3. Further, the hydrogen of the phenyl group can be simply _F, TM ΠΗ 3, _qch 2f, _ 〇 2 or - OCFq.
— —^ 通式(IX)中,A4以及A5分別獨立地表示單鍵、-〇_ (此處爲非連續)、-COO-、-0C0-、-CONH·、-CH=CH-或者碳數爲1〜12的魏基,r2j^r3分職立地表示_F 或者-CH3,環s獨立地表示L4-亞苯基、丨,4_亞環己基、 R4 (IX) 25 200927790 1,3-二°惡炫-2,5-二基、嘴咬·2,5·二基、π比淀-2,5-二基、秦-1,5-二基、萘-2,7-二基或者蒽-9,10·二基,R4表示-Η、-F、碳數 爲1〜30的烷基、碳數爲1〜30的氟取代烷基、碳數爲1 〜30 的烷氧基、-CN、-OCH2:F、-OCHF2 或者-OCF3,a 以 及b分別表示0〜4的整數,c、d以及e分別表示0〜3的 整數,f以及g分別獨立地表示0〜2的整數,並且c + d + 1。In the general formula (IX), A4 and A5 independently represent a single bond, -〇_ (here is discontinuous), -COO-, -0C0-, -CONH·, -CH=CH- or carbon. Wei Ke, number 1~12, r2j^r3 stands for _F or -CH3, and ring s independently represents L4-phenylene, anthracene, 4_cyclohexylene, R4 (IX) 25 200927790 1,3 -2° dioxin-2,5-diyl, mouth bite, 2,5·diyl, π-precipitate-2,5-diyl, qin-1,5-diyl, naphthalene-2,7-di Or -9,10.diyl, R4 represents -Η, -F, an alkyl group having 1 to 30 carbon atoms, a fluorine-substituted alkyl group having 1 to 30 carbon atoms, and an alkoxy group having 1 to 30 carbon atoms. Base, -CN, -OCH2:F, -OCHF2 or -OCF3, a and b respectively represent integers of 0 to 4, c, d, and e represent integers of 0 to 3, respectively, and f and g independently represent 0 to 2, respectively. The integer, and c + d + 1.
通式(X)以及(XI)中,R5獨立地表示-Η或者-CH3, R6表示-Η或者碳數爲1〜20的烷基或烯基,A6獨立地表 示單鍵、-C(=0)-或者-CH2-。而且通式(XI)中,R7以及 R8分別獨立地表示碳數爲1〜20的烷基或者苯基。In the general formulae (X) and (XI), R5 independently represents -Η or -CH3, R6 represents -Η or an alkyl or alkenyl group having a carbon number of 1 to 20, and A6 independently represents a single bond, -C(= 0) - or -CH2-. Further, in the formula (XI), R7 and R8 each independently represent an alkyl group having 1 to 20 carbon atoms or a phenyl group.
26 20092779026 200927790
〇 通式(XII)以及(XIII)中,Α7獨立地表示-ο-或者 石反數爲1〜6的亞烧基。而且通式(XII)中,R9表示-Η或 者碳數爲1〜30的烷基,該烷基中,碳數爲2〜3〇的烷基 的任意的-CH2_可以經-〇-(此處爲非連續)、_ch=:ch-或者 所取代,A8表示單鍵或者碳數爲i〜3的亞烷基,環 T表示1,4-亞苯基或者1,4-亞環己基,h表示〇或者〗。而 且,通式(XIII)中,R10表示碳數爲6〜22的烷基,Rll 表示碳數爲1〜22的烷基。〇 In the formulae (XII) and (XIII), Α7 independently represents -o- or a pyridene group having a stone inverse of 1 to 6. Further, in the formula (XII), R9 represents -Η or an alkyl group having 1 to 30 carbon atoms, and any -CH2_ of the alkyl group having 2 to 3 carbon atoms in the alkyl group may be -? Here is discontinuous), _ch=:ch- or substituted, A8 represents a single bond or an alkylene group having a carbon number of i~3, and ring T represents a 1,4-phenylene group or a 1,4-cyclohexylene group. , h means 〇 or 〗. Further, in the formula (XIII), R10 represents an alkyl group having 6 to 22 carbon atoms, and R11 represents an alkyl group having 1 to 22 carbon atoms.
以通式(VIII)表示的二胺例如可以列舉以下述通式 (yin—υ〜通式(VIII—37)以及以結構式(vm_38) 〜結構式(VIII —43)表示的二胺。Examples of the diamine represented by the formula (VIII) include a diamine represented by the following formula (yin-υ~ formula (VIII-37) and a structural formula (vm_38) to a structural formula (VIII-43).
(VIII-5) R23(VIII-5) R23
H2N (Vlll«6) 27 200927790H2N (Vlll«6) 27 200927790
(VIII-9) (VIII-10)(VIII-9) (VIII-10)
(VIII-11) 通式(VIII-l)〜通式(VIII—11)中,R23優選的是 表示碳數爲1〜30的烷基或者碳數爲1〜30的烷氧基,更 加優選的是表示碳數爲5〜25的烷基或者碳數爲5〜25的 烷氧基。而且,R24優選的是表示碳數爲1〜30的烷基或者 碳數爲1〜30的烷氧基,更加優選的是表示碳數爲3〜25 的烷基或者碳數爲3〜25的烷氧基。(VIII-11) In the formula (VIII-1) to the formula (VIII-11), R23 preferably represents an alkyl group having 1 to 30 carbon atoms or an alkoxy group having 1 to 30 carbon atoms, more preferably It is an alkyl group having a carbon number of 5 to 25 or an alkoxy group having a carbon number of 5 to 25. Further, R24 preferably represents an alkyl group having 1 to 30 carbon atoms or an alkoxy group having 1 to 30 carbon atoms, more preferably an alkyl group having 3 to 25 carbon atoms or a carbon number of 3 to 25 carbon atoms. Alkoxy.
R25 r25 R25R25 r25 R25
(VIII-12) (VIII-13) (VIII-14) (VIIJ-15) R26(VIII-12) (VIII-13) (VIII-14) (VIIJ-15) R26
(VIII-16) (VIII-17) 28 200927790 通式(VIII—12)〜通式(VIII-15)中,R25優選的 是表示碳數爲4〜30的烷基,更加優選的是表示碳數爲6 〜25的烷基。通式(VIII-16)以及通式(VIII-17)中, R26優選的是表示碳數爲6〜30的烷基,更加優選的是表示 h2n 碳數爲8〜25的烷基。 h2n h2n(VIII-16) (VIII-17) 28 200927790 In the formula (VIII-12) to the formula (VIII-15), R25 preferably represents an alkyl group having a carbon number of 4 to 30, and more preferably represents carbon. The number is 6 to 25 alkyl groups. In the formula (VIII-16) and the formula (VIII-17), R26 preferably represents an alkyl group having 6 to 30 carbon atoms, and more preferably an alkyl group having a carbon number of 8 to 25 in h2n. H2n h2n
(VIII-18) h2n (VIII-19)(VIII-18) h2n (VIII-19)
H2N (VI"-24)H2N (VI"-24)
(VIII-25)(VIII-25)
29 20092779029 200927790
h2n h2n (VIII-27) (VIII-28)H2n h2n (VIII-27) (VIII-28)
(VIII-29)(VIII-29)
(VIII-30)(VIII-30)
SISI
(VIII-32)(VIII-32)
H2N (VIII-33) (VIII-34) Η2Ν ο 普1 h2n (VIII-35) (VIII-36) \ r,~λ Γ~\ ?h3 ?h3 ^jK^Si-O-Si-R27 ch3 ch3 R28 (Vill-37) 通式(VIII—18)〜通式(VIII —37)中,R27優選的 是表示碳數爲1〜30的烷基或者碳數爲1〜30的烷氧基, 更加優選的是表示碳數爲3〜25的烷基或者碳數爲3〜25 的烷氧基。而且,R28優選的是表示-H、-F、碳數爲1〜30 30 200927790 的烷基、碳數爲1〜30的烷氧基、-CN、_OCH2F、-OCHF2 或者-OCF3,更加優選的是表示碳數爲3〜25的烷基或者 碳數爲3〜25的烷氧基。H2N (VIII-33) (VIII-34) Η2Ν ο 普1 h2n (VIII-35) (VIII-36) \ r,~λ Γ~\ ?h3 ?h3 ^jK^Si-O-Si-R27 ch3 ch3 R28 (Vill-37) In the formula (VIII-18) to the formula (VIII-37), R27 preferably represents an alkyl group having 1 to 30 carbon atoms or an alkoxy group having 1 to 30 carbon atoms, more Preferably, it is an alkyl group having a carbon number of 3 to 25 or an alkoxy group having a carbon number of 3 to 25. Further, R28 is preferably an alkyl group having -H, -F, a carbon number of 1 to 30 30 200927790, an alkoxy group having 1 to 30 carbon atoms, -CN, -OCH2F, -OCHF2 or -OCF3, more preferably It is an alkyl group having a carbon number of 3 to 25 or an alkoxy group having a carbon number of 3 to 25.
這些二胺中,優選以通式(VIII—1)〜通式(VIII — 11)表示的二胺,更加優選以通式(VIII —2)以及通式(VIII —4)〜通式(VIII—6)表示的二胺。 以所述通式(X)表示的二胺優選的是,在通式(X) 31 200927790 中兩個“NHyPh λ 6 位,另-個鍵^”中的一個鍵合於類固醇骨架的3 碳上,優_“^位;^且’兩個氨基分別鍵合於笨環 位上。 對於Α的鍵合位置而鍵合在間位或者對 fY ^,式,(X)表示的二胺例如可以列舉以下述結構式 (X-1)〜結構,Among these diamines, a diamine represented by the formula (VIII-1) to the formula (VIII-11) is preferred, and a formula (VIII-2) and a formula (VIII-4) to a formula (VIII) are more preferred. -6) represents a diamine. The diamine represented by the above formula (X) is preferably one of two "NHyPh λ 6 positions, another bond" in the formula (X) 31 200927790 bonded to the 3 carbon of the steroid skeleton. Upper, _"^ position; ^ and 'two amino groups are respectively bonded to the stupid ring position. For the bonding position of the oxime, bonding to the meta position or for the diamine represented by fY ^, formula (X), for example The following structural formula (X-1) to structure can be cited.
ΟΟ
(X-3) 、NH2 (X^) 、NH2 ο 以所,通式(XI)表示的二胺中,在通式(XI)中兩 個“NH2_(R-)Ph_A6办,,分別鍵合於苯環的碳上,優選的是 相對於_醇骨騎鍵合的碳_合於間位或者對位的碳 上。而6且氨基分別鍵合於笨軸碳上,優選的是相 對於A而鍵合在間位或者對位上。 以通式(XI)表示的二胺例如可以列舉以下述結構式 OQ-”〜結構式(χί—8)表示的二胺。 32 分。(X-3), NH2 (X^), NH2 ο In the diamine represented by the formula (XI), in the formula (XI), two "NH2_(R-)Ph_A6, respectively, are bonded On the carbon of the benzene ring, it is preferred that the carbon bonded to the skeletal bond is bonded to the meta or para carbon, and the 6 and the amino group are respectively bonded to the abaxial carbon, preferably relative to In the case of the diamine represented by the formula (XI), for example, a diamine represented by the following structural formula OQ-"~ structural formula (χί-8) can be exemplified. 32 points.
Q 200927790 h2n ❹Q 200927790 h2n ❹
nh2Nh2
33 20092779033 200927790
34 200927790 以所述通式(XII)表示的二胺中,在通式(XII)中 兩個氨基分別鍵合於苯環的碳上,優選的是相對於A7而鍵 合在間位或者對位上。 以通式(XII)表示的二胺例如可以列舉以下述通式 (XII— 1)〜通式(XII — 8)表示的二胺。 R29 R2934 200927790 In the diamine represented by the above formula (XII), in the formula (XII), two amino groups are bonded to the carbon of the benzene ring, respectively, preferably bonded to the meta or relative to A7. On the bit. The diamine represented by the formula (XII) may, for example, be a diamine represented by the following formula (XII-1) to (XII-8). R29 R29
35 20092779035 200927790
R30R30
,29 示·Η、碳數爲1〜30的烷基或者碳數爲1〜30的烷氧基, 更加優選的是表示碳數爲3〜30的烧基或者碳數爲3〜30 的烷氧基。而且,通式(XII —4)〜通式(ΧΙΙ-8)中, R3G優選的是表示-Η、碳數爲1〜30的烷基或者碳數爲1 〜30的烷氧基,更加優選的是表示碳數爲3〜30的烷基或 者碳數爲3〜30的烷氧基。 以所述通式(XIII)表示的二胺中,在通式(XIII)中 36 200927790 苯環的破上,優選—鍵 (ΧΙΠ)表不的二胺例如可以列舉以下述通式 (ΧΠΙ—3)表示的二胺。29, Η, an alkyl group having a carbon number of 1 to 30 or an alkoxy group having a carbon number of 1 to 30, more preferably an alkyl group having a carbon number of 3 to 30 or an alkane having a carbon number of 3 to 30 Oxygen. Further, in the general formulae (XII-4) to (?-8), R3G preferably represents -Η, an alkyl group having 1 to 30 carbon atoms or an alkoxy group having 1 to 30 carbon atoms, more preferably It is an alkyl group having a carbon number of 3 to 30 or an alkoxy group having a carbon number of 3 to 30. In the diamine represented by the above formula (XIII), in the general formula (XIII), in the breaking of the benzene ring, preferably, the diamine represented by the bond (ΧΙΠ) can be exemplified by the following formula (ΧΠΙ- 3) The diamine represented.
(ΧΙΙΙ-3) /-νη2 η2ν-/(ΧΙΙΙ-3) /-νη2 η2ν-/
=UlII-1)〜通式(Xm_3)中,r31優選的是 =¼數爲6〜22的烧基’ $加優選的是表示碳數爲6〜 烷基。R優選的是表示-H或者碳數爲1〜22的烷基, 更加優選的是表示碳數爲1〜10的烷基。 所述具有侧鍵結構的二胺優選的是選自以通式(viii 2)、通式(VIII—4)〜通式(νπι —6)、通式(χπ —2)、 通式(XII —4)以及通式(ΧΠ_6)表示的化合物中的至 少一種。 從使液晶顯示元件中表現出所需的預傾角的觀點考 慮,所述具有侧鏈結構的二胺在構成本發明液晶配向劑中 的聚醯胺酸的二胺中,以莫耳比計優選爲含有1%〜90%, 更加優選爲含有5%〜70%。 所述不具有侧鏈結構的二胺是指不具有如下取代基 (侧鏈)的二胺,該取代基在將連結氨基的取代基作爲主 鏈時自主鏈分支,並且可以表現出所需的預傾角。所述不 37 200927790 具有侧鏈結構的二胺可以列舉以下述通式(i)〜通式(νπ) 以及通式(χν)表示的化合物。In the formula (Xm_3), r31 is preferably a group of 6 to 22, and preferably has a carbon number of 6 to alkyl. R preferably represents -H or an alkyl group having 1 to 22 carbon atoms, and more preferably an alkyl group having 1 to 10 carbon atoms. The diamine having a side bond structure is preferably selected from the group consisting of the formula (viii 2), the formula (VIII-4) to the formula (νπι-6), the formula (χπ-2), and the formula (XII). — 4) and at least one of the compounds represented by the formula (ΧΠ_6). From the viewpoint of exhibiting a desired pretilt angle in the liquid crystal display element, the diamine having a side chain structure is preferably selected from a molar ratio of a polyamine of a polylysine constituting the liquid crystal alignment agent of the present invention. It is contained in an amount of 1% to 90%, and more preferably contains 5% to 70%. The diamine having no side chain structure means a diamine having no substituent (side chain) which branches autonomously when a substituent linking an amino group is used as a main chain, and can exhibit a desired Pretilt angle. The above-mentioned diamine having a side chain structure may be a compound represented by the following general formula (i) to the general formula (νπ) and the general formula (??).
HgN—X—NH2 (I) H2N〇NH2 (,,) Η2Ν〇-γ-〇ΝΗ2 (丨丨丨)HgN—X—NH2 (I) H2N〇NH2 (,,) Η2Ν〇-γ-〇ΝΗ2 (丨丨丨)
通式(I)中,X表示-(CH2)m- ( m表示1〜6的整數), 通式(III)以及通式(V)〜通式(VII)中,γ獨立地表 示單鍵、-0-、各、-S-S-、-S〇2-、-CO-、-CONH-、-NHCO-、 -NH- > -N(CH3HCH2)m-N(CH3)- > -C(CH3)2- > -C(CF3)2- ' -(CH2)m-、-0-(CH2)m_0-、-S-(CH2)m-S- (m 表示 1 〜6 的整 數),通式(V)中’ Z表示單鍵或者不存在,通式(χν) 中’ R33以及R34分別獨立地表示碳數爲1〜3的烷基或者 3& 200927790 苯基’ A3獨立地表示亞曱基、亞苯基或者經烷基取代的亞 苯基。1表示1〜ό的整數,m表示的整數,通式(II) 〜(VII)中,環己烧環或者苯環上所鍵合的氫可以獨立地 被取代爲-F、-CH3、-CF3、-oh、、-P〇3H2 ’In the formula (I), X represents -(CH2)m- (m represents an integer of 1 to 6), and in the formula (III) and the formula (V) to the formula (VII), γ independently represents a single bond , -0-, each, -SS-, -S〇2-, -CO-, -CONH-, -NHCO-, -NH- > -N(CH3HCH2)mN(CH3)- > -C(CH3 ) 2- > -C(CF3)2- ' -(CH2)m-, -0-(CH2)m_0-, -S-(CH2)mS- (m represents an integer from 1 to 6), In V), 'Z represents a single bond or does not exist. In the formula (χν), 'R33 and R34 each independently represent an alkyl group having a carbon number of 1 to 3 or 3&200927790 phenyl 'A3 independently represents an anthracenylene group, A phenylene group or an alkyl substituted phenylene group. 1 represents an integer of 1 to ό, and an integer represented by m. In the general formula (II) to (VII), a hydrogen bonded to a cyclohexane ring or a benzene ring may be independently substituted with -F, -CH3, - CF3, -oh,, -P〇3H2 '
通式(IV)中的本壤上所鍵合的氫可以經节基所取代。 以通式(I)表不的一胺例如可以列舉以下述,结構式(I —1)〜結構式(I一3)表示的二胺。 H2N(CH2)2NH2 H2N(CH2)4NH2 H2N(CH2)6NH2 (1-1) (I-2) (I-3) 以通式(II)表示的二胺例如可以列 下述結構式 (II—1)、結構式(II-2)表示的二胺。 H2N^3^NH2 H2N-0pNH2 (11-1) (11-2) 以通式(III)表示的二按例 結構式 (III-1)〜結構式(III-3)表示舉以The hydrogen bonded to the soil in the general formula (IV) may be substituted by a benzyl group. The monoamine represented by the formula (I) is, for example, a diamine represented by the following structural formula (I-1) to structural formula (I-3). H2N(CH2)2NH2 H2N(CH2)4NH2 H2N(CH2)6NH2 (1-1) (I-2) (I-3) The diamine represented by the formula (II) can be, for example, the following structural formula (II- 1) A diamine represented by the formula (II-2). H2N^3^NH2 H2N-0pNH2 (11-1) (11-2) Two examples represented by the general formula (III) Structural formula (III-1) to structural formula (III-3)
ch3 -NHa CH3 以通式(w)表示的二胺例述結構式 (IV—1)〜結構式(IV—17)矣_別舉以 J辰不的二 •胺 h2nCh3 -NHa CH3 The diamine represented by the formula (w) is exemplified by the structural formula (IV-1) to the structural formula (IV-17) 矣 别 别 J J J • • • • • •
nh2 (IV-1) (IV-2)Nh2 (IV-1) (IV-2)
H2NH2N
nh3 (inM) (IV-3) 39 200927790Nh3 (inM) (IV-3) 39 200927790
以通式(v)表示的二胺例如可以列舉以下述結構式 (V—1)〜結構式(V-37)表示的二胺。The diamine represented by the formula (v) is, for example, a diamine represented by the following structural formula (V-1) to structural formula (V-37).
40 /)-^2 200927790 ❹40 /)-^2 200927790 ❹
(V-12) η2ν-〇^°^〇ρ' nh2 h2n(V-12) η2ν-〇^°^〇ρ' nh2 h2n
(V-15) (V-13) (V-14) Η2Ν_〇κ〇^〇ν〇κνη2 (V-16)(V-15) (V-13) (V-14) Η2Ν_〇κ〇^〇ν〇κνη2 (V-16)
/-nh2 (V-17) h2n^〇^c/-nh2 (V-17) h2n^〇^c
nh2 H2N—^Nh2 H2N—^
/-NH2 (V-19) (V-18) nh2 h2n-〇^°^^°^nh2 (V-20) (V-21) H2N~^~^~s~s~C~^~NH2 h2n— ❹ (V-22) (V-23) (V-25) (V-24)/-NH2 (V-19) (V-18) nh2 h2n-〇^°^^°^nh2 (V-20) (V-21) H2N~^~^~s~s~C~^~NH2 h2n — ❹ (V-22) (V-23) (V-25) (V-24)
H2N (V-26) v^/ NHz h2n (V-27) NH2 41 200927790H2N (V-26) v^/ NHz h2n (V-27) NH2 41 200927790
ΟΟ
νη2 (V-31) ΝΗ2Ηη2 (V-31) ΝΗ2
(V-33) (V-32) OH ΟΗ(V-33) (V-32) OH ΟΗ
(V-34)(V-34)
(V-37)(V-37)
(V-36)(V-36)
以通式(VI)表示的二胺例如可以列舉以下述結構式 (VI-1)〜結構式(VI —6)表示的二胺。The diamine represented by the formula (VI) is, for example, a diamine represented by the following structural formula (VI-1) to structural formula (VI-6).
(VI-D(VI-D
(VI-2) ΝΗ2 (V1-3) (VI-4)(VI-2) ΝΗ 2 (V1-3) (VI-4)
(VI-5) (VI-6) 42 200927790(VI-5) (VI-6) 42 200927790
丨 2 H2N- (VIM) (VII-2) ❹丨 2 H2N- (VIM) (VII-2) ❹
/—nh2 h2n (VII-7)/—nh2 h2n (VII-7)
(VII-4) NHa H2N(VII-4) NHa H2N
(VII-6) /-nh2 h2n(VII-6) /-nh2 h2n
(VII-8) H2N~^^0s^3^0^〇v0^nh2 hjn~(^0v〇^ch2^C^〇vC)knh2 (VII-9) (VII-10) ❿ h2n(VII-8) H2N~^^0s^3^0^〇v0^nh2 hjn~(^0v〇^ch2^C^〇vC)knh2 (VII-9) (VII-10) ❿ h2n
(νιμιΐ) h3c ch3 (VH-12) 分明令。^_〇^〇~nh2(νιμιΐ) h3c ch3 (VH-12) distinct order. ^_〇^〇~nh2
(VII-14) o II (VIM 5} (VII-16) 以通式(XV)表示的二胺例如可以列舉以下述結構式 Cxv—1)表示的化合物。 (VII-13) f3Q cf3(VII-14) o II (VIM 5) (VII-16) The diamine represented by the formula (XV) is, for example, a compound represented by the following structural formula Cxv-1). (VII-13) f3Q cf3
ch3 ch3 HaN-CsHe-知一0-‘C3H6-NH2 ch3 ch3 (XV-1) 43 200927790 ❹Ch3 ch3 HaN-CsHe-知一0-‘C3H6-NH2 ch3 ch3 (XV-1) 43 200927790 ❹
這些二胺中,所述不具有侧鍵結構的二胺優選以結構 式GV—1)〜結構式(IV—5)、結構式(IV—15)〜結 構式(IV-17)、結構式(vy)〜結構式(v—12)、結 構式(V —26)、結構式(v_27)、結構式(v_3i)、結 構式(V 33)、結構式(v_35)〜結構式(v_37)、結 構式(vi-i)、結構式(VI_2)、結構式(νι—6)、結構 式(V11—1)〜結構式(VII —5)以及結構式(χν—D 表示的二胺,更加優選以結構式Gv—丨)、結構式(ιν— 2)、結構式(IV—15)〜結構式(IV—17)、結構式(v_ υ〜結構式(V—12)、結構式(V—33)、結構式(v_ 35)〜結構式(V-37)、結構式(VII_2)以及結構式(χν —1)表不的二胺。 攸便狀曰曰顯不元件中表現出離子密度等所需的電特性 的觀點考慮’所財具有舰結構的二胺在構成本發明液 晶配向劑中的聚軸酸的二胺中,以莫耳比計優選 1%〜98°/° ’更加優選爲含有10%〜95%。 二發Λ?—二胺可以使用所述的以通式⑴〜通式 m〜通式(χπι)表示的二胺以外的 萘ri的其他二胺例如可以列舉··具有萘結構的 ϋ〜uf(flu〇rene)結構㈣系二胺、以及通式 ιχπ)以外的具有侧鏈結構的二胺。 表示的化2例如可以列舉町述通式(1')〜通式⑼ 44 200927790Among these diamines, the diamine having no side bond structure preferably has the structural formula GV-1) to the structural formula (IV-5), the structural formula (IV-15) to the structural formula (IV-17), and the structural formula. (vy)~Structure (v-12), Structural Formula (V-26), Structural Formula (v_27), Structural Formula (v_3i), Structural Formula (V 33), Structural Formula (v_35)~Structure Formula (v_37) , structural formula (vi-i), structural formula (VI_2), structural formula (νι-6), structural formula (V11-1)~ structural formula (VII-5), and structural formula (diamine represented by χν-D, More preferably, it is a structural formula Gv-丨), a structural formula (ιν-2), a structural formula (IV-15)~ a structural formula (IV-17), a structural formula (v_ υ~ structural formula (V-12), a structural formula (V-33), structural formula (v_35)~Structure formula (V-37), structural formula (VII_2) and structural formula (χν-1) represent diamines. From the viewpoint of the required electrical characteristics such as the ion density, it is considered that the diamine having a ship structure has a polyamine in the polyhydric acid constituting the liquid crystal alignment agent of the present invention, preferably 1% to 98° in terms of a molar ratio. ° 'More preferably contains 10% ~ 9 5%. The other diamines other than the diamines other than the diamines represented by the above formula (1) to the formula m to the formula (χπι) can be used, for example, as the naphthalene structure. ϋ~uf(flu〇rene) structure (IV) is a diamine having a side chain structure other than a diamine and a formula ιχπ). The chemical expression 2 can be, for example, a general formula (1') to a general formula (9) 44 200927790
(3,)(3,)
在構成本發明液晶配向劑中的聚醯 =其他二胺可以在不損及本發明效果的程度=圍中内^ 對於所述二胺來說,可以在各二胺中單 (m_amine)相對於二胺的比率爲4〇莫耳 耳%以下的範_,將—部分二胺替換爲單胺。j 7能够引起生成聚㈣酸時的聚合反應的終止 Uennmation) ’從而能够抑制聚合反應的進一 此’通過這樣的替換,可以容易地控制 的:。因 酿胺酸或者其触物)較子量,糾物(聚 明的效果而改善液晶配向綱塗布特 貝及本發 /、要不損及本發 45 200927790 明的效果,則智 /么 Jl? TC_ Ί _* » ,則替換爲單胺的二The polyfluorene = other diamine constituting the liquid crystal alignment agent of the present invention may be in a range that does not impair the effects of the present invention = within the range of the diamine, in the case of the diamine, a single (m_amine) may be used in each diamine. The ratio of diamine is 4 〇 mole % or less, and the partial diamine is replaced by a monoamine. j 7 can cause the termination of the polymerization reaction when the poly(tetra) acid is formed. Thus, it is possible to suppress the progress of the polymerization reaction. By such substitution, it can be easily controlled: Because of the amount of arginine or its touch, it is better to improve the liquid crystal alignment coating and the present hair/, or to damage the effect of the hair. TC_ Ί _* » is replaced by the second amine
正壬胺、正癸胺、正十一胺、 四胺、正十五胺、正十六胺、正十七胺 鞍可以是一種,也可以是兩 可以列舉:苯胺、4-羥基笨 •正己胺、正庚胺、正辛胺、 正十二胺、正十三胺、正十 、正十八胺以及正 二十胺。 本發明中使用的四叛酸二酐可以是一種化合物’也可 以是兩種或者兩種以上的化合物。所述四羧酸可以列舉芳 0 香族四羧酸二酐、脂環式四羧酸二酐以及脂肪族四羧酸二 所述芳香族四羧酸二酐,是兩個酸酐中的至少一個爲 由鍵舍於芳香族化合物上的兩個祕所得的酸酐的化合 物。所述芳麵四醜二義如可好j料f述結構式⑴ 〆結構式(18)表示的化合物。N-decylamine, n-decylamine, n-undecamine, tetraamine, n-pentadecylamine, n-hexadecylamine, n-heptadecane saddle may be one type or two types: aniline, 4-hydroxy stupid • positive Amine, n-heptylamine, n-octylamine, n-dodecylamine, n-tridecylamine, n-decene, n-octadecylamine and n-dodecylamine. The tetra-retensive dianhydride used in the present invention may be a compound ' or two or more compounds. The tetracarboxylic acid may, for example, be an aromatic 0 aryl tetracarboxylic dianhydride, an alicyclic tetracarboxylic dianhydride, or an aliphatic tetracarboxylic acid; the aromatic tetracarboxylic dianhydride, which is at least one of two acid anhydrides. It is a compound of an acid anhydride obtained by bonding two secrets on an aromatic compound. The aromatic smear is as good as the compound represented by the structural formula (1).
(1) (2) (3)(1) (2) (3)
46 20092779046 200927790
所述芳香族四羧酸二酐優選以所述結構式(1)、結構 式(2)、結構式(5)〜結構式(7)以及結構式(14)表 示的化合物,更加優選以所述結構式(1)表示的化合物。 所述脂環式四羧酸二酐,是兩個酸酐中的至少一個爲 由鍵合於脂環式化合物上的兩個羧基所得的酸酐的化合 物。所述脂環式四羧酸二酐例如可以列舉以下述結構式 (19)〜結構式(22)、結構式(24)〜結構式(44)以及 結構式(49)〜結構式(65)表示的化合物。 47 200927790The aromatic tetracarboxylic dianhydride is preferably a compound represented by the above structural formula (1), structural formula (2), structural formula (5) to structural formula (7), and structural formula (14), and more preferably The compound represented by the structural formula (1). The alicyclic tetracarboxylic dianhydride is a compound in which at least one of the two acid anhydrides is an acid anhydride obtained by bonding two carboxyl groups bonded to the alicyclic compound. Examples of the alicyclic tetracarboxylic dianhydride include the following structural formula (19) to structural formula (22), structural formula (24) to structural formula (44), and structural formula (49) to structural formula (65). The compound represented. 47 200927790
48 20092779048 200927790
(42) (43) (44)(42) (43) (44)
(54) (55) (56)(54) (55) (56)
49 200927790 所述月曰環式四缓酸二酐優選以所述結構式(I9)、結構 式結構式(35)〜結構式(37)、結構式(39)、結 構式以及結構式(49)表示的化合物,更加優選以 所述結構式(19)、結構式(37)以及結構式(49)表示的化 舍物。 所述爿曰肪族四羧酸二酐,是具有兩個由鍵合於脂肪族49 200927790 The ruthenium ring type tetrakispernic acid dianhydride preferably has the structural formula (I9), the structural formula (35) to the structural formula (37), the structural formula (39), the structural formula and the structural formula (49). The compound represented by the formula (19), the structural formula (37), and the structural formula (49) are more preferably a compound represented by the formula (49). The bismuth tetracarboxylic dianhydride has two bonds bonded to an aliphatic group
化合物上的兩個綾基所得的酸酐的化合物。所述脂肪族四 羧酸二酐例如可以列舉以下述結構式(23)、結構式(45) ~結構式(48)、結構式(66)以及結構式(67)表示的化 舍物。A compound of an anhydride obtained from two mercapto groups on a compound. The aliphatic tetracarboxylic dianhydride may, for example, be a compound represented by the following structural formula (23), structural formula (45) to structural formula (48), structural formula (66) and structural formula (67).
(66) (67) 所述脂肪族四羧酸二酐優選以所述結構式(23)表示 的化合物。 所述四幾酸二sf也可以使用以結構式(1)〜結構式 (67)表示的四羧酸二酐以外的其他四羧酸二酐。其他四 50 200927790 側r 構的―二 的預傾角。 纖—軒,可明大液晶_兀件 物。及、,構式(69)表示的具有_醇骨架的化合(66) (67) The aliphatic tetracarboxylic dianhydride is preferably a compound represented by the structural formula (23). As the tetrabasic acid sf, other tetracarboxylic dianhydrides other than the tetracarboxylic dianhydride represented by the structural formula (1) to the structural formula (67) can be used. Other four 50 200927790 Side pre-tilt of the two-position. Fiber - Xuan, can be a big LCD _ 兀 pieces. And the combination of the alcohol skeleton represented by the formula (69)
任意==ΓΧ在實私發日峨的範圍内使用 也可以將所述四幾酸二酐的一部分替 ===!起生成聚酿胺酸時的聚合反應的終止, =细控制所獲得的聚合物(聚 善液晶配向劑的塗布特性。發明的效果而改 性瘦醆酐相對於四羧酸二奸的比 51 200927790 t要f不&及本發明效果的範圍㈣可,其基準優選的 γ四魏二軒量的1G莫耳%或10莫耳%以下。只要不 ^及本發明的效果,則替換爲羧酸酐的四羧酸二軒可以曰 舉也兩種或者兩種以上。所述羧酸單酐例如; 歹J舉.馬來_、鄰苯二甲酸軒、衣康酸肝(itac_ 二y ri e)、正癸基伽酸軒、正十二燒基伽酸肝、正 十四燒基琥賴肝、正十六絲琥贈_及環已酸軒。 Ο ❹ 所述四羧酸二酐可以在二羧酸相對於四羧酸二 率爲10莫耳%或1G莫耳%以下的賴内,將__部分四 酸二if替換爲二羧酸。只要不損及本發明的效果,則替換 爲二羧酸的四羧酸二酐可以是一種,也可以是兩種或兩種 以上。 所述聚醯胺酸或者其衍生物的單體中也可以進一步包 含單異氰酸酯(monoisocyanate)化合物。通過使單體中 包含單異氰酸酯化合物,所獲得的聚醯胺酸或者其衍生物 的末端得到修飾,分子量得以調節。通過使用此末端修飾 型聚醯胺酸或者其衍生物,例如可以不損及本發明的效果 而改善液晶配向劑的塗布特性。從所述觀點考慮,單體中 的單異氰酸酯化合物的含量優選的是相對於單體中的二胺 以及四羧酸二酐的總量而爲1莫耳%〜10莫耳%。所述單 異氰酸酯化合物例如可以列舉異氰酸苯酯以及異氰酸 酿。 ' 所述聚醯胺酸或者其衍生物除了使用以通式(N)表 示的二胺以外,可以與聚醯亞胺的膜形成中所使用的衆所 52 200927790 周知的聚醯胺酸或者其衍生物同樣地製造。四竣酸二野的 總添加量優選的是與二胺的總莫耳數大致爲等莫耳(莫耳 比爲0.9〜1.1左右)。 所述聚醯胺酸或者其衍生物的分子量以聚苯乙烯換算 的重量平均分子量(Mw)計,優選爲10,〇〇〇〜5〇〇,〇〇〇, 更加優選爲20,000〜200,〇〇〇。所述聚醯胺酸或者其衍生物 的分子量可以通過利用凝膠滲透色譜(Gel Permeation Chromatography,GPC )法進行測定而求出。 ® 對於所述聚醢胺酸或者其衍生物,可以通過對用大量 不良溶劑進行沉澱而獲得的固體成分實行紅外光譜 (Infrared spectroscopy ’ IR)、核磁共振(Nuclear MagneticAny ==ΓΧ can also be used within the range of the real-time hair 也 也 也 也 一部分 = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = The polymer (the coating property of the polynic liquid crystal alignment agent. The effect of the invention is modified to be compared with the ratio of the tetracarboxylic acid to the tetracarboxylic acid, and the range of the effect of the present invention is (4). 1 G mol% or 10 mol% or less of the amount of γ tetraweishen. As long as the effect of the present invention is not obtained, the tetracarboxylic acid dioxins substituted with the carboxylic anhydride may be used in two or more kinds. Carboxylic acid monoanhydride for example; 歹J lift. Malay _, phthalic acid porphyrin, itaconic acid liver (itac_ two y ri e), n-decyl gamma acid sulphate, sulphide sulphate liver, positive ten The four-burning sulphate is the liver, the hexagram is given _ and the ring is acid 轩. Ο ❹ The tetracarboxylic dianhydride can be 10 mole% or 1G molar in the dicarboxylic acid relative to the tetracarboxylic acid. In the case of less than %, the __ partial tetraacid di if is replaced with a dicarboxylic acid. The tetracarboxylic dianhydride which is substituted with a dicarboxylic acid may be used as long as the effect of the present invention is not impaired. It may be one type or two or more types. The monomer of the polyamic acid or a derivative thereof may further contain a monoisocyanate compound, which is obtained by including a monoisocyanate compound in the monomer. The terminal of the poly-proline or the derivative thereof is modified, and the molecular weight is adjusted. By using the terminal-modified poly-proline or a derivative thereof, for example, the coating property of the liquid crystal alignment agent can be improved without impairing the effects of the present invention. From this viewpoint, the content of the monoisocyanate compound in the monomer is preferably from 1 mol% to 10 mol% with respect to the total amount of the diamine and the tetracarboxylic dianhydride in the monomer. The monoisocyanate compound may, for example, be phenyl isocyanate or isocyanate. The polylysine or a derivative thereof may be a film of a polyimine in addition to the diamine represented by the formula (N). The polyamines or their derivatives known in the art are used in the same manner. The total amount of tetradecanoic acid is preferably the total molar amount of the diamine. The molar ratio is about 0.9 to 1.1. The molecular weight of the polyamic acid or derivative thereof is preferably 10 in terms of polystyrene-equivalent weight average molecular weight (Mw), 〇〇〇~ 5〇〇,〇〇〇, more preferably 20,000 to 200, 〇〇〇. The molecular weight of the polyamic acid or a derivative thereof can be determined by using a gel permeation chromatography (GPC) method. For the poly-proline or its derivatives, infrared spectroscopy (IR) and nuclear magnetic resonance (Nuclear Magnetic) can be performed on solid components obtained by precipitation with a large amount of poor solvent.
Resonance ’ NMR)分析來確認其存在。而且,可以通過 對用KOH或NaOH等强鹼的水溶液對所述聚醯胺酸或者 其衍生物的分解物的有機溶劑進行萃取所得的萃取物實行 氣相色譜(Gas Chromatography’GC)、高效液相色譜(High Performance Liquid Chromatography,HPLC)或者氣相色 〇 譜-質譜(Gas Chromatograph-Mass Spectrometer,GC-MS ) 分析,來確認所使用的單體。 本發明的液晶配向劑可以進一步含有所述聚醯胺酸或 者其衍生物以外的其他成分。其他成分可以是一種,也可 以是兩種或者兩種以上。 例如’從使液晶顯示元件的電特性長期穩定的觀點考 慮,本發明的液晶配向劑可以進一步含有烯基取代納迪克 酿亞胺化合物。所述歸基取代納迪克醢亞胺化合物可以是 53 200927790 一種化合物’也可以是兩種或者兩種以上的化合物。從所 述觀點考慮,所述烯基取代納迪克醯亞胺化合物的含量以 相對於液晶配向劑中的聚醯胺酸或者其衍生物的重量比 計’優選爲0.01〜1.00,更加優選爲0.01〜〇 70,進一步 優選爲0.01〜0.50。 所述烯基取代納迪克醯亞胺化合物優選可以在溶解本 發明中使用的聚醯胺酸或者其衍生物的溶劑中溶解的化合Resonance ''NMR) analysis confirmed its presence. Further, gas chromatography (Gas Chromatography 'GC), high-efficiency liquid can be carried out by extracting an extract obtained by extracting an organic solvent of a polyamine derivative or a derivative of a derivative thereof with an aqueous solution of a strong alkali such as KOH or NaOH. The high-performance liquid Chromatography (HPLC) or Gas Chromatograph-Mass Spectrometer (GC-MS) analysis was used to confirm the monomers used. The liquid crystal alignment agent of the present invention may further contain other components other than the polyamic acid or a derivative thereof. The other ingredients may be one type or two or more types. For example, the liquid crystal alignment agent of the present invention may further contain an alkenyl-substituted nadickimine compound from the viewpoint of stabilizing the electrical characteristics of the liquid crystal display element for a long period of time. The group-substituted nadicylimine compound may be 53 200927790 A compound ' or two or more compounds. From the viewpoint of the above, the content of the alkenyl-substituted nadic ylidene imine compound is preferably from 0.01 to 1.00, more preferably 0.01, based on the weight ratio of the polyglycine or the derivative thereof in the liquid crystal alignment agent. More preferably, it is 0.01 to 0.50. The alkenyl-substituted nadicylimine compound is preferably a compound which can be dissolved in a solvent which dissolves the poly-proline or the derivative thereof used in the present invention.
物。這樣的烯基取代納迪克醯亞胺化合物的例子可以列i 以下述通式(Ina)表示的化合物。 0Things. An example of such an alkenyl-substituted nadicylimine compound can be a compound represented by the following formula (Ina). 0
叹八甲,以及1/分别鉬Λ 1L 士 _ ❹ 爲卜的烧基、碳數爲3〜6的稀示風、碳數 烧基:芳基或者f基,η表示爲5〜8的環 當n=l時,W表示碳數爲i — u 〜6的埽基、碳數爲5〜8的環燒基、碳二:、^數^2 ί基、以(Ζι、以另〜的方基、 碳數爲2〜6的亞烧基,q表示〇或者i及^獨立地表示 3〇,整數)表示的基團、以_(ZVb_二表;1: 地表示碳數爲1〜4的魏基或者碳(以及Z獨立 基,B表示亞苯基,而且s表示的環亞烧 以表示的基團、 表不-CH2-、-C(CH3)2·、 54 200927790 -Ο-、-CO-、-S-或者S〇2_)表示的基團、或者這些基團的 1個〜3個氫經羥基所取代的基團。 此時,優選的W是碳數爲1〜8的烷基、碳數爲3〜4 的烯基、環己基、苯基、苄基、碳數爲4〜1〇的聚(乙烯氧) 乙基、苯氧基苯基、苯基曱基苯基、苯基異亞丙基苯基以 及這些基團的1個或者2個氫經羥基所取代的基團。 當通式(Ina)中n = 2時’ W表示碳數爲2〜20的亞 烷基、碳數爲5〜8的環亞烷基、碳數爲6〜12的亞芳基、 © a_zl_〇-(z2〇)r-Z3- (Z1〜Z3以及r的含義如上所述)表示 的基團、以-Z4-B-Z5- (Z4、Z5以及B的含義如上所述)表 示的基團、以-B-(0-B)s-T-(B-0)s-B- (B表示亞苯基,T表 示碳數爲1〜3的亞烷基、·〇_或者_s〇2-,s表示〇或者1) 表示的基團、或者這些基團的1個〜3個氫經羥基所取代 的基團。 此時,優選的W是碳數爲2〜12的亞烷基、亞環己基、 亞苯基、苯亞曱基、亞二甲苯基、以-C3H6-0-(Z2-0)r-0-C3H6_ 〇 (Z2表示碳數爲2〜6的亞烧基,r表示1或者2)表示的 基團、以(B表示亞苯基,而且T表不-CH^-、-0_ 或者-S02-)表示的基團、以_b-〇-B-C3H6-B-〇-B- (B表示 亞苯基)表示的基團、以及這些基團的1個或者2個氫經 羥基所取代的基團。 這樣的烯基取代納迪克醯亞胺化合物例如可以使用: 如日本專利第2729565號公報所記載的那樣,通過將烯基 取代納迪克酸酐衍生物和二胺在80°C〜220°C的溫度下保 55 200927790 持0·5小時〜2〇小時而合成所得的化合物;或者市售的化 合物。烯基取代納迪克醯亞胺化合物的具體例可以列舉以 下所示的化合物。 Ν-甲基-稀丙基雙環[2.2.1]庚-5-烯-2,3-二甲酿亞胺 (N-methyl-allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboximide )、N-曱基-晞丙基甲基雙環[2.2.1]庚-5-烯-2,3-二甲酿亞 胺、N-甲基-曱基烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞 胺、N-甲基-曱基烯丙基曱基雙環[2.2.丨]庚冰稀_2,3_二甲醯 © 亞胺、N-(2·乙基己基)-烯丙基雙環[2.2.1]庚_5_稀_2,3_二甲 醯亞胺、N_(2-乙基己基)·婦丙基(甲基)雙環[221]庚_5_烯 -2,3-二曱酿亞胺、N-稀丙基-稀丙基雙環[2.2.1]庚烯_2,3_ 二曱醯亞胺、N-烯丙基_烯丙基甲基雙環[2 21]庚_5_烯_2,3_ 二曱醯亞胺、N-烯丙基-曱基烯丙基雙環[22庚_5_稀_2,3_ 二甲醯亞胺、Ν-異丙烯基-烯丙基雙環[2 21]庚_5_烯_2,3_ 二曱醯亞胺、Ν-異丙烯基-烯丙基(曱基)雙環ρ 2丨]庚_5_烯 -2,3-二甲醯亞胺、N-異丙烯基-甲基烯丙基雙環[2 2 ^庚孓 ® 烯-2,3_二曱醯亞胺、N_環己基-烯丙基雙環P.2.1]庚-5-烯 _2,3_二甲醯亞胺、N-環己基-婦丙基(曱基)雙環ρ.2.η庚_5_ 烯-2,3-二甲醯亞胺、Ν-環己基·曱基烯丙基雙環[2 21]庚_5· 稀-2,3-二曱酿亞胺、Ν-苯基-烯丙基雙環ρ.2.η庚_5_稀_2,3· 二曱醯亞胺、Ν·笨基-稀丙基(甲基)雙環[2 2 ^_5_稀_2,3_ 一甲醯亞,、Ν-节基-烯丙基雙環[221]庚_5_婦_2,3_二甲酿 亞胺、Ν:节基-稀丙基甲基雙環[2 21]庚_5_稀·2,3_二甲釀亞 胺、Ν-节基·曱基烯丙基雙環[2 2 ^庚·^稀_2,3_二曱酿亞 56 200927790 胺、N-(2·經基乙基)_稀丙基雙環[⑶]庚· 亞:、N侧乙基)顧甲基)雙銀二 二甲醯亞胺' N_(2_誠乙基)_甲基稀丙基雙卯 ,- 稀-2,3-—甲酿亞胺、N-(2 2--甲其1 甘 ]庚5· 環叫_,3_丄亞- ❹ =丙^甲基某)雙環[2.2.1]庚傅2,3_二“二丙 亞基雙環[2.2.1]庚傅2,3^^ 庚-5 躲二二N=, 雙卿.收·5= : Ψ =f環叫柄基(甲基) 基雙環[2.2.1]庚_5_烯_2 3_ 、^(4令基苯基)·烯丙 丙基(曱基)雙雜叫庚冰烯_2,3 ^夕基二基>稀 苯基 > 甲基烯丙基雙基 苯基).甲基柄基…“ 胺N-(3-羥基苯基)_婦丙基 二甲峨傳雜叫_基^)==,3_ 稀_2,3-二甲酿亞胺、N_( =[2.2.1]庚-5- 傳&二甲醯亞胺、 雙環[2.2.1]庚_5_稀_2 3 -二,基乙氧基)乙基卜稀丙基 Ν-{2-(2.經基乙氧基)乙基 基雙二:酿亞胺、 f 基娜.2.·‘一亞二:=ί 57 200927790 乙氧基)乙氧基}乙基]-稀丙基雙環p 2 η庚_5_稀_2,3_二曱 醯亞胺、Ν-[2-{2-(2-羥基乙氧基)乙氧基}乙基;I-蝉丙基(曱 基)雙環[2.2.1]庚-5-烯-2,3-二曱醯亞胺、Ν-[2-{2_(2-羥基乙 氧基)乙氧基}乙基]-曱基烯丙基雙環[22.η庚_5_烯_2,3_二 甲酿亞胺、Ν-{4·(4·羥基苯基異亞丙基)苯基卜稀丙基雙環 [2.2.1] 庚-5-烯-2,3-二曱醯亞胺、Ν-{4-(4-羥基苯基異亞丙基) 本基}•稀丙基(甲基)雙環[2.2.1]庚-5-豨-2,3-二曱醯亞胺、 Ν-{4_(4_羥基苯基異亞丙基)苯基}-曱基烯丙基雙環[2.2.1] 庚-5-烯-2,3-一曱酿亞胺、以及它們的低聚物(〇iig〇mer); N,N’-亞乙基-雙(烯丙基雙環卩二^庚-^烯—^二曱醯 亞胺)(N,N -ethylene-bisCallylbicyclol^HJhept-S-eneJ’S-dicarboximide) ) 、 N,N’-亞乙基雙 (稀 丙基曱 基雙環 [221] 庚-5-婦-2,3-二甲醯亞胺)、N,N,·亞乙基-雙(甲基烯丙基雙環 [2.2.1] 庚-5-稀-2,3-二曱疏亞胺)、ν,Ν’·三亞曱基·雙(稀丙基 雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)、ν,Ν,-六亞曱基-雙(烯 丙基雙環[2.2.1]庚-5-婦-2,3-二甲醯亞胺)、ν,Ν,-六亞甲基- ® 雙(稀丙基曱基雙環[2.2.1]庚-5-烯-2,3-二曱酿亞胺)、ν,Ν,- 十二亞曱基雙(烯丙基雙環[2·2 ”庚-、烯_2,3_二甲醯亞 胺)、Ν,Ν’-十二亞甲基-雙(烯丙基甲基雙環卩.21]庚_5_烯 -2,3-二曱醯亞胺)、Ν,Ν,_亞環己基_雙(烯丙基雙環[2 21]庚 -5-烯-2,3-二甲醢亞胺)、ν,Ν,-亞環己基-雙(烯丙基曱基雙環 Ρ.2.1]庚-5-烯·2,3-二曱醯亞胺)、以雙^,〆稀丙基雙環 P.2.1]庚_5_烤-2,3-二甲醯亞胺)丙氧基}乙烷、u-雙{3,_(婦 丙基甲基雙環P.2.1]庚-5-烯_2,3_二甲醯亞胺)丙氧基}乙 58 200927790 , 烷、1,2-雙{3,-(甲基烯丙基雙環[2.2.1]庚_5_烯_2,3_二甲醯亞 胺)丙氧基}乙燒、雙Ρ’·{3’·(稀丙基雙環[2.2.1]庚_5·烯·2,3_ 二甲醯亞胺)丙氧基}乙基]醚、雙[2,-{3l(烯丙基甲基雙環 [2.2.1] 庚-5-烯-2,3-二曱醯亞胺)丙氧基}乙基]醚、i 4•雙 {3·-(稀丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)丙氧基}丁 烷、1,4-雙{3'-(烯丙基甲基雙環卩上^庚^-烯义^二曱醯亞 胺)丙氧基}丁院、N,N'-對亞苯基-雙(稀丙基雙環[2 2.1]庚 _5_烯-2,3_二甲醯亞胺)、N,N’-對亞苯基-雙(烯丙基曱基雙環 [2.2.1] 庚-5-烯-2,3-二甲醯亞胺)、n,N’-間亞笨基_雙(烯丙基 雙環[2.2.1]庚-5-烯-2,3-二曱醯亞胺)、N,N,_間亞苯基_雙($ 丙基甲基雙環[2.2.1]庚-5-烯-2,3-二曱醯亞胺)、nkoi 基)-2,4-亞苯基}-雙(烯丙基雙環烯义3_二甲醯 亞胺)、N,N,-對亞二曱苯基-雙(烯丙基雙環[2·2 η庚_5_烯 -2,3·二曱醯亞胺)、Ν,Ν,_對亞二曱苯基_雙(烯丙基曱基雙環 [2.2.1] 庚-5-烯-2,3-二甲醯亞胺)、Ν,Ν,-間亞二曱苯基_雙(烯 丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)、Ν,Ν,-間亞二甲苯 ® 基-雙(烯丙基曱基雙環Ρ.2.1]庚-5-烯-2,3-二甲醯亞胺)、2,2_ 雙[Μ4·(烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)苯氧 基}笨基]丙烧、2,2_雙[4_{4_(烯丙基甲基雙環[2 21]庚·5_稀 二甲醯亞胺)苯氧基}苯基]丙烷、2,2_雙[4_{4兴曱基烯 丙基雙環Ρ.2.1]庚-5-烯-2,3-二甲醯亞胺)苯氧基}苯基]丙 烷、雙{4-(烯丙基雙環烯_2,3_二甲醯亞胺)苯基} H、雙{4-(稀丙基甲基雙環[2·2· 1]庚_5·埽·2,3_:甲醯1 胺)笨基}甲烷、雙{((甲基烯丙基雙環 59 200927790 二曱醯亞胺)苯基}曱烷、雙{4-(甲基烯丙基甲基雙環[2.2.1] 庚-5-烯_2,3-二曱醯亞胺)苯基}甲烷、雙{4-(烯丙基雙環 [2.2.1]庚-5-烯-2,3-二甲醯亞胺)苯基}醚、雙{4-(烯丙基甲基 雙環[2.2.1]庚-5-烯-2,3-二曱醯亞胺)苯基}醚、雙{4-(甲基烯 丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)苯基}醚、雙{4-(烯 丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)苯基}颯、雙{4-(烯 丙基曱基雙環[2.2.1]庚-5-烯-2,3-二曱醯亞胺)苯基}砜、雙 {4-(曱基烯丙基雙環[2.2.1]庚-5-烯-2,3-二曱醯亞胺)苯基} © 砜、1,6-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3二甲醯亞胺)-3-羥基-己烷、U2-雙(曱基烯丙基雙環[2.2.1]庚-5-烯-2,3-二 甲醯亞胺)-3,6-二羥基-十二烷、1,3-雙(烯丙基雙環[2.2.1] 庚-5-烯-2,3-二曱醯亞胺)-5-羥基-環己烷、1,5-雙{3·-(烯丙基 雙環P.2.1]庚-5-烯-2,3-二曱醯亞胺)丙氧基}-3-羥基-戊 烷、1,4-雙(烯丙基雙環[2·2·1]庚-5-烯-2,3-二甲醯亞胺)-2-羥基苯、1,4-雙(烯丙基曱基雙環[2.2.1]庚-5-烯-2,3-二甲醯 亞胺)-2,5-二羥基-苯、N,N’-對-(2-羥基)亞二甲苯基-雙(烯丙 〇 基雙環P.2.1]庚-5-烯-2,3-二甲酿亞胺)、N,N’-對-(2-羥基) 亞二曱苯基-雙(烯丙基甲基環[2.2.1]庚-5-烯-2,3-二曱醯亞 胺)、N,N’-間-(2-羥基)亞二曱苯基-雙(烯丙基雙環[2.2.1]庚 5-烯-2,3-二曱醯亞胺)、Ν,Ν·-間-(2-羥基)亞二曱苯基-雙(甲 基烯丙基雙環[2.2.1]庚-5-烯-2,3-二曱醯亞胺)、Ν,Ν’-對 -(2,3-二羥基)亞二曱苯基-雙(烯丙基雙環[2.2.1]庚-5-烯 -2,3-二甲醯亞胺)、2,2-雙[4-{4-(烯丙基雙環[2.2.1]庚-5-烯 -2,3_二曱醯亞胺)-2-羥基-笨氧基}苯基]丙烷、雙{4-(烯丙基 200927790 J基f 烯心’3-二甲酿亞胺)_2-經基·苯基}甲 炫、雙(3_(烯丙基雙環[2.2.. 基-苯基}醚、雙{3彳甲μ 亞胺毯 二(婦丙基雙環Ρ.2.1]庚_5_稀-2,3-二甲 ,/ },,三{4_(烯丙基尹基雙環 」. 、_,3_一甲醯亞胺)}苯氧基曱基丙烷、N,N',N”- 一(亞乙基甲基烯丙基雙環[2 2」]庚_5_稀_2,3•二?醯亞胺) 異氰尿酸酯,以及它們的低聚物等。叹八甲, and 1/ respectively molybdenum Λ 1L 士 ❹ ❹ is a burning base, a carbon number of 3 to 6, a rare wind, a carbon number base: an aryl group or an f group, and η is a ring of 5 to 8 When n=l, W represents a fluorenyl group having a carbon number of i—u ~6, a cycloalkyl group having a carbon number of 5 to 8, a carbon two: a ^^^ yl group, and a (Ζι, a square group, a subring group having a carbon number of 2 to 6, q represents a group represented by 〇 or i and ^ independently represents a group represented by 3 〇, an integer, and _(ZVb_二表; 1: indicates a carbon number of 1) ~4 Wei group or carbon (and Z independent group, B represents phenylene group, and s represents a group represented by ring-burning, not -CH2-, -C(CH3)2·, 54 200927790 -Ο a group represented by -, -CO-, -S- or S〇2_), or a group in which one to three hydrogens of these groups are substituted with a hydroxyl group. In this case, a preferred W is a carbon number of 1~ An alkyl group of 8, an alkenyl group having a carbon number of 3 to 4, a cyclohexyl group, a phenyl group, a benzyl group, a poly(ethyleneoxy)ethyl group having a carbon number of 4 to 1 fluorene, a phenoxyphenyl group, or a phenyl fluorenyl group. a phenyl group, a phenylisopropylidene phenyl group, and a group in which one or two hydrogens of these groups are substituted by a hydroxyl group. When n = 2 in the formula (Ina) W represents an alkylene group having 2 to 20 carbon atoms, a cycloalkylene group having 5 to 8 carbon atoms, an arylene group having 6 to 12 carbon atoms, © a_zl_〇-(z2〇)r-Z3-( a group represented by Z1 to Z3 and r as defined above), a group represented by -Z4-B-Z5- (wherein Z4, Z5 and B are as described above), and -B-(0-B) sT-(B-0)sB- (B represents a phenylene group, T represents an alkylene group having a carbon number of 1 to 3, 〇 _ or _s 〇 2, and s represents a group represented by hydrazine or 1), Or a group in which one to three hydrogens of these groups are substituted with a hydroxyl group. In this case, preferred W is an alkylene group having a carbon number of 2 to 12, a cyclohexylene group, a phenylene group, a phenylarylene group, a group represented by xylylene, -C3H6-0-(Z2-0)r-0-C3H6_ 〇 (Z2 represents a alkylene group having a carbon number of 2 to 6, and r represents 1 or 2), and (B) a group represented by a phenylene group and having a T group not represented by -CH^-, -0_ or -S02-), represented by _b-〇-B-C3H6-B-〇-B- (B represents a phenylene group) a group, and a group in which one or two hydrogens of these groups are substituted by a hydroxyl group. Such an alkenyl-substituted nadicylimine compound can be used, for example, as in Japanese Patent No. 2729565 As described, the obtained compound is synthesized by substituting an alkenyl-substituted nadic anhydride anhydride derivative and a diamine at a temperature of 80 ° C to 220 ° C for 0.55 hours to 2 hours, or a commercially available product. Specific examples of the compound-alkenyl substituted nadic ylidene compound include the compounds shown below. Ν-Methyl-dilylbicyclo[2.2.1]hept-5-ene-2,3-dimethyla Amine (N-methyl-allylbicyclo[2.2.1]hept-5-ene-2,3-dicarboximide), N-mercapto-mercaptomethylbicyclo[2.2.1]hept-5-ene-2,3 - Dimethylimine, N-methyl-mercaptopropylbicyclo[2.2.1]hept-5-ene-2,3-dimethylimine, N-methyl-decylallyl Bicyclo[2.2.丨]hepteose _2,3_dimethylhydrazine©imine, N-(2·ethylhexyl)-allylbicyclo[2.2.1]g _5_diluted_2,3 _ dimethyl quinone imine, N_(2-ethylhexyl) propyl (methyl) bicyclo [221] hept-5-ene-2,3-diindole, N-dilyl-thin Propylbicyclo[2.2.1]heptene_2,3_diimide, N-allyl-allylmethylbicyclo[2 21]hept-5-ene-2,3_diimine , N-allyl-mercaptopropyl bicyclo [22 g _5_ 稀_2,3_ dimethyl hydrazine , Ν-isopropenyl-allylbicyclo[2 21]hept-5-ene-2,3_diimine, oxime-isopropenyl-allyl (fluorenyl)bicyclo ρ 2丨]g 5-ene-2,3-dimethylimine, N-isopropenyl-methylallyl bicyclo [2 2 ^heptan® ene-2,3-diimine, N-cyclohexyl- Allyl bicyclophene P.2.1]hept-5-ene_2,3-dimethylimine, N-cyclohexyl-propylpropyl (fluorenyl)bicyclo ρ.2.ηg _5_ ene-2,3 -dimethylimine, fluorene-cyclohexyl-decylallyl biscyclo[2 21]hept-5, dilute-2,3-diindole, imine-phenyl-allyl bicyclo ρ.2 .η庚_5_稀_2,3· Diimine, Ν·笨基-Dilyl (methyl)bicyclo[2 2 ^_5_稀_2,3_一甲醯亚,,Ν- Alkyl-allylbicyclo[221]hept-5_wo-2,3-dimethylanimine, anthracene: benzyl-dipylmethylbicyclo[2 21]g_5_lean·2,3 _ dimethyl imino, Ν-knot group 曱 allyl bis bicyclo [2 2 ^ ng · ^ dil _2, 3 _ 曱 亚 亚 56 200927790 amine, N- (2 · thioethyl) _ Dilyl biscyclo[[3)]heptyl], N-side ethyl)g-methyl)di-silver dimethylimineimine' N_(2_-ethyl)-methyl-dip-biguanide, - dilute-2, 3-—I, imino, N-(2 2--methyl 1 1 ) · Ring called _, 3_丄亚- ❹ = propyl ^ methyl a) double ring [2.2.1] Geng Fu 2,3_ two "dipropenylene bicyclo [2.2.1] Geng Fu 2,3 ^ ^ G -5 躲二二N=,双卿.收·5= : Ψ =f ring called stalk (methyl) bisbicyclo[2.2.1]g _5_ene_2 3_ , ^ (4 phenyl) ) allylpropyl (fluorenyl) double heterogeneous heptene 2,3 oxime diyl > dilute phenyl > methallyl bisphenylyl). methyl aryl ... "amine N-(3-hydroxyphenyl)- propylpropyl dimethyl hydrazine-transferred _ group ^) ==, 3_ dilute _2,3-dimethyl urethane, N_( =[2.2.1]g-5 - && dimethyl quinone imine, bicyclo [2.2.1] g _5_ dilute _2 3 - bis, ethoxylated) ethyl bromide Ν - {2- (2. Ethyl) bis-bis: tyrosine, f quinane. 2. ''-Asian two:=ί 57 200927790 ethoxy)ethoxy}ethyl]-dilylbicyclop 2 ηg _5 _ dilute _2,3 bis quinone imine, Ν-[2-{2-(2-hydroxyethoxy)ethoxy}ethyl; I- propyl propyl (fluorenyl) bicyclo [2.2.1 Hg-5-ene-2,3-diimineimine, Ν-[2-{2_(2-hydroxyethoxy)ethoxy}ethyl]-mercaptopropyl bicyclo [22.η Geng_5_ene_2,3-dimethylanimine, Ν-{4·(4.hydroxyphenylisopropylidene)phenyl Diallylbicyclo[2.2.1]hept-5-ene-2,3-diimineimine, Ν-{4-(4-hydroxyphenylisopropylidene) benzyl}•dilyl Methyl)bicyclo[2.2.1]hept-5-indole-2,3-diimineimine, Ν-{4_(4-hydroxyphenylisopropylidene)phenyl}-mercaptopropyl double ring [2.2.1] G--5-ene-2,3-one brewed imine, and their oligomers (〇iig〇mer); N,N'-ethylene-bis(allylbicycloindole) (N,N-ethylene-bisCallylbicyclol^HJhept-S-eneJ'S-dicarboximide) , N,N'-ethylene bis(dipropyl fluorenylbicyclo[ 221] G-5-Wo-2,3-dimethylimine), N,N,·Ethylene-bis(methylallylbicyclo[2.2.1]hept-5-rare-2,3 - bismuth imine), ν, Ν'·triamyl bis(dipropylbicyclo[2.2.1]hept-5-ene-2,3-dimethylimine), ν, Ν, - Hexamethylene-bis(allylbicyclo[2.2.1]hept-5-female-2,3-carboximine), ν, Ν,-hexamethylene-® bis (l-propyl hydrazine) Bicyclo[2.2.1]hept-5-ene-2,3-diindoleimine), ν, Ν, - 12 fluorenyl bis(allylbicyclo[2·2 ”h-, ene 2,3_dimethylimine ), Ν,Ν'-docamethylene-bis(allylmethylbicyclic guanidine.21]hept-5-ene-2,3-diimineimine), ruthenium, osmium, _cyclohexylene _Bis(allylbicyclo[2 21]hept-5-ene-2,3-dimethylimineimine), ν,Ν,-cyclohexylene-bis(allylhydrazylbicycloindole.2.1) -5-ene·2,3-diimineimine), bis, 〆 propyl bisbicyclic P.2.1] g _5_ roasted-2,3-dimethyl quinone imine) propoxy} Alkane, u-double {3, _ (propyl propyl methyl bicyclic P.2.1) hept-5-ene 2,3-dimethylimine imine) propoxy} ethyl 58 200927790 , alkane, 1,2- Double {3,-(methallylbicyclo[2.2.1]hept-5-ene-2,3-dimethylimine)propoxy}ethyl bromide, biguanide··{3'·(lean Propylbicyclo[2.2.1]hept-5·ene·2,3_dimethylimine imine)propoxy}ethyl]ether, bis[2,-{3l (allylmethylbicyclo[2.2.1 ]hept-5-ene-2,3-diimineimine)propoxy}ethyl]ether, i 4•double {3·-(dilylbicyclo[2.2.1]hept-5-ene- 2,3-dimethylimine imine)propoxy}butane, 1,4-bis{3'-(allylmethylbicyclic oxime^heptene-ene^diimide)propoxy丁丁丁, N, N'-p-phenylene-bis(dil-propylbicyclo[2 2.1]hept-5-ene -2,3_dimethylimine imine), N,N'-p-phenylene-bis(allylhydrazinobicyclo[2.2.1]hept-5-ene-2,3-dimethylimine ), n, N'-meta-phenylene _ bis (allyl bicyclo [2.2.1] hept-5-ene-2,3-diimine imine), N, N, _ m-phenylene _ Bis($propylmethylbicyclo[2.2.1]hept-5-ene-2,3-diimineimine), nkoiyl)-2,4-phenylene}-bis(allylbiscycloolefin 3_dimethylimine imine), N,N,-p-diphenylene phenyl-bis(allylbicyclo[2·2 ηhept-5-ene-2,3·diimide), Ν, Ν, _ p-diphenyl phenyl bis (allyl fluorenylbicyclo [2.2.1] hept-5-ene-2,3-dimethyl quinone imine), hydrazine, hydrazine, - mica曱Phenyl-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-carboximine), hydrazine, hydrazine, m-xylene-based bis-allyl Bicyclic guanidine .2.1] hept-5-ene-2,3-dimethyl quinone imine), 2,2 bis [Μ4·(allylbicyclo[2.2.1]hept-5-ene-2,3- Dimethyl imidate) phenoxy} phenyl] propane, 2,2 bis [4_{4_(allylmethylbicyclo[2 21]hept-5-dimethyl dimethylimine) phenoxy }phenyl]propane, 2,2_bis[4_{4曱曱ylallylbicycloindole.2.1]hept-5-ene-2,3-dimethylhydrazine Imine)phenoxy}phenyl]propane, bis{4-(allylbiscycloalkenene-2,3-dimethylimine)phenyl}H, bis{4-(dilylmethylbicyclo[ 2·2· 1]g _5·埽·2,3_: formazan 1 amine) stupid} methane, double {((methylallyl bis-cyclic 59 200927790 bis-imine) phenyl} decane, Double {4-(methylallylmethylbicyclo[2.2.1]hept-5-ene-2,3-diimideimine)phenyl}methane, double {4-(allylbicyclo[2.2 .1]hept-5-ene-2,3-dimethylimine)phenyl}ether, bis{4-(allylmethylbicyclo[2.2.1]hept-5-ene-2,3- Dimethyleneimine)phenyl}ether, bis{4-(methylallylbicyclo[2.2.1]hept-5-ene-2,3-dimethylimine)phenyl}ether, double { 4-(allylbicyclo[2.2.1]hept-5-ene-2,3-carboximine)phenyl}indole, bis{4-(allylhydrylbicyclo[2.2.1]g -5-ene-2,3-diimineimine)phenyl}sulfone, bis{4-(mercaptoallylbicyclo[2.2.1]hept-5-ene-2,3-dioxime Amine)phenyl} © sulfone, 1,6-bis(allylbicyclo[2.2.1]hept-5-ene-2,3 dimethylimine)-3-hydroxy-hexane, U2-double ( Mercaptopropyl bicyclo [2.2.1] hept-5-ene-2,3-dimethylimine)-3,6-dihydroxy-dodecane, 1,3-bis(allyl Ring [2.2.1] hept-5-ene-2,3-diimineimine)-5-hydroxy-cyclohexane, 1,5-bis{3·-(allylbicycloP.2.1]g -5-ene-2,3-diimineimine)propoxy}-3-hydroxy-pentane, 1,4-bis(allylbicyclo[2·2·1]hept-5-ene- 2,3-dimethylimine)-2-hydroxybenzene, 1,4-bis(allylhydrylbicyclo[2.2.1]hept-5-ene-2,3-dimethylimine)- 2,5-dihydroxy-benzene, N,N'-p-(2-hydroxy)-xylylene-bis(allyl-ylbicyclo-P.2.1]hept-5-ene-2,3-dimethyl Imine), N, N'-p-(2-hydroxy) stilbene phenyl-bis(allylmethylcyclo[2.2.1]hept-5-ene-2,3-diimine ),N,N'-m-(2-hydroxy)pyridinium-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-diimineimine), hydrazine, hydrazine ·---(2-hydroxy) stilbene phenyl-bis(methylallylbicyclo[2.2.1]hept-5-ene-2,3-diimineimine), hydrazine, Ν'- P-(2,3-dihydroxy)pyridinium-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-carboximine), 2,2-dual [ 4-{4-(allylbicyclo[2.2.1]hept-5-ene-2,3-diimideimine)-2-hydroxy-indolyl}phenyl]propane, double {4-( Allyl 200927790 J-based f-ene '3-dimethylanimine>_2-trans-phenyl·methyl}methyl, bis (3_(allylbicyclo[2.2.. phenyl-phenyl} ether, double {3 彳 μ μ imide blanket II ( Ft-propyl bicyclic guanidine .2.1]g _5_rare-2,3-dimethyl, / },, three {4_(allyl-propylbicyclo). Oxydecylpropane, N,N',N"--(Ethylene-methylallylbicyclo[2 2"]hept_5_diluted_2,3•2? Iridoids, isocyanurates, and oligomers thereof.
另外,本發明中使用的烯基取代納迪克醯亞胺化合物 也可以是非對稱的含有亞烷基、亞苯基的以卞述結構式表 示的化合物。Further, the alkenyl-substituted nadicylimine compound used in the present invention may be an asymmetric compound containing an alkylene group or a phenylene group as a structural formula.
61 200927790 亞胺化合物中優選的 以下列舉所述烯基取代納迪克醯61 200927790 Preferred among imine compounds The following alkenyl substituted nadik 醯
稀-2,3·二甲酿亞胺)、 N,NL亞乙基·雙(烯丙基雙環[2.2.1]庚_5_烯_2,3 庚-5_稀-2,3·二甲醯亞胺)、耶六亞f基鲁^|德傻Dilute-2,3·dimethylanimine), N, NL ethylene·bis(allylbicyclo[2.2.1]hept-5-ene-2,3 hept-5_rare-2,3· Dimethyl imine), Yeriya fakilu ^| De silly
-雙(烯丙基甲基雙環[221]庚_5 亞乙基-雙(甲基締丙錢環[2 2 η庚 、Ν,Ν,_三亞曱基-雙(烯丙基雙環[2.2.1] 厂ΙΜ,Γ、卜十二亞甲基 二甲醯亞胺)、NJST-十二 亞甲基-雙(稀丙基曱基雙環[2.2.1]庚·542,3·」甲酿^ 胺)、Ν,Ν,-亞環己基-雙(稀丙基雙環[2 21]庚_5_稀_2 3二曱 釀亞胺)、Ν,Ν,-亞環己基雙(缔丙基甲基雙環[221]庚二烯 -2,3-二曱醯亞胺)、Ν,Ν,-對亞笨基_雙(烯丙基雙環[2 2丨]庚 -5-烯-2,3-二甲醯亞胺)、Ν,Ν,_對亞苯基-雙(烯丙基甲基雙環 [2.2.1]庚-5_烯-2,3-二曱醯亞胺)、Ν,Ν,-間亞苯基-雙(烯丙基 ❹ 雙壤[2.2.1]庚-5-稀-2,3-·一曱酿亞胺)、Ν,Ν’-間亞苯基_雙(婦 丙基曱基雙環[2·2·1]庚-5-烯-2,3-二甲酿亞胺)、ν ν,_{(1-甲 基)-2,4-亞笨基}雙(烯丙基雙環[2.2.1]庚·5^_2,3_二甲醯 亞胺)、Ν,Ν-對亞一曱本基-雙(婦丙基雙環[2.2.1]庚-5-蛾 -2,3-二曱醯亞胺)、Ν,Ν·-對亞二曱苯基-雙(烯丙基甲基雙環 Ρ.2.1]庚-5-稀-2,3-二甲醢亞胺)、Ν,Ν’·間亞二甲苯基_雙(稀 丙基雙環[2.2.1]庚-5-稀-2,3-二曱酿亞胺)、ν,ν,_間亞二甲苯 基-雙(稀丙基甲基雙環[2.2.1]庚-5-稀-2,3-二曱酿亞胺)、2,2- 62 200927790 雙[4-{4·(稀丙基雙環[2.2.1]庚-5|2,3_二甲醢亞胺)苯氧 基}苯基]丙烧、2,2-雙[M4·(稀丙基曱基雙環[工糾庚·5.稀 -2,3-一甲酿亞胺)苯氧基}苯基]丙燒、2,2_雙[4_㈣甲基稀 丙基雙環[2·2.1]庚-5m曱酿亞胺)笨氧基}苯基]丙 烧、雙{4·(稀丙基雙環阳如姻,3_二甲酿亞胺)苯基} 甲烷、雙{4_(烯甲基雙環[2.2庚·- bis(allylmethylbicyclo[221]hept-5ethylene-bis(methyl-propionate ring [2 2 ηhept, hydrazine, hydrazine, _trientylene-bis(allylbicyclo[2.2] .1] ΙΜ, Γ, 卜, methylene dimethyl quinone imine), NJST-docamethylene-bis (l-propyl fluorenyl bicyclo [2.2.1] G · 542, 3 · A Brewed amines, hydrazine, hydrazine, - cyclohexylene-bis (dilyl propyl bicyclo [2 21] g _5_ dil _2 3 bis-imine), hydrazine, hydrazine, - cyclohexylene bis ( Propylmethylbicyclo[221]heptadiene-2,3-diimineimine), anthracene, fluorene,-p-stylene-bis(allylbicyclo[2 2丨]hept-5-ene- 2,3-dimethylimine), hydrazine, hydrazine, _p-phenylene-bis(allylmethylbicyclo[2.2.1]hept-5-ene-2,3-diimideimine) , Ν, Ν, - m-phenylene-bis(allyl hydrazine double soil [2.2.1] hept-5-lean-2,3-·one brewed imine), hydrazine, Ν'-m-phenylene Base_bis(f-propyl decylbicyclo[2·2·1]hept-5-ene-2,3-dimethylenimine), ν ν,_{(1-methyl)-2,4- Substrate } bis (allyl bicyclo [2.2.1] g · 5 ^ 2, 3 - dimethyl quinone imine), hydrazine, hydrazine - p-indenyl quinone-bis (propyl propyl bicyclo [2.2. 1] G-5-Moth-2,3-diimine), Ν Ν·-p-p-phenylene-bis(allylmethylbicycloindole.2.1]hept-5-lean-2,3-dimethylimine), hydrazine, Ν'·m-xylylene _ Bis(dilylbiscyclo[2.2.1]hept-5-rare-2,3-diindoleimine), ν,ν,_m-xylylene-bis(trimylmethylbicyclo[2.2. 1]g-5-rare-2,3-di-anthracene imine), 2,2- 62 200927790 bis [4-{4·(dilyl bis-bicyclo[2.2.1]hept-5|2,3_ Dimethyl imidate) phenoxy} phenyl] propyl ketone, 2, 2- bis [M 4 · (dilyl propyl bis bicyclo [ 克 · · 5 5 . . , , , , ) ) ) ) ) )) Phenoxy}phenyl]propane, 2,2_bis[4_(tetra)methyldipylbicyclo[2·2.1]hept-5m曱iimide) phenyloxy}phenyl]propane, double {4· (dilyl propyl bicyclic cations, 3 dimethyl imipenem) phenyl} methane, double {4_(enmethylbicyclo[2.2 g·
胺)苯基}甲院、終(▼基烯丙基雙觀叫庚-5-U· :甲^亞胺)苯基}甲院、雙{4_(甲基婦丙基甲基雙環[2 21] 庚-5务2,3-二甲醯亞胺)苯基}甲燒、雙卜(稀丙基雙環 [2.2.1]庚_5_烯·2,3_:甲酿亞胺)苯基渖、雙{4_(婦丙基〒基 雙環[2.2:1]庚_5_埽_2,3_二甲醯亞胺)苯基}鱗、雙㈣甲基稀 丙基雙=[Ζ2.1]庚-5_晞_2,3-二甲酿亞胺)苯基、雙㈣稀 丙基雙祁.2.1]庚_5_烯_2,3_二曱酿亞胺)苯基}硬、雙㈣稀 丙基甲基雙壞[2.2.1]庚_5_埽_2,3-二甲酿亞胺)苯基}颯、雙 ^(甲基稀丙基雙環[2.2.lm_5|2,3·二甲酿亞胺)苯基} 以下列舉更加優選的烯基取代納迪克醯亞胺化合物。 N,N亞乙基-雙(烯丙基雙環P.2.1]庚-5-婦-2,3-二甲醯 亞胺} ' N’N'•亞乙基·雙(稀丙基甲基雙環P.2.1]庚-5-嫦-2,3--甲酿亞胺)、N,N’_亞乙基.雙(甲基婦丙基雙環[2 21]庚_5_ 稀-2,3-二甲酿亞胺)、_,_三亞甲基雙(稀丙基雙環[⑵] 庚-5-烯-2,3-二甲醯亞胺)、Ν,Ν,_六亞曱基_雙(烯丙基雙環 [2.2.1]庚-5-烯_2,3-二甲醯亞胺)、n,n,_a亞甲基_雙(烯丙基 甲基雙環[2.2.1]庚_5·稀·2,3·4醢亞胺)、N,NL十二亞p基 63 200927790 胺)、t 甲雔基雙環Μ.1]庚傳2,3·二甲酿亞 23 1疏,;π;π己基-雙烯丙基甲基雙環[2.2.1]庚烯 5,烯、Ν,Ν,對亞苯基_雙(烯丙基雙環[2·2. j i % ' N’N’.苯基·雙(婦丙基 Ο ❹ 丙基甲基雙環甲Γ_間亞苯基销 置… 庚席,曱醯亞胺)、职-{(1_甲 土 )_2,4·亞苯基卜雙(稀丙基雙環[Μ狀士稀办工甲醯 =、_,_對亞二¥苯基·雙(柄基雙環[⑵]庚领 :N,NL對亞二甲笨基,婦丙基甲基雙環 ; 甲醯亞胺)、取,.間亞二甲苯基_雙(稀 =雙衣[2.2.1]庚·5_烯_2,3·二甲酿亞胺)、N,N,·間亞二甲苯 ^雙(稀丙基甲基雙環[2.2·_5.2,3_二甲酿亞胺)、2,2_ 雙[4-{4-(烯丙基雙環[2.2.1:1庚_5_婦·2,3_ 麟基]丙院、2,2·雙陣(烯丙基甲基雙環[221=二 •2,3-二甲醯亞胺)苯氧基}苯基]丙烷、 丙基雙環⑽]庚傅二甲酿亞胺)笨 烧、雙{4-(烯丙基雙環[2.2.^.5.烯办二甲酿亞胺)苯基} 甲烷、雙{4·(稀丙基甲基雙環[2.21]庚_5_稀_2,3_二甲酿亞 胺)苯基}f烧、雙忤(甲基烯丙基雙環[221]庚_5_#_2,3_ -甲酿亞㈤苯基烧、雙{4_(甲基婦丙基甲基雙環[221] 庚-5·烯_2,3-二甲醯亞胺)苯基}f烷。 200927790 而且’特別優選的烯基取代納迪克醯亞胺化合物可以 2舉如下所叫⑽構式(Ina-1)表示的雙{4_(烯丙基雙 環[2·2.1]庚-5-歸_2,3-二甲醯亞胺)苯基}曱院、以結構式(1仙 一2)表示的N,N,_間亞二甲苯基_雙(烯丙基雙環[2 21]庚_5_ 烯2’3 一甲醯亞胺)、以及以結構式(Ina_3)表示的N,N'-六亞甲基·雙(稀丙基雙環[2.2.1]庚·5·稀·2,3·二曱酿亞胺)。Amine) phenyl} 甲院, the final (▼ base ally propyl double-called g--5-U · : methyl imine) phenyl} A hospital, double {4_ (methyl propyl propyl bicyclo [2 21] Geng-5, 2,3-dimethylimine, phenyl}, and bis(dipropylbicyclo[2.2.1]hept-5-ene·2,3_:carnimine)benzene Base, double {4_(propyl propyl hydrazinobicyclo[2.2:1]g _5_埽_2,3_dimethylimine) phenyl} scale, bis(tetra)methyl propyl propyl = [Ζ2 .1] G-5-晞_2,3-dimethylenimine)phenyl, bis(tetra)propylidene hydrazide.2.1]hept-5-ene-2,3_diphenylenimine)phenyl } hard, bis (tetra) propyl propyl double bad [2.2.1] g _5_ 埽 2, 3- dimethyl imino) phenyl} 飒, bis (methyl propyl bicyclo [2.2. Lm_5|2,3·dimethylenimine)phenyl} The more preferred alkenyl substituted nadic quinone imine compound is listed below. N,N ethylidene-bis(allylbicyclo P.2.1]hept-5-female-2,3-dimethylimine]} 'N'N'•ethylene·bis(l-propylmethyl) Bicyclophene P.2.1]hept-5-oxime-2,3--carboimine), N,N'-ethylidene.bis(methylpropylpropylbicyclo[2 21]hepta-5_zinc-2, 3-dimethylimine), _,_trimethylenebis(dilylbicyclo[(2)]hept-5-ene-2,3-dimethylimine), hydrazine, hydrazine, _hexamethylene fluorenyl _ bis (allyl bicyclo [2.2.1] hept-5-ene 2,3-dimethyl quinone imine), n, n, _a methylene _ bis (allyl methyl bicyclo [2.2.1 ]g _5·lean·2,3·4 yimine), N, NL, tau, p-group 63 200927790 amine), t-mercaptobicyclopurine.1]g. 2,3·dimethyl ya 23 1 sparse; π; π-hexyl-bisallylmethylbicyclo[2.2.1]heptene 5, alkene, anthracene, anthracene, p-phenylene-bis(allylbiscyclo[2·2. ji % ' N'N'. Phenyl bis (propyl propyl hydrazide propyl propyl bicyclomethyl hydrazine _ m-phenylene pinned ... Geng Xi, 曱醯 imine), job - { (1_ 甲土) _2, 4· phenylene b double (dilyl propyl bicyclo [Μ 士 稀 办 醯 醯 、 、 、 、 、 、 、 、 、 、 、 亚 亚 柄 柄 柄 柄 : : : : : : : : : : : : : : : : : : : : A stupid base, propyl propyl bicyclol; Mercaptoimine), taken, m-xylylene _ bis (diluted = double coat [2.2.1] hept-5-ene-2,3 dimethylanimine), N, N, · ya Xylene^bis(dilylpropylbicyclo[2.2._5.2,3-dimethylenimine), 2,2_bis[4-{4-(allylbicyclo[2.2.1:1g] 5_妇·2,3_ 麟基]Binyuan, 2,2·double array (allylmethylbicyclo[221=2,2,3-dimethylimine]phenoxy}phenyl]propane, Propyl bicyclo (10)] Gengfu diimide) Stupid, double {4-(allyl bicyclo [2.2.^.5. olefinic xylenimide) phenyl} methane, double {4 · (red propylene Methylbicyclo[2.21]glycol-5-diluted _2,3-diennimine)phenyl}f-fired, biguanide (methylallylbicyclo[221]hept_5_#_2,3_-A Stuffed (5) phenyl, double {4_(methylpropylpropylmethylbicyclo[221]hept-5-ene-2,3-dimethylimine)phenyl}f-alkane. 200927790 and 'particularly preferred The alkenyl-substituted nadicylimine compound can be exemplified by the following double (4) (allylbicyclo[2·2.1]hept-5-return-2,3-dimethyl group represented by the (10) configuration (Ina-1). ,imino)phenyl} 曱, N,N,_m-xylylene _bis(allylbicyclo[2 21]g _5 represented by the structural formula (1 sen 2) _ olefin 2'3 monomethylimine), and N,N'-hexamethylene bis (dipropyl biscyclo[2.2.1] gh·5·dilute 2, represented by the structural formula (Ina_3), 3. Two brewed imines).
(I na— 3) 而且,例如從使液晶顯示元件的電特性長期穩定的觀 醫 財慮,本發明的液晶配向劑可以進_步 聚合性不飽和雙鍵的化合物。所述具有自由=== 和雙鍵的化合物可以是一種化合物,也可以是兩種或者兩 種以上的化合物。另外,所述具有自由基聚合性不飽和雙 鍵的化合物中不包括所述絲取代納迪克酿亞胺化合物。 從所述觀點考慮,所述具有自由基聚合性不飽和雙鍵的化 合物的含量以相對於聚醯胺酸或者其衍生物的重量比計, 優選爲0.01〜1.00,更加優選爲0 01〜0 70,進一步優選 65 200927790 爲 0.01 〜〇 5〇。 另外,從降低液晶顯示元件的離子密度、抑制離子密 度2隨時間增大、而且抑制殘像的觀點考慮,具有自由基 聚合性不飽和雙鍵的化合物相對於稀基取代納迪克酿亞胺 :匕5合:的比率以重量比計,優選爲0.1〜10 ’更加優選爲 所述具有自由基聚合性不飽和雙鍵的化合物可以列舉 (曱基)丙烯酸酯、(曱基)丙烯醢胺等(曱基)丙烯酸衍生物以 及雙馬來醯亞胺(bismaleimide)。所述具有自由基聚合性 不飽和雙鍵的化合物更加優選具有兩個或兩個以上的自由 基聚合性不飽和雙鍵的(甲基)丙烯酸衍生物。 (曱基)丙稀酸酯的具體例,例如可以列舉:(甲基)丙稀 酸環己酯、(甲基)丙烯酸2-甲基環己酯、(甲基)丙烯酸二環 戊酯、(曱基)丙烯酸二環戊氧基乙酯、(曱基)丙烯酸異冰片 酯(isobornyl (meth)acrylate)、(曱基)丙烯酸苯酯、(曱基) 丙烯酸苄酯、(甲基)丙烯酸2-羥基乙酯以及(曱基)丙稀酸 φ 2-羥基丙酯。 雙官能(甲基)丙烤酸酯的具體例,例如可以列舉:雙 丙烯酸乙二酯’東亞合成化學工業股份有限公司的産品 ARONIX M-210、ARONIX M-240 和 ARONIX M-6200,日(I na-3) Further, for example, from the viewpoint of stabilizing the electrical characteristics of the liquid crystal display element for a long period of time, the liquid crystal alignment agent of the present invention can be a compound of a polymerizable unsaturated double bond. The compound having a free === and a double bond may be one compound or two or more compounds. Further, the filament-substituted nadick-bromide compound is not included in the compound having a radical polymerizable unsaturated double bond. From the viewpoint of the above, the content of the compound having a radical polymerizable unsaturated double bond is preferably 0.01 to 1.00, more preferably 0 01 to 0, based on the weight ratio of the polyglycine or the derivative thereof. 70, further preferably 65 200927790 is 0.01 ~ 〇 5 〇. Further, from the viewpoint of lowering the ion density of the liquid crystal display element, suppressing the increase of the ion density 2 with time, and suppressing the afterimage, the compound having a radical polymerizable unsaturated double bond is substituted with a dilute group of Nadick's acrylonitrile: The ratio of 匕5: is preferably 0.1 to 10' by weight. More preferably, the compound having a radical polymerizable unsaturated double bond may be (mercapto) acrylate, (mercapto) acrylamide or the like. (Mercapto) acrylic acid derivatives and bismaleimide. The compound having a radical polymerizable unsaturated double bond is more preferably a (meth)acrylic acid derivative having two or more free radically polymerizable unsaturated double bonds. Specific examples of the (mercapto) acrylate include, for example, (meth)acrylic acid cyclohexyl ester, (meth)acrylic acid 2-methylcyclohexyl ester, and (meth)acrylic acid dicyclopentyl ester. (fluorenyl) dicyclopentyloxyethyl acrylate, isobornyl (meth)acrylate, phenyl (meth) acrylate, (benzyl) benzyl acrylate, (meth) acrylate 2-hydroxyethyl ester and (fluorenyl) acrylic acid φ 2-hydroxypropyl ester. Specific examples of the difunctional (meth)propionic acid ester include, for example, a product of AEDIX M-210, ARONIX M-240 and ARONIX M-6200.
本化藥股份有限公司的産品KAYARAD HDDA、 KAYARAD HX-220、KAYARAD R-604 和 KAYARAD R-684,大阪有機化學工業股份有限公司的産品V260、 V312和V335HP,以及共榮社油脂化學工業股份有限公司 66 200927790 的産品 Light Acrylate BA-4EA、Light Acrylate BP-4PA 和 Light Acrylate BP-2PA。Products of KAICRAD HDDA, KAYARAD HX-220, KAYARAD R-604 and KAYARAD R-684, products of Osaka Organic Chemical Industry Co., Ltd. V260, V312 and V335HP, and Co., Ltd. Company 66 200927790's products Light Acrylate BA-4EA, Light Acrylate BP-4PA and Light Acrylate BP-2PA.
三官能或者三官能以上的多官能(甲基)丙烯酸酯的具 體例,例如可以列舉:4,4'-亞曱基雙(N,N-二羥基亞乙基丙 烯酸酯苯胺)、ARONIX M-400、ARONIX M-405、ARONIX M-450、ARONIX Μ-Ή00、ARONIX M-8030、ARONIX M-8060、KAYARAD TMPTA、KAYARAD DPCA-20、 KAYARAD DPCA-30、KAYARAD DPCA-60、KAYARAD 〇 DPCA-120、以及大阪有機化學工業股份有限公司的産品 VGPT。 (甲基)丙烯醯胺衍生物的具體例,例如可以列舉:N-異丙基丙烯醯胺,N-異丙基甲基丙烯醯胺、N-正丙基丙烯 醯胺、N-正丙基曱基丙烯醯胺、N-環丙基丙烯醯胺、N-環 丙基曱基丙烯醯胺、N-乙氧基乙基丙烯醢胺、N-乙氧基乙 基曱基丙烯醯胺、N-四氫糠基丙烯醯胺 (N-tetrahydrofurfuryl acrylamide ),N-四氫糠基曱基丙烯 ❹ 醯胺、N-乙基丙烯醯胺、N-乙基-N-曱基丙烯醯胺、N,N-二乙基丙烯醯胺、N-甲基-N-正丙基丙烯醯胺、N-甲基-N-異丙基丙烯醯胺、N-丙烯醯基呱啶(N-acryloyl piperidine)、N-丙婦酿基吼嘻烧(N-acryl〇yl pyrrolidine)、 n,n'-亞甲基雙丙烯醯胺、n,N’-亞乙基雙丙烯醯胺、n,n’-二羥基亞乙基雙丙烯醯胺、N-(4-羥基苯基)曱基丙烯醯 胺、N-苯基甲基丙烯醯胺、N-丁基曱基丙烯醢胺、N-(異丁 氧基甲基)曱基丙烯醯胺、N-[2-(N,N-二甲基氨基)乙基]甲 67 200927790 基丙烯醯胺、N,N-二甲基甲基丙婦酿胺、n-[3-(二甲基氨 基)丙基]甲基丙烯醯胺、N-(曱氧基甲基)甲基丙烯醯胺、 N-(羥基甲基)_2_甲基丙烯醯胺、N苄基·2·曱基丙烯醯胺以 及Ν,Ν'-亞甲基雙甲基丙烯醯胺。 所述的(甲基)丙烯酸衍生物中,特別優選Ν,Ν,_亞甲基 雙丙烯醯胺、Ν,Ν’-二羥基亞乙基-雙丙烯醯胺、雙丙烯酸 乙二酯以及4,4,_亞甲基雙(Ν,Ν-二羥基亞乙基丙烯酸酯苯 胺)。Specific examples of the trifunctional or trifunctional or higher polyfunctional (meth) acrylate include, for example, 4,4'-fluorenylene bis(N,N-dihydroxyethylene acrylate aniline), ARONIX M- 400, ARONIX M-405, ARONIX M-450, ARONIX Μ-Ή00, ARONIX M-8030, ARONIX M-8060, KAYARAD TMPTA, KAYARAD DPCA-20, KAYARAD DPCA-30, KAYARAD DPCA-60, KAYARAD 〇DPCA-120 And VGPT, a product of Osaka Organic Chemical Industry Co., Ltd. Specific examples of the (meth) acrylamide derivative include, for example, N-isopropyl acrylamide, N-isopropyl methacrylamide, N-n-propyl acrylamide, N-n-propyl Alkyl acrylamide, N-cyclopropyl acrylamide, N-cyclopropyl decyl acrylamide, N-ethoxyethyl acrylamide, N-ethoxyethyl decyl acrylamide , N-tetrahydrofurfuryl acrylamide, N-tetrahydrofurfuryl acrylamide guanamine, N-ethyl acrylamide, N-ethyl-N-mercapto acrylamide , N,N-diethyl acrylamide, N-methyl-N-n-propyl acrylamide, N-methyl-N-isopropyl acrylamide, N-propylene decyl acridine (N- Acryloyl piperidine), N-acryl〇yl pyrrolidine, n,n'-methylenebis acrylamide, n,N'-ethylenebis acrylamide, n, N'-dihydroxyethylene bis propylene amide, N-(4-hydroxyphenyl) decyl acrylamide, N-phenyl methacrylamide, N-butyl decyl acrylamide, N- (isobutoxymethyl)mercaptopropenylamine, N-[2-(N,N-dimethylamino)ethyl]methyl 67 200927790 , N,N-dimethylmethyl propyl melamine, n-[3-(dimethylamino)propyl]methacrylamide, N-(decyloxymethyl)methacrylamide, N-(hydroxymethyl)_2-methacrylamide, Nbenzyl·2·decyl acrylamide, and hydrazine, Ν'-methylene bis methacrylamide. Among the (meth)acrylic acid derivatives, particularly preferred are ruthenium, osmium, dimethylene bis decyl decylamine, hydrazine, Ν'-dihydroxyethylene-bis acrylamide, ethylene diacrylate, and 4 , 4, _ methylene bis (hydrazine, hydrazine - dihydroxy ethylene acrylate aniline).
® 雙馬來醯亞胺例如可以列舉:ΚΙ CHEMICAL INDUSTRY股份有限公司製造的bMi_7〇和bMI_8〇,以及 大和化成工業股份有限公司製造的BMI-1000、 BMI-3000、BMI-4000、BMI-5000 和 BMI-7000。 而且’例如從液晶顯示元件的電特性的長期穩定性的 觀點考慮,本發明的液晶配向劑可以進一步含有鳴嗪化合 物。所述β惡嗪化合物可以是一種化合物,也可以是兩種或 者兩種以上的化合物。從所述觀點考慮,所述噁嗪化合物 G 的含量相對於所述聚醯胺酸或者其衍生物,優選爲〇.丨重 量°/。〜50重量%,更加優選爲i重量%〜4〇重量%,進一 步優選爲1重量%〜20重量%。 所述噁嗪化合物優選的是’可溶於溶解聚醯胺酸或者 其衍生物的溶劑中、而且具有開環聚合性的噁嗪化合物。 而且’所述噁嗪化合物中的噁嗪結構的數量並無特別 限定。 關於嗔嗓的結構’已知有各種結構。本發明中,β惡嗪 68 200927790 的結構並無特別限定,所述噁嗪化合物中的噁嗪結構可以 列舉本並°惡唤(benzoxazine )或者蔡並β惡唤(naphth〇xazine ) 等具有包含縮合多環芳香族基團的芳香族基團的噁嗪結 構。 所述噁嗪化合物例如可以列舉下述通式(a)〜通式(f) 所表示的化合物。另外,下述通式中,朝向環的中心所表 示的鍵,表示鍵合於構成環並且能够鍵合取代基的任一個 碳上。® Bismaleimide can be exemplified by: bMi_7〇 and bMI_8〇 manufactured by INDUSTRY CHEMICAL INDUSTRY Co., Ltd., and BMI-1000, BMI-3000, BMI-4000, BMI-5000 and manufactured by Daiwa Kasei Kogyo Co., Ltd. BMI-7000. Further, the liquid crystal alignment agent of the present invention may further contain a azine compound, for example, from the viewpoint of long-term stability of electrical characteristics of the liquid crystal display element. The β-oxazine compound may be one compound or two or more compounds. From the viewpoint of the above, the content of the oxazine compound G is preferably 〇.丨 by weight / relative to the polyamic acid or a derivative thereof. It is preferably 50% by weight, more preferably i% by weight to 4% by weight, still more preferably 1% by weight to 20% by weight. The oxazine compound is preferably an oxazine compound which is soluble in a solvent which dissolves polyamic acid or a derivative thereof and which has ring-opening polymerizability. Further, the number of the oxazine structure in the oxazine compound is not particularly limited. Regarding the structure of the crucible, various structures are known. In the present invention, the structure of β-oxazine 68 200927790 is not particularly limited, and the oxazine structure in the oxazine compound may be exemplified by benzoxazine or naphth〇xazine. The oxazine structure of the aromatic group of the condensed polycyclic aromatic group. The oxazine compound may, for example, be a compound represented by the following formula (a) to formula (f). Further, in the following formula, the bond represented toward the center of the ring means that it is bonded to any of the carbon constituting the ring and capable of bonding the substituent.
所述通式(a)〜通式(c)中,Ri以及R2表示碳數爲 1〜30的有機基團。而且,所述通式(a)〜通式(f)中, R3至R6表示氫或者锬數爲1〜6的烴基。而且所述通式 (c)、通式(d)以及通式(f)中,X表示單鍵、_〇、_s_、 -S_S-、-S〇2-、-CO-、-CONH-、-NHCO-、-C(CH3)2-、 -C(CF3)2-、-(CH2)m-、-〇_(CH2)m_〇·、_s (CH2)m_s。此處 m 爲1〜6的整數。而且,所述通式(e)以及通式(f)中, 69 200927790 Υ 獨立地表亦單鍵、-Ο-、-S-、-CO-、-c(CH3)2-、-C(CF3)2_ 或者碳數爲1〜3的亞烧基。所述Y的鍵合於苯環、萘環 上的氫可以獨立地被取代爲_F、-CH3、-OH、、 ,so3h、-ρ〇3Η2 〇 而且,所述噁嗪化合物中包括侧鏈上具有噁嗪結構的 ίΐ物或者聚合物、主鏈中具有噁嗪結構的低聚物或者聚 Ο 以通式(a)表示的嗯唤化合物例如可以列舉以下的嗔 ^^化合物。In the above formulae (a) to (c), Ri and R2 represent an organic group having 1 to 30 carbon atoms. Further, in the above formulae (a) to (f), R3 to R6 represent hydrogen or a hydrocarbon group having a number of turns of 1 to 6. Further, in the above formula (c), formula (d) and formula (f), X represents a single bond, _〇, _s_, -S_S-, -S〇2-, -CO-, -CONH-, -NHCO-, -C(CH3)2-, -C(CF3)2-, -(CH2)m-, -〇_(CH2)m_〇·, _s(CH2)m_s. Here m is an integer from 1 to 6. Moreover, in the general formula (e) and the general formula (f), 69 200927790 Υ independently represents a single bond, -Ο-, -S-, -CO-, -c(CH3)2-, -C(CF3 ) 2_ or a sub-alkyl group having a carbon number of 1 to 3. The hydrogen bonded to the benzene ring or the naphthalene ring of Y may be independently substituted into _F, -CH3, -OH, , , so3h, -ρ〇3Η2 〇 and the side chain of the oxazine compound is included. The ruthenium or the polymer having an oxazine structure, the oligomer having an oxazine structure in the main chain, or the polyfluorene. The compound represented by the formula (a) is exemplified by the following compounds.
R1 式中’ V優選碳數爲1〜30的烷基,更加優選碳數爲 1〜20的烷基。In the formula, R is preferably an alkyl group having 1 to 30 carbon atoms, more preferably an alkyl group having 1 to 20 carbon atoms.
以通式(b )表示的噁嗪化合物可以例如以下的噁嗪化 合物。The oxazine compound represented by the formula (b) may, for example, be the following oxazine compound.
70 20092779070 200927790
(b-9) (b-10) 式中,R1優選碳數爲1〜30的烷基,更加優選碳數爲 1〜20的燒基。 以通式(c)表示的噁嗪化合物可以列舉以下述通式(I) 表示的σ惡嗪化合物。 71 (I) 200927790(b-9) (b-10) In the formula, R1 is preferably an alkyl group having 1 to 30 carbon atoms, more preferably an alkyl group having 1 to 20 carbon atoms. The oxazine compound represented by the following formula (I) is exemplified by the oxazine compound represented by the following formula (I). 71 (I) 200927790
Ο 所述通式(I)中,R1以及R2表示碳數爲1〜30的有 機基團,R3至R6表示氳或者碳數爲1〜6的烴基,X表示 單鍵、-CH2-、-C(CH3)2-、_CO-、0_、-S02-或者-C(CF3)2-。 以所述通式(I)表示的噁嗪化合物例如可以列舉以下的喔 嗓化合物。Ο In the above formula (I), R1 and R2 represent an organic group having a carbon number of 1 to 30, R3 to R6 represent an anthracene or a hydrocarbon group having 1 to 6 carbon atoms, and X represents a single bond, -CH2-, - C(CH3)2-, _CO-, 0_, -S02- or -C(CF3)2-. The oxazine compound represented by the above formula (I) is exemplified by the following anthraquinone compound.
CC
72 20092779072 200927790
(〇13)(〇13)
(014)(014)
73 200927790 式中,R1優選碳數爲1〜30的烷基,更加優選碳數爲 1〜20的烧基。 以通式(d)表示的噁嗪化合物例如可以列舉以下的噁 噃化合物。73 200927790 In the formula, R1 is preferably an alkyl group having 1 to 30 carbon atoms, and more preferably an alkyl group having 1 to 20 carbon atoms. The oxazine compound represented by the formula (d) is exemplified by the following oxime compounds.
以通式(e)表示的σ惡唤化合物例如可以列舉以下的°惡 唤化合物。 74 200927790The σ-killing compound represented by the formula (e) is exemplified by the following ? 74 200927790
(e-5)(e-5)
以通式(f)表示的噁嗪化合物例如可以列舉以下的噁 喚化合物。The oxazine compound represented by the formula (f) is exemplified by the following acetonide compounds.
75 20092779075 200927790
物中’更加優選的是,可以列舉以式(b ❹ 式(二a(d、4(:r'3)(、;V;-5)、w-7)、 _4). -V rf_9N 4 ,式(d—6)、式(e-3)、式(e ^ 〜工(f〜4)表示的噁嗪化合物。 所述V秦化合物可_與崎公開聰觸通號小 册子、日本專利特開平u]2258號公報、日本專利特開 2004-352670號公報所述的方法相同的方法來製造。 例如,以通式(a)表示的噁嗪化合物可以通過使笨紛 化合物、伯胺以及醛(aldehyde)反應而獲得(參照國際 公開2004/009708號小册子)。 76 200927790 方二得以t(b)表示的亀合物可以通過以下的 方去而獲侍.使用將伯胺緩緩添加 應之後,添加具有雜(naphth〇1)系 反應(參照國際公開2004/009708號° 、行 方二得以通::(c)表示的鱗 =可二過以下的 劑中’在脂肪族仲胺、脂肪族叔胺 或者驗性含_環化合物的存在下,使〗莫耳苯盼化合More preferably, it can be exemplified by the formula (b ❹ (2a(d, 4(:r'3)(, ;V;-5), w-7), _4). -V rf_9N 4 , the oxazine compound represented by the formula (d-6), the formula (e-3), and the formula (e^~work (f~4). The V-Qin compound can be _Sakizaki-Cong Cong-tong booklet, Japan It is produced by the same method as the method described in JP-A-2004-352670. For example, the oxazine compound represented by the formula (a) can be obtained by making a compound or a primary compound. And an aldehyde reaction (refer to International Publication No. 2004/009708 pamphlet). 76 200927790 The bismuth compound represented by t(b) can be obtained by the following method. After the addition, the reaction with a hetero (naphth〇1) system is added (refer to International Publication No. 2004/009708°, Line 2:: (c), scale = can be used in the following agent' in the aliphatic secondary amine In the presence of an aliphatic tertiary amine or an intrinsic _ ring-containing compound,
物、相對於其—個雜_至少爲2莫耳或者2莫耳以上 的搭、以及1莫耳伯胺進行反應(參照國際公開 2004/009708號小册子和日本專利特開平號公 報)。 而且,以通式⑷〜通式⑴表示的嘴嗪化合物可 以通過以下的方法而獲得:使4,4,_二氨基二苯基曱烷等具 有多個笨環和鍵合這些苯環的有機基團的二胺、福爾馬林 (formalin )等酸·以及苯紛在正丁醇中,在9〇。〇或9〇〇c以 上的溫度下進行脫水縮合反應(參照日本專利特開 2004-352670 號公報)。 而且’例如從液晶顯示元件的電特性的長期穩定性的 觀點考慮’本發明的液晶配向劑可以進·—步含有β惡峻琳化 合物。所述噁唑啉化合物是具有噁唑啉結構的化合物。所 述噁唑啉化合物可以是一種化合物,也可以是兩種或者兩 種以上的化合物。從所述觀點考慮,所述噁唑啉化合物的 含量相對於所述聚醯胺酸或者其衍生物,優選爲0.1重量 %〜50重量%,更加優選爲1重量%~40重量°/❶,進一步 77 200927790 所 優選爲1重量%〜20重量%。出 述邊嗤琳化入物的人Θ卷、登S ,從上述觀點來說,ny U琳化口物的3置優選的是,將。惡唾琳化 琳時’相對於所述聚酿胺酸或二 生物而爲0·1重量%〜4〇重量%。The substance is reacted with respect to a mash thereof of at least 2 moles or more than 2 moles, and 1 mole of azide (refer to International Publication No. 2004/009708 pamphlet and Japanese Patent Laid-Open Publication No.). Further, the oxime compound represented by the general formulae (4) to (1) can be obtained by an organic method of having a plurality of acyclic rings and bonding benzene rings such as 4,4,-diaminodiphenyl decane. The group's diamine, formalin and other acids and benzene are in n-butanol at 9 〇. Dehydration condensation reaction is carried out at a temperature of 〇 or above 9 〇〇c (refer to Japanese Laid-Open Patent Publication No. 2004-352670). Further, the liquid crystal alignment agent of the present invention can be further contained, for example, from the viewpoint of long-term stability of electrical characteristics of the liquid crystal display element. The oxazoline compound is a compound having an oxazoline structure. The oxazoline compound may be one compound or two or more compounds. From such a viewpoint, the content of the oxazoline compound is preferably 0.1% by weight to 50% by weight, and more preferably 1% by weight to 40% by weight, based on the polyamic acid or a derivative thereof. Further 77, 200927790 is preferably from 1% by weight to 20% by weight. From the above point of view, it is preferable that the three sets of the ny U lining mouth are. When the phlegm is phlegm, it is 0.1% by weight to 4% by weight relative to the polyamic acid or the second organism.
❹ 所述射琳化合物可以在—個化合物中僅具有一種過 峻琳結構,也可以在-個化合物中具有兩種或者兩種以: 的噪峻琳結構。而且,所料姆化合似要在—個化人 物中具有-個所述射倾構即可,優選的是具有兩個二 兩個以上㈣姆結構。而且ϋ魏合物可以是侧鍵 上具有t㈣環結構的聚合物,也可以是共聚物。侧鍵上 具有射賴構㈣合物可以是侧鏈上具有射琳結構的 單體的均聚物’也可以S側鏈上具有射琳結構的單體與 不具有噁唑啉結構的單體的共聚物。側鏈上具有噁唑啉結 構的共,物可以是側鏈上具有噁唑啉結構的兩種或者兩種 以上的單體的共聚物,也可以是側鏈上具有噁β坐琳結構的 兩種或者兩種以上的單體與不具有噁唑琳結構的單體的共 聚物。 所述噁唑啉結構優選的是,存在於噁唑啉化合物中以 使噁唑啉結構中的氧以及氮中的一方或者兩方與聚醯胺酸 的羰基可以進行反應的結構。 所述噁唑啉化合物例如可以列舉:2,2’-雙(2-噁唑琳)、 1,2,4_ 三-(2-11 惡嗤琳基-2)- :^(l,2,4-tris-(2-oxazolinyl-2)-benzene )、4-π夫喝-2-基亞曱基-2-苯基-4H- °惡《坐·5- _ (4-furan-2-ylmethylene-2-phenyl-4H-oxazole,5-one)、1,4- 78 200927790 雙(4,5-二氫-2-噁唑基)苯、ι,3-雙(4,5-二氫_2-噁唑基)苯、 2,3-雙(4-異丙稀基_2·»惡σ坐琳_2_基)丁燒、2,2,·雙节基_2一❹ The Celine compound may have only one type of structure in one compound, or two or two types in one compound: Further, it is desirable that the compounding has a structure of one or more of the above-described structures, and it is preferable to have two or more (four) m structures. Further, the oxime compound may be a polymer having a t(tetra) ring structure on a side bond or a copolymer. The conjugated (tetra) compound on the side bond may be a homopolymer of a monomer having a shooter structure on the side chain, or a monomer having a shooter structure on the S side chain and a monomer having no oxazoline structure. Copolymer. The oxazoline structure in the side chain may be a copolymer of two or more monomers having an oxazoline structure in a side chain, or two of a side chain having a odor β sitting structure. A copolymer of two or more kinds of monomers and a monomer having no oxazoline structure. The oxazoline structure is preferably a structure which is present in the oxazoline compound to allow one or both of oxygen and nitrogen in the oxazoline structure to react with the carbonyl group of the polylysine. The oxazoline compound may, for example, be 2,2'-bis(2-oxazole), 1,2,4_tri-(2-11 oxalinyl-2)-:^(1,2, 4-tris-(2-oxazolinyl-2)-benzene), 4-π-Bus-2-yl-indenyl-2-phenyl-4H- ° Evil "Sit 5- _ (4-furan-2- Ylmethylene-2-phenyl-4H-oxazole, 5-one), 1,4-78 200927790 Bis(4,5-dihydro-2-oxazolyl)benzene, ι,3-bis(4,5-dihydrogen) _2-oxazolyl)benzene, 2,3-bis(4-isopropionyl-2·»oxo-salt_2_yl) butadiene, 2,2,·double-base 2
Ο 嚼唾琳、2,6-雙(異丙基_2_嗯唑啉_2_基)吼咬、2,2,·異亞^基 雙(4-叔丁基-2-噁唑啉)、2,2,-異亞丙基雙(4_苯基_2_噁二 琳)、2,2匕亞甲基雙(4·叔丁基_2_喔唑啉)以及2,2’_亞曱基雙 (4-苯基-2-噁唑啉)。除這些噁唑啉化合物以外,也可以列 舉如EPOCROS (商品名,曰本催化劑股份有限公司製造) 那樣的具有噁唑基的聚合物或者低聚物。 更加優選的所述噁唑啉化合物例如可以列舉 (2-嚼唾啉)以及二氫_2_噁唑基)苯。 ^而且,例如從液晶顯示元件的電特性的長期穩定性的 觀點考慮,本發明的液晶配向劑可以進一步含有環氧化人 物。所述環氧化合物可以是―種化合物,也可以是二 者兩種以上的化合物。從所述觀點考慮,所述環氧化合物 的含量相對於所述聚醯胺酸或者其衍生物, ^ 量%,重量%,更加優選爲i重量%〜4〇重2^ ^重 步優選wu%〜2〇m 更重進一 、環氧化合物可以列舉分子内具有一個或者兩個 以上環氧_各種化合物^分子内具有—個環氧環人 ,如可以列舉:苯基縮水甘油醚、丁基縮水甘_、3j ,甲基環氧城(3,3,3捕_卿yleneQxide)、氣’ 本乙烯(Styrene 0Xide)、六氟環氧丙烷、氧化 (cydohexene oxide )、3_縮水甘油氧基丙基三石 烧、2-(3,4-環氧環己基)乙基三甲氧基魏、n'缩水甘ς 79 200927790 , 鄰苯二曱酿亞胺、(九氟_N_ 丁基)環氧化物 ((n〇nafluoro-N-butyl)ep0xicie )、全氟乙基縮水甘油醚、表 氯醇(印ichlorohydrin)、表溴醇、N,N•二縮水甘油基苯胺 以及3-[2_(全氟己基)乙氧基]-1,2-環氧丙烧。 分子内具有兩個環氧環的化合物例如可以列舉:乙二 醇二縮水甘油醚(ethyleneglycol diglycidyl ether )、聚乙二 醇二縮水甘油醚、丙二醇二縮水甘油醚、三丙二醇二縮: ❹嚼 chewed salin, 2,6-bis(isopropyl-2-oxazoline-2-yl) bite, 2,2,·iso- benzyl bis(4-tert-butyl-2-oxazoline ), 2,2,-isopropylidene bis(4_phenyl_2-oxadiline), 2,2 benzylidene bis(4.tert-butyl-2-oxazoline), and 2,2 '_Alkenylene bis(4-phenyl-2-oxazoline). In addition to these oxazoline compounds, a polymer or oligomer having an oxazolyl group such as EPOCROS (trade name, manufactured by Sakamoto Co., Ltd.) may be mentioned. More preferably, the oxazoline compound is exemplified by (2-charyphyrin) and dihydro-2-oxazolyl)benzene. Further, for example, from the viewpoint of long-term stability of electrical characteristics of the liquid crystal display element, the liquid crystal alignment agent of the present invention may further contain an epoxidized human. The epoxy compound may be a "species compound" or a combination of two or more kinds. From the viewpoint of the above, the content of the epoxy compound is more preferably i% by weight to 4% by weight relative to the polyamic acid or a derivative thereof. %~2〇m More important, the epoxy compound may have one or two or more epoxy groups in the molecule. The various compounds have an epoxy ring in the molecule, such as phenyl glycidyl ether and butyl. Reduced water _, 3j, methyl epoxy city (3,3,3 catch _qingyleneQxide), gas 'Benzene 0Xide, hexafluoropropylene oxide, oxidized (cydohexene oxide), 3_glycidoxy Propyl tricalcium, 2-(3,4-epoxycyclohexyl)ethyltrimethoxywei, n'glycolate 79 200927790 , phthalic acid imine, (nonafluoro_N_butyl) epoxy ((n〇nafluoro-N-butyl)ep0xicie), perfluoroethyl glycidyl ether, epichlorohydrin, epibromohydrin, N,N• diglycidyl aniline, and 3-[2_(all Fluorohexyl)ethoxy]-1,2-epoxypropane. Examples of the compound having two epoxy rings in the molecule include ethyleneglycol diglycidyl ether, polyethylene glycol diglycidyl ether, propylene glycol diglycidyl ether, and tripropylene glycol dicondensation:
甘細、聚丙二醇二縮水甘_、新戊二醇二縮水甘了㈣、 己二醇二縮水甘油醚、甘油二縮水甘油醚、2,2_二溴新 戊二醇二縮水甘油_、3,4環氧環已烯基甲基_3,,4,_環氧環 己燦曱酸醋以及3·(Ν,Ν_二縮水甘油基)氨基丙基三曱氧基 石夕烧。 刀子内具有二個環氧環的化合物例如可以列舉: 某】,丙:基)苯基卜之仰,1-雙[4-([2,3·環氧丙氧 土 J本基)]乙基]苯基]丙烷(Manganese, polypropylene glycol digoxime _, neopentyl glycol dimethyl condensate (tetra), hexanediol diglycidyl ether, glycerol diglycidyl ether, 2,2-dibromo neopentyl glycol diglycidyl _, 3 , 4 epoxy ring hexenylmethyl _ 3,, 4, _ epoxy cyclohexanic acid vinegar and 3 · (Ν, Ν _ diglycidyl) aminopropyl tributary oxylate. Examples of the compound having two epoxy rings in the knives include, for example, a certain one, a propylene group, a phenyl group, and a 1-bis[4-([2,3·epoxypropoxylate J-based)]ethyl group] Phenyl]propane
彻狐”,(三井化學)靖造) ECHM〇RE :子:具有四個環氧環的化合物例如可以列舉: 甘油基从匕醇、取,灿,·四縮水甘油基 、1,3-雙(Ν,Ν-二縮水甘油基袅美甲美、援 烧、n,n,n,,n,_w縮& u 4 /,基藏基甲基)壤己 3·-烯丙基*縮 基二苯基甲烷以及 除所述化合細^基石夕燒。 的單體例轉的絲物絲麵。具有環氧環 』如7以列舉:(甲基)丙烯酸縮水甘油醋、(甲基) 200927790 丙烯酸3,4-環氧環己酯以及(曱基)丙烯酸曱基縮水甘油酯。 與具有環氧環的單體進行共聚合的其他單體,例如可 以列舉:(甲基)丙烯酸、(甲基)丙烯酸曱酯、(甲基)丙烯酸 乙酯 '(甲基)丙烯酸異丙酯、(甲基)丙烯酸丁酯、(曱基)丙 烯酸異丁酯、(甲基)丙烯酸叔丁酯、(曱基)丙烯酸環己酯、 (甲基)丙烯酸苄酯、(甲基)丙烯酸2-羥基乙酯、(甲基)丙烯 酸2-羥基丙酯、苯乙烯、曱基苯乙烯、氯曱基苯乙烯、(甲 ^ 基)丙烯酸(3-乙基-3-環氧丙烷基)甲酯,Ν-環己基馬來醯亞 胺以及Ν-苯基馬來酿亞胺。 具有環氧環的單體的聚合物的優選具體例,可以列舉 聚甲基丙烯酸縮水甘油酯等。而且,具有環氧環的單體與 其他單體的共聚物的優選具體例,可以列舉:Ν-苯基馬來 醯亞胺-曱基丙烯酸縮水甘油酯共聚物、Ν-環己基馬來醯亞 胺-曱基丙烯酸縮水甘油酯共聚物、甲基丙烯酸苄酯-曱基 丙稀酸縮水甘油醋共聚物、甲基丙浠酸丁醋-甲基丙烯酸縮 水甘油酯共聚物、甲基丙烯酸2-羥基乙酯_曱基丙烯酸縮水 Ο 甘油酯共聚物、甲基丙烯酸(3-乙基-3-環氧丙烷基)曱酯-曱 基丙烯酸縮水甘油酯共聚物以及苯乙烯甲基丙烯酸縮水 甘油醋共聚物。 這些例子中,特別優選Ν,Ν,Ν',Ν’-四縮水甘油基-間苯 二曱胺、1,3-雙(Ν,Ν-二縮水甘油基氨基曱基)環己烷、 Ν,Ν,Ν,,Ν'-四縮水甘油基-4,4’-二氨基二苯基甲烷、商品名 “TECHMORE VG3101L”、3,4-環氧環己烯基曱基-3·,4'-環 氧環己烯曱酸酯、Ν-苯基馬來醯亞胺-甲基丙烯酸縮水甘油 81 200927790 酯共聚物以及2-(3,4-環氧環己基)乙基三甲氧基石夕烷。 更加系統地來說,所述環氧化合物例如可以列舉 甘油醚、縮水甘加旨、縮水甘油胺、含環氧基的丙稀 樹脂、縮水甘油巧、異氰尿_水甘㈣、雜脂肪族 型環氧化合物錢雜脂職型環氧化合物。另外 化合物是指具有環氧基的化合物,環氧翻旨是指具有環 基的樹脂。"Che fox", (Mitsui Chemical) Yasushi) ECHM〇RE: Sub-compound: Compounds having four epoxy rings are exemplified by: glyceryl groups from decyl alcohol, decene, glycerol, tetraglycidyl, 1,3-double ( Ν, Ν- diglycidyl hydrazine, carbamide, n, n, n, n, _w condensed & u 4 /, basal methyl) lysine 3 ·-allyl * condensed Phenyl methane and a filament of a filament which is exemplified by the monomerization of the compound. The epoxy group has an epoxy ring such as 7 to give: (meth)acrylic acid glycidic vinegar, (methyl) 200927790 acrylic acid 3,4-epoxycyclohexyl ester and decyl glycidyl (mercapto) acrylate. Other monomers copolymerized with a monomer having an epoxy ring may, for example, be (meth)acrylic acid or (methyl) ) decyl acrylate, ethyl (meth) acrylate 'isopropyl (meth) acrylate, butyl (meth) acrylate, isobutyl (meth) acrylate, tert-butyl (meth) acrylate, (曱) Cyclohexyl acrylate, benzyl (meth) acrylate, 2-hydroxyethyl (meth) acrylate, 2-hydroxypropyl (meth) acrylate, styrene, decyl benzene Alkene, chlorodecyl styrene, (3-ethyl-3-epoxypropenyl)methyl (meth) acrylate, fluorene-cyclohexylmaleimide, and fluorenyl-phenylmaleimine. Preferable specific examples of the polymer of the monomer having an epoxy ring include polyglycidyl methacrylate, etc. Further preferred examples of the copolymer of the monomer having an epoxy ring and another monomer include: Ν-phenylmaleimide-glycidyl methacrylate copolymer, fluorene-cyclohexylmaleimide-glycidyl methacrylate copolymer, benzyl methacrylate-mercapto acrylic acid shrinkage Glycerin copolymer, butyl acetonate-glycidyl methacrylate copolymer, 2-hydroxyethyl methacrylate hydrazide hydrazide glyceride copolymer, methacrylic acid (3-ethyl- 3-glycidyl) decyl ester-glycidyl methacrylate copolymer and styrene methacrylic acid glycidyl vinegar copolymer. Among these examples, Ν, Ν, Ν', Ν'-tetraglycidyl group are particularly preferred. -m-phenylenediamine, 1,3-bis(indole, hydrazine-diglycidylaminodecyl)cyclohexane, hydrazine ,Ν,Ν,,Ν'-tetraglycidyl-4,4'-diaminodiphenylmethane, trade name "TECHMORE VG3101L", 3,4-epoxycyclohexenylindolyl-3·,4 '-Epoxycyclohexene decanoate, fluorenyl-phenylmaleimide-glycidol methacrylate 81 200927790 Ester copolymer and 2-(3,4-epoxycyclohexyl)ethyltrimethoxylate More specifically, the epoxy compound may, for example, be a glyceryl ether, a glycidyl glycoside, a glycidylamine, an epoxy group-containing acryl resin, a glycidol, a isocyanuric acid, or a water. Aliphatic epoxy compound, money and fat type epoxy compound. Further, the compound means a compound having an epoxy group, and the epoxy group means a resin having a ring group.
所述縮水甘油_如可以列舉:魏A型環氧化人 物、雙紛F型環氧化合物、雙紛s型環氧化合物、雙盼二 環氧化合物、氫化魏_A型魏化合物、氫化魏型 氧化合物、i化㈣_S型環氧化合物、氫化雙_環氧化 合物、姐㈣_A魏氧化合物、糾雙科型環氧化合 物、苯祕駿清漆(phenolnovolac)型環氧化合物、甲齡 祕清漆(咖丨_lae) _氧化合物、献苯盼轉 清漆型環氧化合物、溴化曱酚酚醛清漆型環氧化合物、 盼A雜清漆型環氧化合物、含萘骨架崎氧化^物、芳 香族聚縮水甘油趟化合物、雙環戍二稀盼型環氧化合物、 脂環式二縮水甘油_化合物、脂肪族聚縮水甘油^化合 物、多硫化物(P〇lySulflde)型二縮水甘油趟化合物以及 聯苯酚型環氧化合物。 所述縮水甘油醋例如可以列舉二縮水甘油醋化合物以 及縮水甘油基酯環氧化合物。 所述縮水甘油胺例如可以列舉多縮水甘油胺化合物。 所述含環氧基的丙烯酸系化合物例如可以列舉具有環 82 200927790 氧乙烧基的單體的均聚物以及共聚物 所述縮水甘油醯胺例如可 化合物。 以列舉縮水甘油醯胺型環氧 所述鏈狀脂肪族型環氧化合物例如可以列舉:將稀煙 化合物的碳錢鍵氧化而獲得的含有環氧基的化合物。 所述環狀脂肪族型環氧化合物例如可以列舉將環_ 化合物的碳·碳雙鍵氧化而獲得的含有環氧基的化合物。 所述雙酚Α型環氧化合物例如可以列舉:828、1〇〇1、 1002、1003、1004、1007、1〇1〇(均爲日本環氧樹脂製造), EPOTOHTO YD-128 (東都化成公司製造),DER 331、 Ο ο DER-332、DER-324 (均爲 Dow Chemical 公司製造), EPICLON 840、EPICLON 850、EPICLON 1050 (均爲大日 本油墨製造)’ EPOMIC R-140、EPOMIC R-301 和 EPOMIC R-304 (均爲三井化學製造)。 所述雙酚F型環氧化合物例如可以列舉:806、807、 4004P (均爲曰本環氧樹脂製造),EPOTOHTO YDF-170、 EPOTOHTO YDF-175S、EPOTOHTO YDF-2001 (均爲東都 化成公司製造),DER-354 ( Dow Chemical公司製造), EPICLON 830和EPICLON 835 (均爲大日本油墨製造)。 所述雙酚型環氧化合物例如可以列舉:2,2-雙(4-羥基 苯基)-1,1,1,3,3,3-六氟丙烷的環氧化物。 所述氫化雙酚-A型環氧化合物例如可以列舉: SUNTOHTO ST-3000 (東都化成公司製造)、RIKARESIN HBE-100 (新日本理化製造)以及DENACOL EX-252 83 200927790 (Nagase chemtex 公司製造)0 所述氫化雙_環氧化合物例如可以列舉 2· -經基苯基H,U,3,3,3_六氟丙燒的環氧化物。 所述漠化雙紛-A型環氧化合物例如可以列舉:5〇5〇、 5051 (均爲日本環氧樹脂製造),Ερ〇τ〇Ητ〇 細、 EPOTOHTO YDB-400 (均爲東都化成公司製造), DER-530、DER-538 (均爲 D〇w Chemical 公司製造), 脈:L〇N152和EPICLONl53 (均爲大日本油墨製造)。 ^ 所述苯酚酚醛清漆型環氧化合物例如可以列舉:152、 154 (均爲日本環氧樹脂製造),YDpN_638 (東都化成公 司製造),DEN431、DEN438 (均爲 D〇w Chemical 公司製 造)’ EPICLONN-770 (大日本油墨化學工業股份有限公司 製造),EPPN-201和EPPN-202 (均爲日本化藥股份有限 公司製造)。 所述甲酚酚醛清漆型環氧化合物例如可以列舉: 180S75 (日本環氧樹脂製造)’ ydcN-701、YDCN-702 (均 〇 爲東都化成公司製造),EPICLON N-665、EPICLON N-695 (均爲大曰本油墨化學工業股份有限公司製造), EOCN-102S、EOCN-103S、EOCN-104S、EOCN-1020、 EOCN-1025和EOCN-1027 (均爲日本化藥股份有限公司 製造)。 所述雙盼A紛搭清漆型環氧化合物例如可以列舉: 157S70(日本環氧樹脂股份有限公司製造)、以及epjclON N-880 (大日本油墨化學工業股份有限公司製造)。 84 200927790 所述3萘月架的環氧化合物例如可以列舉:epiclon HP-4032、EPICLON HP-4700、EPICLON HP-4770 (均爲 大曰本油墨化學工業股份有限公司製造),以及NC-7000 (曰本化藥公司製造)。 所述芳香族聚縮水甘油醚化合物例如可以列舉:對苯 二紛二縮水甘油越(hydroquinone diglycidyl ether,下述結 構式E101)、鄰苯二紛二縮水甘油醚(catechol diglycidyl ether,下述結構式E102 )、間苯二酚二縮水甘油醚The glycidol_ can be exemplified by: Wei A type epoxidized character, double F type epoxy compound, double s type epoxy compound, double expectant diepoxide compound, hydrogenated Wei_A type Wei compound, hydrogenated Wei type Oxygen compound, i (4) _S type epoxy compound, hydrogenated bis-epoxy compound, sister (four) _A Wei oxygen compound, singular type epoxy compound, phenolnovolac type epoxy compound, aging varnish丨_lae) _Oxygen compound, benzene-promoting varnish-type epoxy compound, brominated phenolic phenolic varnish-type epoxy compound, Pan-A varnish-type epoxy compound, naphthalene-containing slag oxide, aromatic polycondensation Glycerol bismuth compound, bicyclic fluorene diene epoxy compound, alicyclic diglycidyl compound, aliphatic polyglycidyl compound, polysulfide (P〇lySulflde) type diglycidyl hydrazine compound, and biphenol type ring Oxygen compound. The glycidol vinegar may, for example, be a diglycidyl vinegar compound or a glycidyl ester epoxy compound. The glycidylamine may, for example, be a polyglycidylamine compound. The epoxy group-containing acrylic compound may, for example, be a homopolymer of a monomer having a epoxidizing group of ring 82 200927790 and a copolymer of the glycidyl amide such as a compound. The glycidylamine type epoxy compound is exemplified as the epoxy group-containing epoxy compound. For example, an epoxy group-containing compound obtained by oxidizing a carbon bond of a dilute tobacco compound can be mentioned. The cyclic aliphatic epoxy compound may, for example, be an epoxy group-containing compound obtained by oxidizing a carbon-carbon double bond of a ring-based compound. Examples of the bisphenolphthalein type epoxy compound include 828, 1〇〇1, 1002, 1003, 1004, 1007, and 1〇1〇 (all manufactured by Japan epoxy resin), and EPOTOHTO YD-128 (Dongdu Chemical Company) Manufactured), DER 331, Ο ο DER-332, DER-324 (all manufactured by Dow Chemical Company), EPICLON 840, EPICLON 850, EPICLON 1050 (all manufactured by Dainippon Ink) ' EPOMIC R-140, EPOMIC R-301 And EPOMIC R-304 (both manufactured by Mitsui Chemicals). Examples of the bisphenol F-type epoxy compound include 806, 807, and 4004P (all manufactured by sakamoto epoxy resin), EPOTOHTO YDF-170, EPOTOHTO YDF-175S, and EPOTOHTO YDF-2001 (all manufactured by Dongdu Chemical Co., Ltd.). ), DER-354 (manufactured by Dow Chemical Co., Ltd.), EPICLON 830 and EPICLON 835 (all manufactured by Dainippon Ink). The bisphenol type epoxy compound may, for example, be an epoxide of 2,2-bis(4-hydroxyphenyl)-1,1,1,3,3,3-hexafluoropropane. Examples of the hydrogenated bisphenol-A type epoxy compound include: SUNTOHTO ST-3000 (manufactured by Tohto Kasei Co., Ltd.), RIKARESIN HBE-100 (Nippon Chemical and Chemical Manufacturing Co., Ltd.), and DENACOL EX-252 83 200927790 (manufactured by Nagase Chemtex Co., Ltd.) The hydrogenated bis-epoxy compound may, for example, be an epoxide of 2·-phenylphenyl H,U,3,3,3-hexafluoropropane. Examples of the desertification-type A-type epoxy compound include: 5〇5〇, 5051 (all manufactured by Japanese epoxy resin), Ερ〇τ〇Ητ〇, EPOTOHTO YDB-400 (both Dongdu Chemical Company) Manufactured), DER-530, DER-538 (all manufactured by D〇w Chemical Co., Ltd.), veins: L〇N152 and EPICLONl53 (all manufactured by Dainippon Ink). ^ The phenol novolac type epoxy compound may, for example, be 152, 154 (all manufactured by Japan epoxy resin), YDpN_638 (manufactured by Tohto Kasei Co., Ltd.), DEN431, DEN438 (all manufactured by D〇w Chemical Co., Ltd.) ' EPICLONN -770 (manufactured by Dainippon Ink Chemical Industry Co., Ltd.), EPPN-201 and EPPN-202 (both manufactured by Nippon Kayaku Co., Ltd.). Examples of the cresol novolac type epoxy compound include: 180S75 (manufactured by Nippon Epoxy Resin) ydcN-701, YDCN-702 (all manufactured by Dongdu Chemical Co., Ltd.), EPICLON N-665, EPICLON N-695 ( Manufactured by Otsuka Ink Chemical Industry Co., Ltd., EOCN-102S, EOCN-103S, EOCN-104S, EOCN-1020, EOCN-1025 and EOCN-1027 (all manufactured by Nippon Kayaku Co., Ltd.). For example, 157S70 (manufactured by Nippon Epoxy Resin Co., Ltd.) and epjclON N-880 (manufactured by Dainippon Ink Chemicals Co., Ltd.) can be cited as the varnish-type epoxy compound. 84 200927790 The epoxy compound of the 3 naphthalene matrix can be exemplified by epiclon HP-4032, EPICLON HP-4700, EPICLON HP-4770 (all manufactured by Otsuka Ink Chemical Industry Co., Ltd.), and NC-7000 ( Made by Sakamoto Chemical Co., Ltd.). The aromatic polyglycidyl ether compound may, for example, be hydroquinone diglycidyl ether (formula E101 below) or catechol diglycidyl ether (the following structural formula) E102), resorcinol diglycidyl ether
(resorcinol diglycidyl ether ’ 下述結構式 E103)、三(4-縮 水甘油氧基苯基)曱烷(下述結構式E105 )’ l〇31S、1032H60 (均爲曰本環氧樹脂製造),TACTIX-742 (D〇w Chemical 公司製造),DENACOL EX-201 (Nagase chemtex 公司製造),DPPN-503、DPPN-502H、DPPN-5〇1H、NC6_ (均 爲日本化藥股份錄公4造)’ T顧MGRE VG31〇1L (三井化學公司製造),以下述結構式·6表示的化合物 以及以下述結構式Ε107表济的化合物(resorcinol diglycidyl ether 'the following structural formula E103), tris(4-glycidoxyphenyl)decane (the following structural formula E105)' l〇31S, 1032H60 (all manufactured by sakamoto epoxy resin), TACTIX -742 (manufactured by D〇w Chemical Co., Ltd.), DENACOL EX-201 (manufactured by Nagase Chemex), DPPN-503, DPPN-502H, DPPN-5〇1H, NC6_ (both made by Nippon Chemical Co., Ltd.) T MGRE VG31〇1L (manufactured by Mitsui Chemicals, Inc.), a compound represented by the following structural formula *6, and a compound represented by the following structural formula Ε107
(Ε101) 0:(Ε101) 0:
:0 (Ε102) Ο:0 (Ε102) Ο
(Ε103)(Ε103)
85 20092779085 200927790
ΤΑ二述:環戊二婦盼型環氧化合物例如可以列舉:ΤΑ二述: The cyclopentane-type epoxy compound can be exemplified by, for example:
Γρ 7,ππ (D〇W ChCmiCal ^5lt^)-^EPICL0N οΓρ 7,ππ (D〇W ChCmiCal ^5lt^)-^EPICL0N ο
HP-7200 (大日本油墨化學工業股份有限公司製造 所述脂環式二縮水甘油醚化合物例如以 烧二甲醇二縮水甘油鍵化合物c舉二己N DME-100 (新日本理化製造)。 所述脂肪族聚縮水甘油醚化合物例如可以列舉:乙二 醇二縮水甘油醚(下述結構式E108)、二乙二醇二縮水: 油鱗(下述結構式E1G9)、聚乙二醇二·甘油丙二 醇二縮水甘油醚(下述結構J刪)、三丙二醇二縮水甘 油醚(下述結構式El11)、聚丙二醇二縮水甘油喊、新戍 二醇二縮水甘_ (博结構式㈣)、以丁^二二 86 200927790 甘油醚(下述結構式E113)、1,6-己二醇二縮水甘油謎(下 述結構式E114)、二溴新戊二醇二縮水甘油醚(下述結構 式 E115),DENACOL EX-810、DENACOL EX-851、 DENACOL EX-8301、DENACOL EX-911、DENACOL EX-920、DENACOL EX-931、DENACOL EX-211、 DENACOL EX-212、DENACOL EX-313 (均爲 Nagase chemtex公司製造),DD-503 (旭電化製造),RIKARESIN 1-100(新日本理化製造),1,3,5,6-四縮水甘油基-2,4-己二 〇 醇(下述結構式Ε116)、甘油聚縮水甘油謎、山梨糖醇聚 縮水甘油趟(sorbitolpolyglycidyl ether)、三羥甲基丙烧聚 縮水甘油醚、季戊四醇聚縮水甘油醚,DENACOL EX-313、DENACOL EX-611、DENACOL EX-321 和 DENACOL EX-411 (均爲 Nagase chemtex 公司製造)〇HP-7200 (Daily Ink Chemical Industry Co., Ltd. manufactures the alicyclic diglycidyl ether compound, for example, by burning dimethanol diglycidyl bond compound c as dihexyl N DME-100 (manufactured by Shin Nippon Chemical Co., Ltd.). Examples of the aliphatic polyglycidyl ether compound include ethylene glycol diglycidyl ether (the following structural formula E108) and diethylene glycol dihydrate: oil scale (the following structural formula E1G9), polyethylene glycol diglycerin Propylene glycol diglycidyl ether (the following structure J), tripropylene glycol diglycidyl ether (the following structural formula El11), polypropylene glycol diglycidyl shunt, neodecanediol dihydrated _ (Bo structural formula (4)), Ding ^ 2 2 86 200927790 glyceryl ether (structure E113 below), 1,6-hexanediol diglycidolithic (the following structural formula E114), dibromo neopentyl glycol diglycidyl ether (the following structural formula) E115), DENACOL EX-810, DENACOL EX-851, DENACOL EX-8301, DENACOL EX-911, DENACOL EX-920, DENACOL EX-931, DENACOL EX-211, DENACOL EX-212, DENACOL EX-313 (all Nagase chemtex company), DD-503 (made by Asahi Kasei), RIKAR ESIN 1-100 (Nippon Chemical and Chemical Manufacturing Co., Ltd.), 1,3,5,6-tetraglycidyl-2,4-hexanediethanol (the following structural formula Ε116), glycerol polyglycidol mystery, sorbitol polymerization Hydroxide polyglycidyl ether, trimethylol propyl polyglycidyl ether, pentaerythritol polyglycidyl ether, DENACOL EX-313, DENACOL EX-611, DENACOL EX-321 and DENACOL EX-411 (both Nagase chemtex) Manufacturing)〇
(E11〇) (E111) (E112)(E11〇) (E111) (E112)
(E113) (E114) 87 200927790(E113) (E114) 87 200927790
(Ε115) (Ε116) … I化物型一縮水甘油驗化合物例如可以列舉: FLDP 50 和 FLDp_6〇 (均爲 T〇ray Thiokol 製造)。 所述聯笨酚型環氧化合物例如可以列舉:YX-4000、 Ο(Ε115) (Ε116) ... I-formation type glycidol test compound can be exemplified by FLDP 50 and FLDp_6 (all manufactured by T〇ray Thiokol). Examples of the biphenol-based epoxy compound include YX-4000, Ο
YL-6121H (均爲曰本環氧樹脂製造),NC-3000P和 NC-3000S (均爲日本化藥股份有限公司製造)。 所述二縮水甘油酯化合物例如<以列舉:對苯二甲酸 二縮水甘油酯(下述結構式117)、鄰笨二曱酸二縮水甘油 一' ^缺構式E118 )、鄰苯二甲酸雙(2_曱基環氧乙烷基 酯下述結構式E119)、以下述結構式E121表示的 化合物、二的化合物。 構式E123表’YL-6121H (all manufactured by Sakamoto Epoxy Resin), NC-3000P and NC-3000S (both manufactured by Nippon Kayaku Co., Ltd.). The diglycidyl ester compound is, for example, <exemplified by: diglycidyl terephthalate (the following structural formula 117), o-dibenzoic acid diglycidyl-'-deficient formula E118), phthalic acid Bis(2- mercapto oxiranyl ester, the following structural formula E119), a compound represented by the following structural formula E121, and a compound of two. Construction E123 table’
甲基)醋作減式E122表㈣化合物以及以下述結Methyl) vinegar as a compound of the formula E122 (IV) and with the following knot
(E119) 88 (£121) 200927790 ο(E119) 88 (£121) 200927790 ο
(Ε123) 所述縮水甘油醋環我化&物例如可以列舉:871、872 (均爲曰本環氧樹脂製造),EPlCL〇N 200、EPICLON 400 0 (均爲大日本油墨化學工業股份有限公司製造), DENACOL EX-711 和 DENACOL EX-721 (均爲 Nagase chemt汊公司製造)。 所述多縮水甘油胺化合物例如可以列舉:N,N_二縮水 甘油基苯胺(下述結構式E124)、n,N-二縮水甘油基-鄰甲 苯胺(下述結構式E125)、N,N-二縮水甘油基-間甲苯胺(下 述結構式E126)、N,N-二縮水甘油基-2,4,6-三漠苯胺(下 述結構式幻27)、3-(凡1^二縮水甘油基)氨基丙基三甲氧基 ^ 矽烷(下述結構式E128)、N,N,〇_三縮水甘油基-對氨基苯 ^ 酚(下述結構式E129)、N,N,0-三縮水甘油基-間氨基苯酚 (下述結構式E130)、1^,:^,抑,冲-四縮水甘油基-間亞二曱 苯基二胺(TETRAD-X (三菱氣體化學),下述結構式 E132 )、I,]-雙(N,N-二縮水甘油基氨基曱基)環己院 (tetrad-c (三菱氣體化學),下述結構式E133)、夂4-雙(n,n-二縮水甘油基氨基甲基)環己炫(下述結構式 El34)、U-雙(Ν,Ν-二縮水甘油基象基)環己烷(下述結構 式£135)、1,4-雙(Ν,Ν-二縮水甘油基氨基)環己烷(下述結 89 〇 ο(Ε123) The glycidol vinegar ring can be exemplified by: 871, 872 (all manufactured by sakamoto epoxy resin), EPlCL〇N 200, EPICLON 400 0 (all are limited by Dainippon Ink Chemical Industry Co., Ltd.) Made by the company), DENACOL EX-711 and DENACOL EX-721 (both manufactured by Nagase Chemt汊). Examples of the polyglycidylamine compound include N,N-diglycidylaniline (the following structural formula E124), n,N-diglycidyl-o-toluidine (the following structural formula E125), N, N-diglycidyl-m-toluidine (structure E126 below), N,N-diglycidyl-2,4,6-tris-aniline (the following structural formula 27), 3-(fan 1 ^Diglycidyl)aminopropyltrimethoxymethoxypropane (Structure of Formula E128 below), N,N,〇-triglycidyl-p-aminophenylphenol (Structure of Formula E129 below), N,N, 0-triglycidyl-m-aminophenol (structural formula E130 below), 1^,:^, thio-tetraglycidyl-m-diphenyl phenyl diamine (TETRAD-X (Mitsubishi Gas Chemical) , the following structural formula E132), I,]-bis(N,N-diglycidylaminomethyl)cyclohexyl (tetrad-c (Mitsubishi Gas Chemical), the following structural formula E133), 夂4-double (n,n-diglycidylaminomethyl)cyclohexan (the following structural formula El34), U-bis(indole, fluorene-diglycidyl)cyclohexane (the following structural formula: £135) , 1,4-bis(indole, fluorene-diglycidylamino)cyclohexane ( Said junction 89 billion ο
(Ε129) 200927790 構式Ε136)、雙(Ν’Ν"二縮水甘油基氨基)苯(下述結構 式Ε137)、1十雙(Ν’Ν_一縮水甘油基氨基)苯(下述麟構式 Ε138)、2,6-雙(ΗΝ-二縮水甘油基氨基甲基)雙環[2.2.1]庚 烧(下述結構式Ε139 )、Ν,Ν,矶Ν’·四縮水甘油基-4,於二氨 基〆環己基甲炫(下述結構式二’基 fN^N,,N,-四縮水甘油基>4,於二氨基二苯基(下述結構 、’£:141)、^1^,]^,:^-四縮水甘油基-4,4,-二氨基二苯基趟 ^<述结構式扪42)、1,3,5-三(心(凡沁二縮水甘油基)氨基 ϋ基)苯(下述結構式E143 )、2,4,4,-三队义二縮水甘油 本氧^ 1細(下述結構式E144)、三(4-(N,N_二縮水 基氧(下述、结構式_、3,4,3’,4’_四 甘法秦)氛基本基)甲1 (下述結構式E146)、3,4,3,,4,_ (N,々,縮水甘油減基)^ 鍵(下述結構式E147)、 四⑺片二縮水甘油基乳物以及以下述結構式EI49 以卞逑結構式EH8表外的% σ 二的化合物 (Ε130) 200927790(Ε129) 200927790 Construction Ε136), double (Ν'Ν" diglycidylamino)benzene (the following structural formula Ε137), ten pairs of (Ν'Ν_-glycidylamino)benzene (the following structure) Ε138), 2,6-bis(indolyl-diglycidylaminomethyl)bicyclo[2.2.1]heptane (the following structural formula Ε139), hydrazine, hydrazine, sandpiper 'tetraglycidyl-4 In the case of diaminopurine cyclohexylmethyl (the following structural formula II' group fN^N, N,-tetraglycidyl group > 4, in diaminodiphenyl (structure described below, '£: 141), ^1^,]^,:^-tetraglycidyl-4,4,-diaminodiphenylfluorene^<the structural formula 扪42), 1,3,5-three (heart (where 沁 沁 缩) Glyceryl)aminomercapto)benzene (the following structural formula E143), 2,4,4,-three-group diglycidyloxy oxy- 1 fine (the following structural formula E144), three (4-(N,N) _ Diverted water based oxygen (described below, structural formula _, 3, 4, 3', 4' _ tetraglyconin) basic base) A (the following structural formula E146), 3, 4, 3, 4 , _ (N, 々, glycidol minus base) ^ bond (the following structural formula E147), four (7) diglycidyl milk, and the following structural formula EI49 with 卞逑 structural formula EH8 % σ II compound (Ε130) 200927790
(E136) (E137)(E136) (E137)
91 20092779091 200927790
(E146)(E146)
(E148)(E148)
92 200927790 所述具有環氧乙烧基的單體的均聚物例如可 甲基丙婦酸縮水甘油酯。所述具有環氧乙絲的單』^ 聚物,例如可以列舉:N_苯基馬來醯亞胺_曱美始二 甘油醋共聚物、N•環己基馬祕亞胺基^酸==92 200927790 The homopolymer of the monomer having an ethylene oxide group is, for example, glycidyl methacrylate. The mono-polymer having an ethylene oxide wire may, for example, be N-phenylmaleimide _ 曱美二二 glycerin copolymer, N•cyclohexylmaramine imino acid ==
醋共聚物、甲基丙烯酸❹旨甲基_酸縮水甘油醋址聚 物、曱基丙烯酸丁醋·曱基丙烯酸縮水甘油酯共聚物、^ 丙婦酸2·錄乙酯·?基_酸縮水甘_絲物、甲基二 稀酸(3-乙基-3_環氧丙院基)甲醋_甲基丙稀酸縮水甘油醋 共t物以及本乙烯-甲基丙浠酸縮水甘油醋共聚物。 所述具有被氧乙烧基的单體例如可以列舉:(曱美)丙 烯酸縮水甘油酯、(曱基)丙烯酸3,4-環氧環己酯以及($基) 丙稀酸甲基縮水甘油酯。 所述具有環乳乙烧基的早體的共聚物中除了所述具有 環氧乙烷基的單體以外的其他單體’例如可以列舉:(曱基) 丙烯酸、(甲基)丙烯酸曱酯、(曱基)丙烯酸乙酯、(甲基)丙 烤西文異丙醋、(甲基)丙稀酸丁醋、(曱基)丙稀酸異丁醋、(曱 基)丙烯酸叔丁酯、(甲基)丙烯酸環己酯、(曱基)丙烯酸节 醋、(曱基)丙烯酸2-幾基乙S旨、(曱基)丙烯酸2-經基丙g旨、 苯乙烯、甲基苯乙烯、氯甲基苯乙婦、(甲基)丙烯酸(3_乙 基-3-環氧丙烧基)曱酯、N-環己基馬來醢亞胺以及N-苯基 馬來酿亞胺。 所述異氰尿酸縮水甘油酯例如可以列舉:1,3,5-三縮水 甘油基-1,3,5-三嗪-2,4,6-(1Η,3Η,5Η)-三酮 (l,3,5-triglycidyl- l,3,5-triazine-2,4,6_(lH,3H,5H)-trione, 93 200927790 下述結構式E150)、ι,3_二縮水甘油基_5_烯丙基4,3,^三嗪 -2,4,6-(111,311,511)-三網(下述結構式£151)以及異氰尿酸 縮水甘油酯型環氧樹脂。A vinegar copolymer, a methacrylic acid-methyl-acid glycidol vinegar site polymer, a methacrylic acid butyl vinegar-glycidyl methacrylate copolymer, and a propylene glycol acid 2. _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ Acid glycidol vinegar copolymer. The monomer having an oxyalkylene group may, for example, be: (comparable) glycidyl acrylate, 3,4-epoxycyclohexyl (meth) acrylate, and (meth) methacrylic methyl glycidol ester. Examples of the monomer other than the monomer having an oxiranyl group in the copolymer of the precursor having a ring-emulsion group include, for example, (fluorenyl)acrylic acid or decyl (meth)acrylate. , (mercapto) ethyl acrylate, (methyl) propyl roasting isopropyl vinegar, (meth) butyl acetonate, (mercapto) isopropyl acetonate, tert-butyl (mercapto) acrylate , (cyclohexyl) (meth) acrylate, (mercapto) acrylate vinegar, (mercapto) acrylate 2-alkyl B, (mercapto) acrylate 2- propyl styrene, styrene, methyl benzene Ethylene, chloromethyl benzene, (meth)acrylic acid (3-ethyl-3-epoxypropyl) decyl ester, N-cyclohexylmaleimide and N-phenyl maleimide . The glycidyl isocyanurate may, for example, be 1,3,5-triglycidyl-1,3,5-triazine-2,4,6-(1Η,3Η,5Η)-trione (l ,3,5-triglycidyl- l,3,5-triazine-2,4,6_(lH,3H,5H)-trione, 93 200927790 The following structural formula E150), ι,3_ diglycidyl _5_ Allyl 4,3,^ triazine-2,4,6-(111,311,511)-trisole (the following structural formula: £151) and an isocyanuric acid glycidyl ester type epoxy resin.
所述鏈狀脂肪族型環氧化合物例如可以列舉:環氧化 〇 聚丁二烯、以及EPOLEAD PB3600 ( DAICEL化學工業股 份有限公司製造)。 所述環狀脂肪族型環氧化合物例如可以列舉:2-甲基 -3,4_環氧環己基曱基-2,-甲基-3’,4’-環氧環己基羧酸酯(下 述結構式E153)、2,3-環氧環戊烷-2’,3’-環氧環戊烷醚(下 述結構式E154)、ε-己内酯改性3,4-環氧環己基甲基 環氧環己基曱酸酯、1,2:8,9-二環氧檸檬烯(l,2:8,9_diepoxy limonene,CELLOXIDE 3000 (DAICEL 化學工業股份有限 Ο 公司製造)、3,4-環氧環己烯基甲基-3’,4'-環氧環己烯甲酸酯 (CELLOXIDE 2021P ( DAICEL化學工業股份有限公司製 造),下述結構式E155)、以下述結構式E156表示的化合 物,CY-175、CY-177、CY-179 (均爲 CIBA-GEIGY 公司 製造),EHPD-3150( DAICEL化學工業股份有限公司製造) 以及環狀脂肪族型環氧樹脂。 94 200927790Examples of the chain aliphatic epoxy compound include epoxidized ruthenium polybutadiene and EPOLEAD PB3600 (manufactured by DAICEL Chemical Industry Co., Ltd.). The cyclic aliphatic epoxy compound may, for example, be 2-methyl-3,4-epoxycyclohexylfluorenyl-2,-methyl-3',4'-epoxycyclohexylcarboxylate ( The following structural formula E153), 2,3-epoxycyclopentane-2',3'-epoxycyclopentane ether (structure E154 below), ε-caprolactone modified 3,4-epoxy Cyclohexylmethylepoxycyclohexyl decanoate, 1,2:8,9-diepoxylimene (1,2:8,9_diepoxy limonene, CELLOXIDE 3000 (DAICEL Chemical Industry Co., Ltd.), 3,4 -Epoxycyclohexenylmethyl-3',4'-epoxycyclohexenecarboxylate (CELLOXIDE 2021P (manufactured by DAICEL Chemical Industry Co., Ltd.), the following structural formula E155), represented by the following structural formula E156 Compounds, CY-175, CY-177, CY-179 (all manufactured by CIBA-GEIGY Co., Ltd.), EHPD-3150 (manufactured by DAICEL Chemical Industry Co., Ltd.), and cyclic aliphatic epoxy resin. 94 200927790
而且,例如本發明的液晶配向劑可以進一步含有各種 添加劑。各種添加劑例如可以列舉聚醯喊以及其衍生物 以外的高分子化合物和低分子化合物,可以根據各自的目 的來選擇並使用。 例如 汀通同刀子化合物可以列舉可溶於有機溶劑中 的馬分子化合物。將這樣的高分子化合物添加到本發明的 液晶配向劑中,從對所形成的液晶配向膜的電特性或者配 向性進行控制峨點考慮較好。該高分子化合物例如可以 列舉:聚醯胺、聚氨基曱酸乙酯(p〇lyurethane)、聚脲 (Pdyurea)、聚酯、聚環氧化物(p〇lyep〇xide)、聚酯多 元醇(polyester polyol )、矽酮改性聚氨基曱酸乙酯以 酮改性聚酯。 7 而且,對於所述低分子化合物,例如,υ當希望提古 塗布性時可以列舉符合該目的界面活性劑,2)當必須提: ^靜電性時可以列舉抗靜電劑,”當希望提高與基板的= 者性或者耐雜(nibbing)性時可以鱗雜偶合 鈦系偶合劑,而且,4) #在低溫下進行酿亞胺化時可以 舉醯亞胺化催化劑。 Η 所述矽烷偶合劑例如可以列舉:乙烯基三甲氧美矽 95 200927790 氧基矽ΐ、Ν♦氨基乙基)_3·氨基丙基甲 基矽烷、ί氨ί二二風基乙基)各氨基丙基甲基三甲氧 #、基二Γ氧基魏、對氨基苯基三乙氧基 r、元3-二而^基二甲氧基魏、間氨基苯基三乙氧基石夕 元 二甲氧基♦燒、3-氨基丙基三乙氧基矽烧、Further, for example, the liquid crystal alignment agent of the present invention may further contain various additives. As the various additives, for example, a polymer compound and a low molecular compound other than the derivative and the derivative thereof may be mentioned, and they may be selected and used according to their respective purposes. For example, the Tingtong Knife Compound can exemplify a horse molecule compound which is soluble in an organic solvent. It is preferable to add such a polymer compound to the liquid crystal alignment agent of the present invention, and to control the electrical characteristics or the alignment property of the formed liquid crystal alignment film. Examples of the polymer compound include polyamine, polyethyl phthalate, polyurea (Pdyurea), polyester, polyepoxide (p〇lyep〇xide), and polyester polyol ( Polyester polyol ), anthrone modified polyaminodecanoate is a ketone modified polyester. 7 Further, for the low molecular compound, for example, when it is desired to improve the applicability, a surfactant suitable for the purpose may be mentioned, and 2) when it is necessary to mention: "electrostatic property, an antistatic agent may be mentioned," when it is desired to improve When the substrate is neutral or nibbing, the titanium coupling agent can be coupled with a scale, and 4) # can be imidized at a low temperature. The oxime coupling agent can be used. For example, vinyl trimethoprim 95 200927790 oxindole, oxime oxime aminoethyl) _3. aminopropyl methyl decane, lutyl sulphate ethyl) aminopropyl methyl trimethoxy #,基二Γ oxy Wei, p-aminophenyl triethoxy r, meta 3-di-dimethoxydi- Wei, m-aminophenyl triethoxy stone oxime dimethoxy ♦ burn, 3 -aminopropyltriethoxy oxime,
Ο 3甲1水a基丙基三Γ氧基石夕烧、3_縮水甘油氧基丙基 亡一故土矽烷、3·氣丙基甲基二曱氧基矽烷、3-氯丙 基三甲氧基残、3·甲基丙_氧基丙基三甲氧基魏、 3-疏基丙基三甲氧基魏、N_(1,3_二甲基亞丁基糾三乙 氧基雜基H-丙胺以及取,_雙[3_(三曱氧基魏基)丙基] 乙二胺。 所述醯亞胺化催化劑例如可以列舉:三曱胺、三乙胺、 三丙胺、三丁胺等脂肪族胺類;N,N_二曱基苯胺、N,N-二 乙基苯胺、曱基取代苯胺、羥基取代苯胺等芳香族胺類; °比咬、曱基取代n比咬、經基取代π比咬、喹琳(quinoline)、 曱基取代喹啉、羥基取代喹啉、異喹啉、甲基取代異喹啉、 羥基取代異喹啉、咪唑、甲基取代咪唑、羥基取代味唾等 環式胺類。所述醯亞胺化催化劑優選的是,選自N,N_二甲 基苯胺、鄰羥基苯胺、間羥基苯胺、對羥基苯胺、鄰經基 吡啶、間羥基吡啶、對羥基吡啶以及異喹啉中的一種或者 兩種或兩種以上。 矽烷偶合劑的添加量通常爲聚醯胺酸或者其衍生物的 總重量的0重量%〜20重量%,優選爲0.1重量%〜10重 量%。 96 200927790 醯亞胺化催化劑的添加量通常相對於聚醯胺酸或者其 衍生物的羰基,而爲〇.〇1當量〜5當量,優選爲〇仍當量 〜3當量。 · 其他添加劑的添加量是根據其用途而有所不同,通常 爲聚醯胺酸或者其衍生物的總重量的〇重量%〜1〇〇重量 %,優選爲0.1重量%〜50重量%。 而且,例如本發明的液晶配向劑可以在不損及本發明 效果的範圍(優選爲所述聚醯胺酸或者其衍生物的2〇重量 %以内的量)内進一步含有:丙烯酸聚合物,丙烯酸酯聚 合物,以及作爲四羧酸二酐、二羧酸或者其衍生物與二胺 的反應産物的聚醯胺醯亞胺等其他聚合物成分。 而且,例如從調整液晶配向劑的塗布性以及所述聚酿 胺酸或者其衍生物的濃度的觀點考慮,本發明的液晶配向 劑可以進一步含有溶劑。所述溶劑只要是具有溶解高分子 成分的能力的溶劑則可以使用’並無特別限制。所述溶劑 廣泛地包括聚酿胺酸、可溶性聚醯亞胺等高分子成分的製 〇 造步驟或者用途方面通常所使用的溶劑,可以根據使用目 的而適當選擇。所述溶劑可以是一種溶劑,也可以是兩種 或者兩種以上溶劑的混合溶劑。 所述溶劑可以列舉:所述聚醯胺酸或其衍生物的良溶 劑、或者以改善塗布性爲目的之其他溶劑。 相對於所述聚醢胺酸或者其衍生物而言爲良溶劑的非 質子性極性有機溶劑,可以列舉:N-甲基-2-吡咯烷酮、二甲 基口米σ坐烧酮(dimethyl imidazolidinone)、N-曱基己内酿胺 97 200927790 (N-methyl caprolactam )、N-甲基丙醯胺(N_methyl propionamide)、N,N-二甲基乙醯胺、二甲基亞砜(出咖邮 sulfoxide )、N,N-二甲基曱醯胺、N,N-二乙基甲醢胺、二乙 基乙醯胺、γ-丁内酯(γ-butyrolactone)等内醋。 所述以改善塗布性等爲目的之其他溶劑的例子可以列 舉:乳酸院基酯、3-曱基-3-甲氧基丁醇、萘滿(tetraUn)、 異佛爾酮(isophorone)、乙二醇單丁醚等乙二醇單烧基醚、 一乙一醇早乙謎等二乙·一醇单烧基縫、乙二醇單烧基或者 ® 苯基乙酸醋、三乙二醇單烧基趟、丙二醇單甲喊及丙二醇 單丁醚等丙二醇單烷基醚、丙二酸二乙酯等丙二酸二燒基 酯、·一丙一醇早曱驗等·一丙一醇單烧基越、它們的乙酸酉旨 類等酯化合物。 這些化合物中,所述溶劑特別優選N-甲基-2-吡咯烷 酿J、二曱基咪σ坐烧酮、γ-丁内醋、乙二醇單丁謎、二乙二 醇單乙醚、丙二醇單丁醚、丙二醇單曱驗以及二丙二醇單 曱謎。 〇 本發明中,液晶配向劑十的包含所述聚醯胺酸或者其 衍生物的高分子成分的濃度並無特別限定,優選〇1重量 %〜40重量%。將該液晶配向劑塗布在基板上時,有時爲 了調整膜厚而必須進行預先用溶劑來將所含有的高分子成 分稀釋的操作。此時,從將液晶配向劑的粘度調整成適合 在液晶配向劑中容易地混合溶劑的粘度的觀點考慮,所述 高分子成分的濃度優選爲40重量%或40重量%以下。 而且,液晶配向劑中的所述高分子成分的濃度有時也 98 200927790 晶配向劑的塗布方法來調整。當液晶配向劑的塗 ,方^旋轉塗布法或者印刷法時,爲了良好地保持膜 父。通常大多使所述高分子成分的濃度爲!。重量%或ι〇 重下。對於其他的塗布方法、例如浸潰法 method)或者噴墨法(ink_jetmethGd)來說,有可能要進 °另—方面’如果所述高分子成分的濃度爲 ㈣Λ 1重量0/0以上,那麼所獲得的液晶配向膜 ❹Ο 3A1 water a propyl propyl sulfoxide, 3 缩 甘油 甘油 亡 故 故 故 故 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 Residue, 3·methylpropoxypropyltrimethoxywei, 3-sulfopropyltrimethoxywei, N_(1,3-dimethylsobutyltriethoxyhydanyl H-propylamine and And bis[3_(trioxyloxywei)propyl]ethylenediamine. The ruthenium amide catalyst may, for example, be an aliphatic amine such as tridecylamine, triethylamine, tripropylamine or tributylamine. Ordinary amines such as N,N-dimercaptoaniline, N,N-diethylaniline, mercapto-substituted aniline, hydroxy-substituted aniline; ° ratio of bite, thiol-substituted n-bite, thiol-substituted π ratio Quino, quinoline, thiol-substituted quinoline, hydroxy-substituted quinoline, isoquinoline, methyl-substituted isoquinoline, hydroxy-substituted isoquinoline, imidazole, methyl-substituted imidazole, hydroxy-substituted saliva The quinone imidization catalyst is preferably selected from the group consisting of N,N-dimethylaniline, o-hydroxyaniline, m-hydroxyaniline, p-hydroxyaniline, o-pyridine, m-hydroxypyridine, p-hydroxyl One or two or more of pyridine and isoquinoline. The amount of the decane coupling agent added is usually from 0% by weight to 20% by weight, preferably 0.1% by weight, based on the total weight of the polyamic acid or a derivative thereof. 96% by weight. 96 200927790 The amount of the ruthenium amide catalyst is usually added in an amount of 〇1〇 to 5 equivalents, preferably 〇 is equivalent to 〜3 equivalents, relative to the carbonyl group of the polyglycolic acid or its derivative. The amount of the additive to be added varies depending on the use thereof, and is usually from 〇% by weight to 1% by weight, based on the total weight of the polyamic acid or a derivative thereof, preferably from 0.1% by weight to 50% by weight. The liquid crystal alignment agent of the present invention may further contain an acrylic polymer or an acrylate polymer in a range which does not impair the effects of the present invention (preferably, the amount of the polyamic acid or a derivative thereof within 2% by weight). And other polymer components such as polyamidoximine which is a reaction product of tetracarboxylic dianhydride, dicarboxylic acid or a derivative thereof and a diamine. Further, for example, the coating property and the liquid crystal alignment agent are adjusted. The liquid crystal alignment agent of the present invention may further contain a solvent, and the solvent may be used as long as it has a solvent capable of dissolving a polymer component, and is not particularly limited. The solvent which is generally used in the production step or the use of a polymer component such as poly-aramidic acid or a soluble polyimine may be appropriately selected depending on the purpose of use. The solvent may be a solvent. The solvent may be a mixed solvent of two or more solvents. The solvent may be a good solvent of the polyaminic acid or a derivative thereof or another solvent for the purpose of improving coatability. An aprotic polar organic solvent which is a good solvent for an amine acid or a derivative thereof, and examples thereof include N-methyl-2-pyrrolidone, dimethyl imidazolidinone, and N-mercaptohexyl. Endo-amine 97 200927790 (N-methyl caprolactam ), N-methyl propionamide, N,N-dimethylacetamide, dimethyl sulfoxide Internal vinegar such as sulfoxide), N,N-dimethyldecylamine, N,N-diethylformamide, diethylacetamide, γ-butyrolactone. Examples of the other solvent for the purpose of improving coatability and the like include lactic acid ester ester, 3-mercapto-3-methoxybutanol, tetraun, isophorone, and B. Ethylene glycol monoalkyl ether such as diol monobutyl ether, monoethylidene alcohol monobutyl base, ethylene glycol monoalkyl or phenylacetate, triethylene glycol monobutyl Base propylene glycol, propylene glycol monomethyl sulfonate and propylene glycol monoalkyl ether such as propylene glycol monobutyl ether, malonic acid dialkyl acrylate such as diethyl malonate, early detection of monopropanol, etc. An ester compound such as acetaminophen or their acetate. Among these compounds, the solvent is particularly preferably N-methyl-2-pyrrolidine, J, dimethyl sulfonium ketone, γ-butyrolactone, ethylene glycol monobutylene, diethylene glycol monoethyl ether, Propylene glycol monobutyl ether, propylene glycol monoterpene test and dipropylene glycol monoterpene puzzle. In the present invention, the concentration of the polymer component containing the polyamic acid or the derivative thereof in the liquid crystal alignment agent is not particularly limited, and is preferably from 1% by weight to 40% by weight. When the liquid crystal alignment agent is applied onto a substrate, it is necessary to perform an operation of diluting the polymer component contained in advance with a solvent in order to adjust the film thickness. In this case, from the viewpoint of adjusting the viscosity of the liquid crystal alignment agent to a viscosity suitable for easily mixing the solvent in the liquid crystal alignment agent, the concentration of the polymer component is preferably 40% by weight or less. Further, the concentration of the polymer component in the liquid crystal alignment agent may be adjusted by the coating method of the crystal alignment agent of 98 200927790. When the liquid crystal alignment agent is coated, the spin coating method or the printing method, in order to maintain the film father well. Usually, the concentration of the polymer component is mostly made! . Weight % or ι〇. For other coating methods, such as the impregnation method or the inkjet method (ink_jetmethGd), it is possible to proceed to another aspect. If the concentration of the polymer component is (four) Λ 1 weight 0/0 or more, then Obtained liquid crystal alignment film
:土旱谷易成爲最佳的厚度。因此,在通常的旋轉塗布法 =印刷法等中’所述向分子成分的濃度爲重量%或 者0.1重量%以上’優選0.5重量%〜10重量%。但是,根 據液晶配向_塗布方法’树也可以在更低的濃度下使 用。 另外,將本發明的液晶配向劑用於製作液晶配向膜 時,本發明的液_向劑_度可以根據形成該液晶配向 劑膜的機構或者方法來决定。例如,使科刷機來形成液 晶配向劑⑽時’從獲得充分的膜厚的觀點考慮,本發明 的液晶配向劑的減優選爲5 mpa·s或者5 mpa.s以上,而 且’從抑制印刷不均的觀點考慮,本發_液晶配向劑的 粘度優選爲100 mPa.s或者100 100 mPa.s以下,更加優選 爲10 mPa.s〜80 mPa.s。利用旋轉塗布法來塗布液晶配向 劑而形成液晶配向劑賴時,從同樣的觀財慮,本發明 的液晶配向劑的粘度優選爲5 mPa.s〜2〇〇 mPa.s,更加優 選爲10 mPa.s〜100 mPa.s。液晶配向劑的粘度可以通過溶 劑的稀釋或者伴隨著攪拌的熟化而减小。 99 200927790 本發明的液晶配向劑可以是含有一種聚醯胺酸或者其 竹生物的形態’也可以是混合了兩種或者兩種以上聚酿胺 酸或者其衍生物的所謂聚合物摻合物的形態。聚合物摻合 物形態的液晶配向劑可以列舉以下的液晶配向劑:其含有 聚醯胺酸或者其衍生物A以及B,並且聚醯胺酸或者其衍 生物A包含二胺中的所述具有侧鏈結構的二胺,且聚醯胺 酸或者其竹生物A以及B的二胺中的一方或者兩方包含以 Q 所述通式(N)表示的二胺。 聚醯胺酸或者其衍生物A是含有所述具有侧鏈結構的 一胺的聚醯胺酸或者其衍生物。聚酿胺酸或者其衍生物B 是含有除了具有側鏈結構的二胺以外的二胺的聚醯胺酸或 者其衍生物。以所述通式(N)表示的二胺,只要包含於 在聚合物摻合物中混合的至少一種聚醯胺酸或者其衍生物 中即可,可以包含於聚醯胺酸或者其衍生物A以及b兩方 中,也可以包含於在聚合物摻合物中混合的所有聚醯胺酸 ^ 或者其衍生物中。 本發明的液晶配向膜是對所述本發明的液晶配向劑的 塗膜進行加熱而形成的膜。本發明的液晶配向膜可以使用 由液晶配向劑來製作液晶配向膜的通常方法而獲得,例 如’本發明的液晶配向膜可以通過形成本發明液晶配向劑 的塗膜的步驟、以及對該塗膜進行加熱並煆燒的步驟而獲 得。對於本發明的液晶配向膜而言,視需要可以對所述煆 燒步驟中獲得的膜進行摩擦處理。 與製作通常的液晶配向膜相同,所述塗膜可以通過在 100 200927790 液晶顯示元件祕板上塗布本發_液晶配向劑而形成。 所述基板可以列舉:可以設置著氧化銦錫(Indium Tin Oxide,ITO)電極等電極以及彩色濾光片(c〇1〇rfilter)等 的玻璃制基板。 將液晶配向劑塗布在基板上的方法,通常已知旋轉器 (Spilmer)法、印刷法、浸潰法、落滴法(falling-drop Ο: Soil Wadi is easy to become the best thickness. Therefore, in the usual spin coating method = printing method or the like, the concentration of the molecular component is % by weight or 0.1% by weight or more, preferably 0.5% by weight to 10% by weight. However, it can also be used at a lower concentration according to the liquid crystal alignment_coating method' tree. Further, when the liquid crystal alignment agent of the present invention is used for producing a liquid crystal alignment film, the liquid_to-agent ratio of the present invention can be determined according to the mechanism or method for forming the liquid crystal alignment agent film. For example, when the liquid crystal alignment agent (10) is formed by a brush machine, the reduction of the liquid crystal alignment agent of the present invention is preferably 5 mpa·s or more, and 5 mpa·s or more, from the viewpoint of obtaining a sufficient film thickness, and From the viewpoint of the average, the viscosity of the liquid crystal alignment agent is preferably 100 mPa·s or 100 100 mPa·s or less, and more preferably 10 mPa·s to 80 mPa·s. When the liquid crystal alignment agent is applied by a spin coating method to form a liquid crystal alignment agent, the viscosity of the liquid crystal alignment agent of the present invention is preferably 5 mPa·s to 2 μmPa·s, and more preferably 10 mPa.s ~ 100 mPa.s. The viscosity of the liquid crystal alignment agent can be reduced by dilution of the solvent or aging with stirring. 99 200927790 The liquid crystal alignment agent of the present invention may be in the form of a polyglycine or a bamboo organism thereof, or a so-called polymer blend in which two or more kinds of polyacrylic acid or a derivative thereof are mixed. form. The liquid crystal alignment agent in the form of a polymer blend may, for example, be a liquid crystal alignment agent containing polylysine or derivatives A and B thereof, and the polyamine or the derivative A thereof contains the diamine The diamine of the side chain structure, and one or both of the polyamic acid or the diamine of the bamboo organism A and B thereof contain a diamine represented by the above formula (N). Polylysine or a derivative thereof A is a poly-proline or a derivative thereof containing the amine having a side chain structure. Polylactoic acid or a derivative thereof B is a polyaminic acid or a derivative thereof containing a diamine other than a diamine having a side chain structure. The diamine represented by the above formula (N) may be contained in at least one polyphthalic acid or a derivative thereof mixed in the polymer blend, and may be contained in polylysine or a derivative thereof. Both A and b may also be included in all of the polyamines or their derivatives mixed in the polymer blend. The liquid crystal alignment film of the present invention is a film formed by heating the coating film of the liquid crystal alignment agent of the present invention. The liquid crystal alignment film of the present invention can be obtained by a usual method for producing a liquid crystal alignment film from a liquid crystal alignment agent, for example, a step of forming a coating film of the liquid crystal alignment agent of the present invention, and a coating film of the liquid crystal alignment film of the present invention It is obtained by the step of heating and calcining. For the liquid crystal alignment film of the present invention, the film obtained in the calcining step can be subjected to a rubbing treatment as needed. Similar to the production of a usual liquid crystal alignment film, the coating film can be formed by coating the present invention with a liquid crystal alignment agent on a 100 200927790 liquid crystal display element. The substrate may be a glass substrate in which an electrode such as an indium tin oxide (ITO) electrode or a color filter (c〇1〇rfilter) may be provided. A method of applying a liquid crystal alignment agent onto a substrate is generally known as a spinner method, a printing method, a dipping method, and a dropping method (falling-drop Ο).
method)、喷墨法等。這射法在本發财仙樣可以應 用0 所述塗膜的煅燒可以在所述聚醯胺酸或者其衍生物進 ^脫水、閉環反應的必要條件下進行。所述塗膜的锻燒通 常已知在烘箱(_)或者紅外爐中進行加熱處理的方法、 在熱板(hot plate)上進行加熱處理的方法等。這些方法 在今發明中也同樣可以應用^通常優選的是在15叱〜 30〇 C左右的溫度下進行丨分鐘〜3小時。 所述摩擦處理可以與通常用來對液晶配向膜進行配向 2的摩擦處關樣地進行,只要是可以使本發明的液晶 •己向膜獲得充分的輯(fetaniatiGn)的條件 ,的條件是’毛壓入量爲〇.2mm〜。.8職,平臺二二 爲5 mm/sec〜250 mm/sec,滾筒轉速爲5⑼卬以〜⑽〇 _。液晶配向膜的配向處理方法除摩擦法以外,通常已 =光配向法或者轉印料。在可續得本發明絲的範圍 可以在所述摩擦處理中併用這些其他的配向處理方法。 本發明的液晶配向膜可以利用除了所述步驟以外進一 步含有其他步_方_適宜祕得。錄的其他步驟可 101 200927790 或者用清洗液對摩擦 以列舉對所述塗膜進行乾燥的步驟、 處理前後的膜進行清洗的步驟等。 與所述煆燒步驟相同,所述乾燥步 或者紅外爐中進行加熱處理的方法、在=== 理的方料。料綠麵魏科财 用。乾燥錢優是在賴_蒸發的範圍⑽溫度下 〇Method), inkjet method, and the like. This shot method can be applied to the present invention. The calcination of the coating film can be carried out under the conditions necessary for the polyglycine or its derivative to undergo dehydration and ring closure reaction. The calcination of the coating film is generally known as a method of heat treatment in an oven (_) or an infrared furnace, a method of performing heat treatment on a hot plate, and the like. These methods are also applicable in the present invention. It is generally preferred to carry out the enthalpy for about 3 to 3 hours at a temperature of about 15 Torr to 30 Torr C. The rubbing treatment can be carried out in the same manner as the rubbing portion which is usually used for the alignment of the liquid crystal alignment film 2, as long as the liquid crystal film of the present invention can obtain a sufficient condition (fetaniatiGn), the condition is ' The amount of capillary intrusion is 〇.2mm~. .8 position, platform 22 is 5 mm / sec ~ 250 mm / sec, the drum speed is 5 (9) 卬 ~ (10) 〇 _. The alignment treatment method of the liquid crystal alignment film usually has a photo-alignment method or a transfer material in addition to the rubbing method. These other alignment treatment methods can be used in combination in the rubbing treatment in the range in which the yarn of the present invention can be continued. The liquid crystal alignment film of the present invention can further contain other steps in addition to the above steps. Other steps recorded may be 101 200927790 or rubbing with a cleaning solution to exemplify a step of drying the coating film, a step of washing the film before and after the treatment, and the like. In the same manner as the calcining step, the drying step or the method of heat treatment in the infrared oven is performed at ===. Green surface Wei Ke Cai. Dry money is at the temperature of the range of evaporation (10) 〇
實施’更舰的是在類述錢步_溫度她相對較低 的溫度下實施。 、用清洗液對配向處理前後的液晶配向膜進行清洗的清 洗方法,可以列舉:刷洗(brushing)、喷霧(加叩㈣、 蒸氣清洗或者超聲波清洗等。這些方法可以單獨進行,也 可以併用。清洗液可以使用:純水,或者甲醇、乙醇、異 丙醇等各種醇類,苯、甲苯、二甲苯等芳香族烴類,二氯 曱烷(methylene Chl0ride)等齒素系溶劑,丙酮、曱基乙 基酮等酮類,但並不限定於這些清洗液。當然,這些清洗 液可以使用經充分純化而雜質少的清洗液。這樣的&洗方 法在形成本發明的液晶配向膜的所述清洗步驟中也可以應 用0 本發明的液晶配向膜的膜厚並無特別限定,優選爲1〇 nm〜300nm,更加優選爲3〇nm〜150nm。本發明的液晶 配向膜的膜厚可以用表面輪廓儀(pr〇f|l〇meter)或者橢偏 儀(ellipSometer)等衆所周知的膜厚測定裝置來測定。 本發明的液晶顯示元件具有··一對基板、含有液晶分 子且形成在所述一對基板間的液晶層、對液晶層施加電壓 102 200927790 的電極、以及將所述液晶分子配向在預定方向上的液晶配 向膜。所述液晶配向膜是使用所述本發明的液晶配向膜。 所述基板可以使用上文中針對本發明的液晶配向膜所 描述的玻璃制基板,所述電極可以使用上文中針對本發明 的液晶配向膜所描述的形成在玻璃制基板上的IT〇電極。 所述液晶層是由被密封在相對向的一對基板間的間隙 中的液晶組成物所形成的,該相對向的一對基板是以所述The implementation of the 'more ship' is implemented at a relatively low temperature. The cleaning method for cleaning the liquid crystal alignment film before and after the alignment treatment with a cleaning liquid may be, for example, brushing, spraying (twisting (four), steam cleaning, ultrasonic cleaning, etc. These methods may be carried out separately or in combination. The cleaning solution can be used: pure water, or various alcohols such as methanol, ethanol, and isopropanol, aromatic hydrocarbons such as benzene, toluene, and xylene; dentate solvents such as methylene Chlride, acetone and hydrazine. The ketones such as ethyl ketone are not limited to these cleaning liquids. Of course, these cleaning liquids may use a cleaning liquid which is sufficiently purified and has few impurities. Such a & washing method is used to form the liquid crystal alignment film of the present invention. The film thickness of the liquid crystal alignment film of the present invention is not particularly limited, but is preferably from 1 nm to 300 nm, more preferably from 3 nm to 150 nm. The film thickness of the liquid crystal alignment film of the present invention can be used. The liquid crystal display element of the present invention has a known thickness measurement apparatus such as a surface profiler (pr〇f|l〇meter) or an ellipsometer (ellipSometer). a plate, a liquid crystal layer containing liquid crystal molecules and formed between the pair of substrates, an electrode for applying a voltage 102 200927790 to the liquid crystal layer, and a liquid crystal alignment film for aligning the liquid crystal molecules in a predetermined direction. The liquid crystal alignment film of the present invention is used. The substrate may use a glass substrate described above for the liquid crystal alignment film of the present invention, and the electrode may be formed using the liquid crystal alignment film described above for the present invention. An IT crucible electrode on a glass substrate. The liquid crystal layer is formed of a liquid crystal composition sealed in a gap between a pair of opposing substrates, the pair of opposing substrates being
-對基板中的-片基板的形成了液晶配向膜的面朝向另一 片基板的方式而對向的。 所述液晶組成物並無特別限制,可以使用介電常數各 ,異性爲正或者負的各種液晶組成物。介電常數各向異性 =的優選液脉成物可㈣舉在以下公報中所揭示的液 曰曰組成物:日本專利第3嶋28號公報、日本專利第 報、日林_平娜=專3 日太直制平9-241644號公報(麵廳 說明書)、日本專興料9_助46號 )): 開平8·199168 號公報(__ 開平9拥56號公報報、日本專利特 (EP885271A1說明書)、日本平9铺643號公報 報⑽觸曰平他議6號公 公報、日本專利特開平1〇_231482平1〇-_6號 2000-087040號公報、日本 '曰本專利特開 寻和特開20〇1_48822號公報等。 103 ❹ Ο 200927790 介電常數各向異性爲負的液晶組 報中所揭示的液晶組成物:曰本專利特二=列f以下公 公報、曰本專利特開平2姻==他號 4掘5號公報、曰本專利特開平曰=特開: 專利特開平8-104869號公報、日土 :53號公報、日本 號公報、日本專利特開平 ^ 號公報、日本專利特開平 報、日本專利特開平10·23_2號公報、日本專利門: 10-237004 ^公報、Q日HU公報、日本專利特開平 本專利特開平他二^ =期號公報、日本和_㈣·細】特開: 本專利特開平10-237448祙八如^ 9 日本專利特開平10_28‘t i^%726=說明書)、- opposing the surface of the substrate in which the liquid crystal alignment film is formed on the substrate toward the other substrate. The liquid crystal composition is not particularly limited, and various liquid crystal compositions having a dielectric constant and a positive or negative anisotropy can be used. The preferred liquid enthalpy of the dielectric anisotropy = (4) The liquid hydrazine composition disclosed in the following publication: Japanese Patent No. 3, 28, Japanese Patent, Japanese, Japanese, and Japanese 3rd, Taichung, No. 9-241644 (the hall manual), Japan's special material 9_Help No. 46)): Kaiping 8.199168 bulletin (__ Kaiping 9 with the 56th bulletin, Japanese patent special (EP885271A1) Manual), Japan's Hira 9 Shop No. 643 Gazette (10) Touching the Ping-Pan No. 6 Public Gazette, Japanese Patent Special Kaiping 1〇_231482 Ping 1〇-_6 No. 2000-087040, Japan's "This Patent" Japanese Patent Laid-Open Publication No. Hei. No. 20-14822. 103 ❹ Ο 200927790 Liquid crystal composition disclosed in liquid crystal group report with negative dielectric anisotropy: 曰本专利特二=列f The following public gazette, 曰本专利Kaiping 2 Marriage == Others No. 4, No. 5, No. 5, and a special patent for this patent: Special Patent: Japanese Patent Publication No. 8-104869, Japanese Journal: No. 53, Japanese Gazette, Japanese Patent Unexamined Japanese Patent Special Open Report, Japanese Patent Special Open No. 10·23_2, Japanese Patent Door: 10-2370 04 ^Gazette, Q-day HU Gazette, Japanese Patent Unexamined Patent, Special Kaiping, Pingji II = = Issue Bulletin, Japan, and _ (four)·fine] Special Opening: This patent is open to the public. 10-237448祙八如^ 9 Japanese Patent Kaiping 10_28'ti^%726=specification),
10_287875號公報、日本真'a艮、日本專利特開平 ,. 孰日本專利特開平10-291945號公報、H 本專利特開平11_029581號公 日 號公報、曰本專利特開2觀麵公=: 八ΐ特開:⑽965公報、日本專利制纖·0726% 公報、日本專利特開·M92657公報等。 伟太二電常數各向異性爲正或者負的液晶組成物’即 =使用-種或者-種以上的光學活性化合物也沒有: 本發明的液晶顯示元件是通過下述方式而獲得的:在 104 200927790 一對基板中的至少一片基板上形成本發明的液晶配向膜, 使液晶配向膜朝内而使所獲得的一對基板隔著間隔物 (spacer)相對向’在形成於基板間的間隙中封入液晶組 成物而形成液晶層。本發明的液晶顯示元件的製造過程 中,視需要可以進一步包含對基板貼附偏光膜等的步驟。 本發明的液晶顯示元件可以形成各種電場方式用的液 晶顯示元件。這樣的電場方式用的液晶顯示元件可以列 舉:所述電極在相對於所述基板的表面爲水平的方向上對 ® 所述液晶層施加電壓的橫向電場方式用的液晶顯示元件、 或者所述電極在相對於所述基板的表面爲垂直的方向上對 所述液晶層施加電壓的縱向電場方式用的液晶顯示元件。 橫向電場方式用的液晶顯示元件即使不表現出較大的 預傾角也無妨,因此,由本發明的液晶配向劑所形成的液 晶配向膜適用於橫向電場方式用的液晶顯示元件,其中本 發明的液晶配向劑含有如由不含具有側鏈結構的二胺之二 胺所得的聚酿胺酸或者其衍生物那樣的不具有侧鍵結構的 0 聚醯胺酸或者其衍生物。 縱向電場方式用的液晶顯示元件需要表現出較大的預 傾角,因此,由本發明的液晶配向劑所形成的液晶配向膜 適用於縱向電場方式用的液晶顯示元件,其中本發明的液 晶配向劑含有如由包含具有侧鏈結構的二胺之二胺所得的 聚酿胺酸或者其衍生物那樣的具有侧鍵結構的聚酿胺酸或 者其衍生物。 如上所述將本發明的液晶配向劑作爲原料而製作的 105 200927790 液曰曰配向膜,通過對其原料即聚合物進行適當選擇,可以 應用於各種顯示驅動方式的液晶顯示元件中。 本發明的液晶顯示元件可以進一步具有所述構成要素 以^的要素。對於這樣的其他構成要素,在本發明的液晶 顯示元件中可以安裝偏光板(偏光膜)、波長板、光散射膜、 驅動電路科晶辭元件巾通常使肖的構成要素。 [實施例] 以下,利用實施例來說明本發明,本發明並不限定於 這些實施例。實施例中使用的化合物如下所述。 <四羧酸二酐>Japanese Patent No. 10_287875, Japanese Patent No. 日本, Japanese Patent Unexamined Patent, Japanese Patent Laid-Open No. Hei 10-291945, H Patent No. 11_029581, and Japanese Patent Publication No. 2: Gossip specials: (10) 965, Japanese Patent No. 0726%, Japanese Patent Unexamined M92657, and the like. A liquid crystal composition in which the electrical anisotropy of positive or negative is positive or negative is the same as that of the optically active compound of the above-mentioned type or the like: The liquid crystal display element of the present invention is obtained by the following means: 200927790 The liquid crystal alignment film of the present invention is formed on at least one of a pair of substrates, such that the liquid crystal alignment film faces inward, and the obtained pair of substrates are opposed to each other in a gap formed between the substrates via a spacer. A liquid crystal composition is sealed to form a liquid crystal layer. In the manufacturing process of the liquid crystal display element of the present invention, a step of attaching a polarizing film or the like to the substrate may be further included as needed. The liquid crystal display element of the present invention can form liquid crystal display elements for various electric field methods. The liquid crystal display element for the electric field method includes a liquid crystal display element for applying a voltage to the liquid crystal layer in a direction horizontal to the surface of the substrate, or the electrode A liquid crystal display element for a vertical electric field mode in which a voltage is applied to the liquid crystal layer in a direction perpendicular to a surface of the substrate. The liquid crystal display element for a lateral electric field method may not exhibit a large pretilt angle. Therefore, the liquid crystal alignment film formed of the liquid crystal alignment agent of the present invention is suitable for a liquid crystal display element for a transverse electric field mode, wherein the liquid crystal of the present invention The alignment agent contains, as a polylactoic acid obtained from a diamine having no diamine having a side chain structure, or a derivative thereof, polyacrylic acid having no side bond structure or a derivative thereof. The liquid crystal display element for the vertical electric field method needs to exhibit a large pretilt angle. Therefore, the liquid crystal alignment film formed by the liquid crystal alignment agent of the present invention is suitable for a liquid crystal display element for a vertical electric field mode, wherein the liquid crystal alignment agent of the present invention contains A poly-brenic acid having a side bond structure or a derivative thereof, such as polyacrylic acid obtained by a diamine having a diamine having a side chain structure or a derivative thereof. The liquid crystal alignment film prepared by using the liquid crystal alignment agent of the present invention as a raw material as described above can be suitably used in liquid crystal display elements of various display driving methods by appropriately selecting a polymer which is a raw material. The liquid crystal display element of the present invention may further have the elements of the above-described constituent elements. In such a liquid crystal display element of the present invention, a polarizing plate (polarizing film), a wavelength plate, a light-scattering film, and a driving circuit-based crystallographic element sheet can be attached to the liquid crystal display element. [Examples] Hereinafter, the present invention will be described by way of Examples, but the present invention is not limited to these Examples. The compounds used in the examples are as follows. <tetracarboxylic dianhydride>
化合物(1).均苯四曱酸二酐(Pyromellitic Dianhydride) : PMDACompound (1). Pyromellitic Dianhydride: PMDA
化合物(19): 1,2,3,4-環丁烷四甲酸二酐(1,2,3,4-cyclobutane tetracarboxylic dianhydride) : CBD ACompound (19): 1,2,3,4-cyclobutane tetracarboxylic dianhydride: CBD A
化合物(23) : 1,2,3,4-丁烷四曱酸二酐:BT 化合物(37): l,3,3a,4,5,9b_六氫-5(四氫-2,5-二氧代-3-© °夫°南基)萘並[1,2-十夫0南-1,3_ :_(l,3,3a,4,5,9b-hexahydro-Compound (23): 1,2,3,4-butane tetradecanoic acid dianhydride: BT compound (37): 1,3,3a,4,5,9b_hexahydro-5 (tetrahydro-2,5 -Dioxo-3-© °夫南基)Naphtho[1,2- 十夫0南-1,3_ :_(l,3,3a,4,5,9b-hexahydro-
5 (tetrahy dro-2,5 -dioxo-3 -furanyl)naphoto [ 1,2-c] furan-1,3 -di one) : TDA5 (tetrahy dro-2,5 -dioxo-3 -furanyl)naphoto [ 1,2-c] furan-1,3 -di one) : TDA
化合物(49 ) : 2,3,5-三羧基環戊基乙酸二酐 (2,3,5-tricarboxy cyclopentyl acetic dianhydride) : TCMP <二胺>Compound (49): 2,3,5-tricarboxycyclopentyl acetic anhydride dianhydride: TCMP <diamine>
化合物:1,4-雙(4-氨基苯基)-1,4-二氮雜環己烷 (l,4-bis(4-aminophenyl)-l,4-diazacyclohexane) · DAC 106 200927790 化合物:4,4·-(呱嗪-1,4-二基)雙(2-甲基苯胺):3MPDA 化合物:1,4-雙(3-氨基丙基)呱嗪:APP 化合物:4,4’-二氨基二苯基甲烷:DDM 化合物:1,2-雙(4-氨基苯基)乙烷:DET 化合物:U-雙[4-(4-氨基苯氧基)苯基]-4·[(4-庚基環己 基)乙基]環己烷:7Η2ΗΒΑCompound: 1,4-bis(4-aminophenyl)-1,4-diazacyclohexane (1,4-bis(4-aminophenyl)-l,4-diazacyclohexane) · DAC 106 200927790 Compound: 4 ,4·-(pyridazine-1,4-diyl)bis(2-methylaniline): 3MPDA Compound: 1,4-bis(3-aminopropyl)pyridazine: APP Compound: 4,4'- Diaminodiphenylmethane: DDM Compound: 1,2-bis(4-aminophenyl)ethane: DET Compound: U-bis[4-(4-aminophenoxy)phenyl]-4·[( 4-heptylcyclohexyl)ethyl]cyclohexane: 7Η2ΗΒΑ
化合物:U-雙[4-(4-氨基苯氧基)苯基-4-(反式-4-正戊 基環己基)環己烧(l,l-bis[4-(4-aminophenoxy)phenyl-4-w (trans-4-n-pentyl cyclohexyl)cyclohexane ) · 5HHBACompound: U-bis[4-(4-aminophenoxy)phenyl-4-(trans-4-n-pentylcyclohexyl)cyclohexane (l,l-bis[4-(4-aminophenoxy)) Phenyl-4-w (trans-4-n-pentyl cyclohexyl)cyclohexane ) · 5HHBA
化合物:1,1-雙[4-(4-氨基苯基)甲基苯基]-4-正庚基環 己烷:7HBZCompound: 1,1-bis[4-(4-aminophenyl)methylphenyl]-4-n-heptylcyclohexane: 7HBZ
化合物:1,3-雙(3-氨基丙基)四甲基二矽氧燒 (l,3-bis(3-aminopropyl)tetramethyldisiloxane) : APDS 化合物··雙(4-氨基-2-曱基苯基)曱烷:MDT 化合物:Ν,Ν·-雙(4-氨基苯基)-Ν,Ν,-二甲基乙二胺: NN2DAMe 〇 化合物.3,6-一 氣基脊 β坐(3,6-diaminocarbazole ):Compound: 1,3-bis(3-aminopropyl)tetramethyldisiloxane: APDS compound··bis(4-amino-2-mercaptobenzene)曱): MDT Compound: Ν, Ν·-bis(4-aminophenyl)-Ν, Ν,-dimethylethylenediamine: NN2DAMe 〇 compound. 3,6-one gas-based ridge β sitting (3, 6-diaminocarbazole ):
DACZ <添加劑>DACZ <Additives>
化合物:雙{4-(烯丙基雙環卩.21]庚_5_烯_2,3_二曱醯 亞胺)苯基}甲烷:BANI-MCompound: bis{4-(allylbicyclopurine.21]hept-5-ene-2,3_dioxinimine)phenyl}methane: BANI-M
化合物· N,N-二經基亞乙基雙丙晞酿胺:HEA 化合物:双(3-苯基_3,4_二氢_211_13_苯并恶嗪_6_基)甲 烷 107 200927790Compound · N,N-di-diethylidene propylene diamine: HEA compound: bis(3-phenyl-3,4-dihydro-211_13_benzoxazine-6-yl)methane 107 200927790
(t>is(3-phenyl-3,4-dihydro-2H-l ,3-benzoxazine-6-yl)methan e) : PBM(t>is(3-phenyl-3,4-dihydro-2H-l,3-benzoxazine-6-yl)methan e) : PBM
化合物:3,4-环氧环己烯基甲基_3,,41_环氧环己烯甲酸 酯:EHECompound: 3,4-epoxycyclohexenylmethyl_3,,41_epoxycyclohexenecarboxylic acid ester: EHE
化合物:2-(3,4-環氧環己基)乙基三甲氧基矽烷:EHSCompound: 2-(3,4-epoxycyclohexyl)ethyltrimethoxydecane: EHS
化合物:1,3_雙(4,5_二氫_2·噁唑基)苯:BOB <溶劑> NMP : N-甲基-2-〇比略院酮 ® GBL:y-丁内酯 BC: 丁基溶纖劑(乙二醇單丁醚) <1.聚醯胺酸的合成> [合成例1] 在具備溫度計、攪拌機、原料投入添加口和氮氣導入 口的100 mL的四口燒瓶中,加入3.651 g的化合物DAC 和54.0 g的脫水NMP’在乾燥氮氣流下進行攪拌溶解。接 著,加入1.237 g的化合物(1)、1.112 g的化合物(19) 〇 以及15.0 g的脫水GBL ’在室溫環境下反應30小時。當 反應過程中反應溫度上升時,將反應溫度抑制在約兀乞或 70°C以下而進行反應。然後在所獲得的溶液中添加25.0 g 的BC,獲得濃度爲6重量%的聚醯胺酸溶液。將該聚醯胺 酸作爲PA卜PA1的重量平均分子量爲34,800。 聚醯胺酸的重量平均分子量是以如下方式求出的:用 磷酸-DMF混合溶液(磷酸/DMF = 0.6/100 :重量比)來稀 釋所獲得的聚醯胺酸,以使聚醯胺酸濃度約爲1重量%, 108 200927790 然後使用2695分離模塊(separatj〇n m〇duie)、2414差示 折射計(Waters製造)’將所述混合溶液作爲展開溶劑並 使用GPC法進行測定’再進行轉乙賴算。另外,管挺 是使用HSPgel RT MB_M (恤⑽製造),在管柱溫度爲 4〇C、流速爲〇·35 mL/min的條件下進行測定。 [合成例2〜合成例31]Compound: 1,3_bis(4,5-dihydro-2-oxazolyl)benzene: BOB <solvent> NMP : N-methyl-2-indole ketone® GBL: y-butane Ester BC: butyl cellosolve (ethylene glycol monobutyl ether) <1. Synthesis of polyglycine> [Synthesis Example 1] 100 mL of four equipped with a thermometer, a stirrer, a raw material input port, and a nitrogen gas inlet port Into the flask, 3.651 g of the compound DAC and 54.0 g of dehydrated NMP' were added and dissolved under a dry nitrogen stream. Next, 1.237 g of the compound (1), 1.12 g of the compound (19) hydrazine, and 15.0 g of the dehydrated GBL' were added to react at room temperature for 30 hours. When the reaction temperature rises during the reaction, the reaction temperature is suppressed to about 兀乞 or 70 ° C or lower to carry out the reaction. Then, 25.0 g of BC was added to the obtained solution to obtain a polyglycine solution having a concentration of 6% by weight. The polyglycolic acid had a weight average molecular weight of PA, PA1 of 34,800. The weight average molecular weight of polylysine is determined in such a manner that the obtained polylysine is diluted with a phosphoric acid-DMF mixed solution (phosphoric acid/DMF = 0.6/100: weight ratio) to make polylysine The concentration is about 1% by weight, 108 200927790, and then the 2695 separation module (separatj〇nm〇duie), 2414 differential refractometer (manufactured by Waters) is used, and the mixed solution is used as a developing solvent and measured by the GPC method. Yi Lai counts. In addition, the tube was measured using HSPgel RT MB_M (manufactured by Shirt (10)) under the conditions of a column temperature of 4 ° C and a flow rate of 〇·35 mL/min. [Synthesis Example 2 to Synthesis Example 31]
、如表1和表2所示那樣變更四羧酸二酐和二胺,除此 以外、,依據合成例1來製備料麟練(pA2) 溶液、(PA31)。包括合成例1,將結果總結於表i和表 。合成例24〜合成例28巾’由於在反應過程中有沉殺 物析出,因此無法合成聚醯胺酸。 109 200927790 [表i] 合成例 No. 酸二酐 蕈耳分 化合物旲:刀 化合;胺莫J分 重量平均分子量 1 PMDA 0.23 CBDA 0.23 DAC 0.54 34800 2 PMDA 0.24 CBDA 0.24 DAC 0.26 DDM 0.26 53200 3 PMDA 0.24 CBDA 0.24 DAC 0.20 DDM 0.32 46800 4 PMDA 0.24 CBDA 0.24 DAC 0.47 5HHBA 0.05 28700 5 PMDA 0.24 CBDA 0.24 DAC 0.47 7H2HBA 0.05 73200 6 PMDA 0.24 CBDA 0.24 DAC 0.47 7HBZ 0.05 40700 7 PMDA 0.35 CBDA 0.10 DAC 0.30 DET 0.10 5HHBA 0.15 56200 8 PMDA 0.10 CBDA 0.38 DAC 0.47 5HHBA 0.05 32000 9 PMDA 0.32 CBDA 0.13 DAC 0.50 5HHBA 0.05 29000 10 PMDA 0.29 CBDA 0.16 DAC 0.39 7HBZ 0.16 33000 11 PMDA 0.23 CBDA 0.23 DAC 0.50 APDS 0.04 45000 12 PMDA 0.27 CBDA 0.19 DAC 0.50 7H2HBA 0.02 5HHBA 0.02 29000 13 PMDA 0.27 CBDA 0.18 DAC 0.36 NN2DAMe 0.14 7HBZ 0.05 62000 14 PMDA 0.27 CBDA 0.19 DAC 0.45 NN2DAMe 0.09 29000 15 PMDA 0.27 CBDA 0.18 DAC 0.39 NN2DAMe 0.14 7H2HBA 0.02 35000 110 200927790Further, the tetracarboxylic dianhydride and the diamine were changed as shown in Tables 1 and 2, and a solution (PA2) and (PA31) were prepared in accordance with Synthesis Example 1. Including Synthesis Example 1, the results are summarized in Tables i and Tables. Synthesis Example 24 to Synthesis Example 28] Since the precipitate was precipitated during the reaction, the polyamine acid could not be synthesized. 109 200927790 [Table i] Synthesis Example No. Acid dianhydride 蕈 ear compound 旲: knife compound; amine Mo J weight average molecular weight 1 PMDA 0.23 CBDA 0.23 DAC 0.54 34800 2 PMDA 0.24 CBDA 0.24 DAC 0.26 DDM 0.26 53200 3 PMDA 0.24 CBDA 0.24 DAC 0.20 DDM 0.32 46800 4 PMDA 0.24 CBDA 0.24 DAC 0.47 5HHBA 0.05 28700 5 PMDA 0.24 CBDA 0.24 DAC 0.47 7H2HBA 0.05 73200 6 PMDA 0.24 CBDA 0.24 DAC 0.47 7HBZ 0.05 40700 7 PMDA 0.35 CBDA 0.10 DAC 0.30 DET 0.10 5HHBA 0.15 56200 8 PMDA 0.10 CBDA 0.38 DAC 0.47 5HHBA 0.05 32000 9 PMDA 0.32 CBDA 0.13 DAC 0.50 5HHBA 0.05 29000 10 PMDA 0.29 CBDA 0.16 DAC 0.39 7HBZ 0.16 33000 11 PMDA 0.23 CBDA 0.23 DAC 0.50 APDS 0.04 45000 12 PMDA 0.27 CBDA 0.19 DAC 0.50 7H2HBA 0.02 5HHBA 0.02 29000 13 PMDA 0.27 CBDA 0.18 DAC 0.36 NN2DAMe 0.14 7HBZ 0.05 62000 14 PMDA 0.27 CBDA 0.19 DAC 0.45 NN2DAMe 0.09 29000 15 PMDA 0.27 CBDA 0.18 DAC 0.39 NN2DAMe 0.14 7H2HBA 0.02 35000 110 200927790
[表2] 合成例 No. 酸二酐 化合物莫^分 化合;胺莫J分 重量平均分子量 16 PMDA 0.23 CBDA 0.23 DAC 0.32 MDT 0.18 7HBZ 0.04 27000 17 PMDA 0.23 TCMP 0.23 DAC 0.50 5HHBA 0.04 59000 18 PMDA 0.23 TDA 0.23 DAC 0.54 37000 19 PMDA 0.27 CBDA 0.14 BT 0.04 DAC 0.50 7HBZ 0.05 34000 20 PMDA 0.23 CBDA 0.23 3MPDA 0.50 5HHBA 0.04 35000 21 PMDA 0.27 CBDA 0.14 BT 0.04 DAC 0.44 NN2DAMe 0.11 25000 22 PMDA 0.24 CBDA 0.24 DAC 0.14 DACZ 0.38 41600 23 PMDA 0.23 CBDA 0.23 DAC 0.39 DACZ 0.13 5HHBA 0.02 37800 24 PMDA 0.50 APP 0.10 DDM 0.40 無法合成 25 PMDA 0.50 APP 0.05 DDM 0.45 無法合成 26 PMDA 0.25 CBDA 0.25 APP 0.50 無法合成 27 PMDA 0.25 CBDA 0.25 APP 0.25 DDM 0.25 無法合成 28 PMDA 0.25 CBDA 0.25 APP 0.05 DDM 0.45 無法合成 29 PMDA 0.25 CBDA 0.25 DDM 0.50 85300 30 PMDA 0.25 CBDA 0.25 DET 0.45 5HHBA 0.05 65400 31 PMDA 0.40 CBDA 0.10 DET 0.30 7HBZ 0.20 31800 111 200927790 , < 2.液晶顯示元件的製作> [實施例1] 在合成例1中所合成的濃度爲6重量%的聚醯胺酸溶 液(PA1)中添加NMP/BC=1/1 (重量比)的混合溶劑, 將整體稀釋成4重量%,製成液晶配向劑。使用所獲得的 液晶配向劑,如下述那樣來製作液晶顯示元件。 <液晶顯示元件的製作方法> 用旋轉器將液晶配向劑塗布在兩片附有ITO電極的玻 璃基板上,形成膜厚爲70 nm的膜。塗膜後在80。(:下加熱 乾燥約5分鐘,然後在21〇。(:下進行20分鐘加熱處理,形 成液晶配向膜。接著,用摩擦裝置對形成了液晶配向膜的 基板的表面進行摩擦處理而實行配向處理。然後,在超純 水中對液晶配向膜進行5分鐘超聲波清洗後,在烘箱中在 120°C下乾燥30分鐘。 在其中一片玻璃基板上散布7 的間隙材料,以使[Table 2] Synthesis Example No. Acid dianhydride compound was mixed; amine Mo J weight average molecular weight 16 PMDA 0.23 CBDA 0.23 DAC 0.32 MDT 0.18 7HBZ 0.04 27000 17 PMDA 0.23 TCMP 0.23 DAC 0.50 5HHBA 0.04 59000 18 PMDA 0.23 TDA 0.23 DAC 0.54 37000 19 PMDA 0.27 CBDA 0.14 BT 0.04 DAC 0.50 7HBZ 0.05 34000 20 PMDA 0.23 CBDA 0.23 3MPDA 0.50 5HHBA 0.04 35000 21 PMDA 0.27 CBDA 0.14 BT 0.04 DAC 0.44 NN2DAMe 0.11 25000 22 PMDA 0.24 CBDA 0.24 DAC 0.14 DACZ 0.38 41600 23 PMDA 0.23 CBDA 0.23 DAC 0.39 DACZ 0.13 5HHBA 0.02 37800 24 PMDA 0.50 APP 0.10 DDM 0.40 Unable to synthesize 25 PMDA 0.50 APP 0.05 DDM 0.45 Unable to synthesize 26 PMDA 0.25 CBDA 0.25 APP 0.50 Unable to synthesize 27 PMDA 0.25 CBDA 0.25 APP 0.25 DDM 0.25 Unable to synthesize 28 PMDA 0.25 CBDA 0.25 APP 0.05 DDM 0.45 Unable to synthesize 29 PMDA 0.25 CBDA 0.25 DDM 0.50 85300 30 PMDA 0.25 CBDA 0.25 DET 0.45 5HHBA 0.05 65400 31 PMDA 0.40 CBDA 0.10 DET 0.30 7HBZ 0.20 31800 111 200927790 , < 2. Production of liquid crystal display elements > [Example 1] Concentration synthesized in Synthesis Example 1 6% by weight of polyamide acid solution (PAl) was added in NMP / BC = a mixed solvent (weight ratio) 1/1, the whole was diluted to 4 wt% to prepare the liquid crystal alignment agent. Using the obtained liquid crystal alignment agent, a liquid crystal display element was produced as follows. <Method for Producing Liquid Crystal Display Element> A liquid crystal alignment agent was applied onto two glass substrates with an ITO electrode by a spinner to form a film having a film thickness of 70 nm. After coating the film at 80. (: heating and drying for about 5 minutes, and then heat-treating for 20 minutes to form a liquid crystal alignment film. Next, the surface of the substrate on which the liquid crystal alignment film is formed is rubbed by a rubbing device to perform alignment treatment. Then, the liquid crystal alignment film was ultrasonically cleaned in ultrapure water for 5 minutes, and then dried in an oven at 120 ° C for 30 minutes. A gap material of 7 was spread on one of the glass substrates to make
形成了液晶配向膜的面爲内側且摩擦方向成反平行的方式 進行對向配置,然後用環氧硬化劑進行密封,製 >的反平料元(antipamlldeell)。在料⑭注^如 :所不的液晶組成物,並使用光固化劑來密封注入口。接 者’在靴下進行30分鐘加熱處理,製作液晶顯示元件。The surface of the liquid crystal alignment film is formed on the inner side and the rubbing direction is anti-parallel, and is disposed in the opposite direction, and then sealed with an epoxy curing agent to produce an anti-prime element (antipamlldeell). In the material 14, a liquid crystal composition is used, and a photocuring agent is used to seal the injection port. The receiver was subjected to heat treatment for 30 minutes under the boot to produce a liquid crystal display element.
17wt·% 112 20092779017wt·% 112 200927790
F C5H11—^f iewt_ %F C5H11—^f iewt_ %
FF
i〇wl% FI〇wl% F
[實施例2][Embodiment 2]
在合成例2中所合成的濃度爲6重量%的聚醯胺酸溶 液(PA2)中添加NMP/BC=1A (重量比)的混合溶劑, 將整體稀釋成4重量%,製成液晶配向劑。然後使用所獲 得的液晶配向劑’與實施例1同樣地製作液晶顯示元件。 [實施例3] 在合成例3中所合成的濃度爲6重量%的聚醯胺酸溶 液(PA3)中添加NMP/BC=1/1 (重量比)的混合溶劑, 將整體稀釋成4重量%,製成液晶配向劑。然後使用所獲 得的液晶配向劑,與實施例1同樣地製作液晶顯示元件。 [實施例4] 在合成例4中所合成的濃度爲6重量%的聚醯胺酸溶 液(PA4)中添加NMP/BC=1/1 (重量比)的混合溶劑, 113 200927790 將整體稀釋成4重量%,製成液晶配向劑。然後使用所獲 得的液晶配向劑,與實施例1同樣地製作液晶顯示元件。 [實施例5] 在合成例S中所合成的濃度爲6重量%的聚醯胺酸溶 液(PA5 )中添加NMP/BC= 1/1 (重量比)的混合溶劑, 將整體稀釋成4重量%,製成液晶配向劑。然後使用所獲 得的液晶配向劑,與實施例1同樣地製作液晶顯示元件。 [實施例6] Ο 在合成例6中所合成的濃度爲6重量%的聚醯胺酸溶 液(PA6)中添加NMP/BC=1/1 (重量比)的混合溶劑, 將整體稀釋成4重量%,製成液晶配向劑。然後使用所獲 得的液晶配向劑,與實施例1同樣地製作液晶顯示元件。 [實施例7] 在合成例7中所合成的濃度爲6重量%的聚醯胺酸溶 液(PA7)中添加NMP/BC=1/1 (重量比)的混合溶劑, 將整體稀釋成4重量%,製成液晶配向劑。然後使用所獲 0 得的液晶配向劑,與實施例1同樣地製作液晶顯示元件。 [實施例8] 將合成例2中所合成的濃度爲6重量%的聚醯胺酸溶 液(PA2)與合成例7中所合成的濃度爲6重量%的聚醯胺 酸溶液(PA7)以8/2的重量比進行混合。在所獲得的混合 物中添加NMP/BC=1/1 (重量比)的混合溶劑,將整體稀 釋成4重量%,製成液晶配向劑。然後使用所獲得的液晶 配向劑,與實施例1同樣地製作液晶顯示元件。 114 200927790 : [實施例9] 將合成例13中所合成的濃度爲6重®%的聚酿胺酸溶 液(PA13)與合成例7中所合成的濃度爲6重量%的聚醯 胺酸溶液(PA7)以8/2的重量比進行混合。在所獲得的混 合物中添加nmp/bc=i/i (重量比)的混合溶劑,將整體 稀釋成4重量% ’製成液晶配向劑。然後使用所獲得的液 晶配向劑’與實施例1同樣地製作液晶顯示元件。 [實施例10] ® 將合成例2中所合成的濃度爲6重量%的聚酿胺酸溶 液(PA2)與合成例15中所合成的濃度爲6重量%的聚醯 胺酸溶液(PA15)以8/2的重量比進行混合。在所獲得的 混合物中添加NMP/BC=1/1 (重量比)的混合溶劑,將整 體稀釋成4重量%,製成液晶配向劑。然後使用所獲得的 液晶配向劑,與實施例1同樣地製作液晶顯示元件。 [實施例11] 在合成例8中所合成的濃度爲6重量%的聚醯胺酸溶 〇 液(PA8)中添加NMP/BC=m (重量比)的混合溶劑, 將整體稀釋成4重量%,製成液晶配向劑。然後使用所獲 得的液晶配向劑,與實施例1同樣地製作液晶顯示元件。 [實施例12] 在合成例9中所合成的濃度爲6重量%的聚酿胺酸溶 液(PA9)中添加NMP/BC= 1/1 (重量比)的混合溶劑, 將整體稀釋成4重量%,製成液晶配向劑。然後使用所獲 得的液晶配向劑,與實施例1同樣地製作液晶顯示元件。 115 200927790 , [實施例13] 在合成例10中所合成的濃度爲6重量%的聚醯胺酸溶 液(PA10)中添hNMP/BC=1/1 (重量比)的混合溶劑, 將整體稀釋成4重量%,製成液晶配向劑。然後使用所獲 得的液晶配向劑’與實施例1同樣地製作液晶顯示元件。 [實施例H] 在合成例12中所合成的濃度爲6重量%的聚醢胺酸溶 液(PA12)中添加NMP/BC=1/1 (重量比)的混合溶劑, ® 將整體稀釋成4重量%,製成液晶配向劑。然後使用所獲 得的液晶配向劑,與實施例1同樣地製作液晶顯示元件。 [實施例15] 在合成例13中所合成的濃度爲6重量%的聚醯胺酸溶 液(PA13)中添加NMP/BC=1/1 (重量比)的混合溶劑, 將整體稀釋成4重量❶/〇,製成液晶配向劑。然後使用所獲 得的液晶配向劑’與實施例1同樣地製作液晶顯示元件。 [實施例16] 〇 在合成例14中所合成的濃度爲6重量%的聚醯胺酸溶 液(PA14)中添加NMP/BC=1/1 (重量比)的混合溶劑, 將整體稀釋成4重量%,製成液晶配向劑^然後使用所獲 得的液晶配向劑’與實施例1同樣地製作液晶顯示元件。 [實施例Π] 在合成例15中所合成的濃度爲6重量%的聚醯胺酸溶 液(PA15)中添加NMP/BC=1/1 (重量比)的混合溶劑, 將整體稀釋成4重量%,製成液晶配向劑。然後使用所獲 116 200927790 得的液晶配向劑,與實施例1同樣地製作液晶顯示元件。 [實施例18] 在合成例16中所合成的濃度爲6重量%的聚醯胺酸溶 液(PA16)中添〜NMP/Bc=l/1 (重量比)的混合溶劑, 將整體稀釋成4重量%,製成液晶配向劑。然後使用所獲 得的液晶配向劑’與實施例1同樣地製作液晶顯示元件。 [實施例19] 在合成例17中所合成的濃度爲6重量%的聚醯胺酸溶 © 液(ΡΑΠ)中添加NMP/BC=1/1 (重量比)的混合溶劑, 將整體稀釋成4重量%,製成液晶配向劑。然後使用所獲 得的液晶配向劑’與實施例1同樣地製作液晶顯示元件。 [實施例20] 在合成例18中所合成的濃度爲6重量%的聚醯胺酸溶 液(PA18 )中添加NMP/BC= 1/1 (重量比)的混合溶劑, 將整體稀釋成4重量%,製成液晶配向劑。然後使用所獲 得的液晶配向劑,與實施例1同樣地製作液晶顯示元件。 〇 [實施例21] 在合成例19中所合成的濃度爲6重量%的聚醯胺酸溶 液(PA19)中添hNMP/Bc=l/l (重量比)的混合溶劑, 將整體稀釋成4重量%,製成液晶配向劑。然後使用所獲 得的液晶配向劑,與實施例1同樣地製作液晶顯示元件。 [實施例22] 在合成例20中所合成的濃度爲6重量%的聚醯胺酸溶 液(PA20 )中添加NMP/BC = 1/1 (重量比)的混合溶劑, 117 200927790 、 將整體稀釋成4重量% ’製成液晶配向劑。然後使用所獲 得的液晶配向劑,與實施例1同樣地製作液晶顯示元件。 [實施例23] 在合成例21中所合成的濃度爲6重量%的聚醯胺酸溶 液(PA21)中添加NMP/BC=1/1 (重量比)的混合溶劑, 將整體稀釋成4重量%,製成液晶配向劑。然後使用所獲 得的液晶配向劑,與實施例1同樣地製作液晶顯示元件。 [實施例24] 在合成例22中所合成的濃度爲6重量。/〇的聚醯胺酸溶 液(PA22)中添加NMP/BC=1/1 (重量比)的混合溶劑, 將整體稀釋成4重量%,製成液晶配向劑。然後使用所獲 得的液晶配向劑,與實施例1同樣地製作液晶顯示元件。 [實施例25] 在合成例23中所合成的濃度爲6重量%的聚醯胺酸溶 液(PA23)中添加NMP/BC=1/1 (重量比)的混合溶劑, 將整體稀釋成4重量% ’製成液晶配向劑。然後使用所獲 Ο 得的液晶配向劑,與實施例1同樣地製作液晶顯示元件。 [實施例26] 在合成例22中所合成的濃度爲6重量%的聚醯胺酸溶 液(PA22)中添加相當於聚合物重量的2〇重量%的bob。 然後,在所獲得的混合物中添加NMP/BC=i/i (重量比) 的混合溶劑,將整體稀釋成5重量%,製成液晶配向劑。 然後使用所獲得的液晶配向劑,與實施例1同樣地製作液 晶顚不元件。 118 200927790 [實施例27] 在合成例11中所合成的濃度爲6重量%的聚醯胺酸溶 液(PA11 )中添加NMP/BC= 1/1 (重量比)的混合溶劑, 將整體稀釋成4重量%,製成液晶配向劑。然後使用所獲 得的液晶配向劑’與實施例1同樣地製作液晶顯示元件。 [實施例28] 在合成例19中所合成的濃度爲6重量%的聚醯胺酸溶 液(PA19)中添加相當於聚合物重量的2〇重量%的 © BANI-M。然後,在所獲得的混合物中添加NMP/BC= (重量比)的混合溶劑,將整體稀釋成5重量%,製成液 晶配向劑。然後使用所獲得的液晶配向劑,與實施例1同 樣地製作液晶顯示元件。 [實施例29] 在合成例19中所合成的濃度爲6重量%的聚醯胺酸溶 液(PA19)中添加相當於聚合物重量的2〇重量❶/◦的HEA。 然後’在所獲得的混合物中添MNMP/BC=i/i (重量比) Ο 的混合溶劑,將整體稀釋成5重量%,製成液晶配向劑。 然後使用所獲得的液晶配向劑,與實施例1同樣地製作液 晶顯不元件。 [實施例30] 在合成例21中所合成的濃度爲6重量%的聚醯胺酸溶 液(PA21)中添加相當於聚合物重量的20重量❶/。的PBM。 然後’在所獲得的混合物中添加NMP/BC=1/1 (重量比) 的混合溶劑’將整體稀釋成5重量%,製成液晶配向劑。 119 200927790 然後使用所獲得的液晶配向劑’與實施例1同樣地製作液 晶顯示元件。 [實施例31] 在合成例21中所合成的濃度爲6重量。/〇的聚醢胺酸溶 液(PA21)中添加相當於聚合物重量的20重量%的 BANI-M。然後,在所獲得的混合物中添加NMP/BC=1/1 (重量比)的混合溶劑,將整體稀釋成5重量%,製成液 晶配向劑。然後使用所獲得的液晶配向劑,與實施例1同 〇 樣地製作液晶顯示元件。 [實施例32] 在合成例21中所合成的濃度爲6重量%的聚酿胺酸溶 液(PA21 )中添加相當於聚合物重量的20重量%的PBM、 相當於聚合物重量的10重量%的EHS。然後,在所獲得的 混合物中添加NMP/BC=1H (重量比)的混合溶劑,將整 體稀釋成5重量%,製成液晶配向劑。然後使用所獲得的 液晶配向劑,與實施例1同樣地製作液晶顯示元件。 〇 [實施例33] 在合成例9中所合成的濃度爲6重量%的聚醯胺酸溶 液(PA9 )中添加相當於聚合物重量的20重量%的 BANI-M、相當於聚合物重量的10重量%的EHS。然後, 在所獲得的混合物中添加NMP/BC=1/1 (重量比)的混合 溶劑,將整體稀釋成5重量%,製成液晶配向劑。然後使 用所獲得的液晶配向劑,與實施例1同樣地製作液晶顯示 元件。 120 200927790 [實施例34] 、在合成例11中所合成的濃度爲6重量%的聚醯胺酸溶 液(PA11)中添加相當於聚合物重量的1〇重量%的ehe。 然後,在所獲得的混合物中添加NMP/BC=1/1 (重量比) 的混合溶劑,將整體稀釋成5重量%,製成液晶配向劑。 然後使用所獲得的液晶配向劑,與實施例丨同樣地製作液 晶顯示元件。 [比較例1] 〇 在合成例29中所合成的濃度爲6重量%的聚醯胺酸溶 液(PA29)中添mNMP/bc=1/1 (重量比)的混合溶劑, 將整體稀釋成4重量%,製成液晶配向劑。然後使用所獲 得的液晶配向劑,與實施例i同樣地製作液晶顯示元件。 [比較例2] 在合成例30中所合成的濃度爲6重量%的聚醯胺酸溶 液(PA30)中添MNMP/Bc=l/1 (重量比)的混合溶劑, 將整體稀釋成4重量%,製成液晶配向劑。然後使用所獲 © 得的液晶配向劑,與實施例1同樣地製作液晶顯示元件。 [比較例3] 在合成例31中所合成的濃度爲6重量%的聚醯胺酸溶 液(PA31)中添加NMP/BC=1/1 (重量比)的混合溶劑, 將整體稀釋成4重量%,製成液晶配向劑。然後使用所獲 得的液晶配向劑,與實施例1同樣地製作液晶顯示元件。 [比較例4] 將合成例29中所合成的濃度爲6重量%的聚醯胺酸溶 121 c 200927790 液(PA29)與合成例30中所合成的濃度爲6重量%的聚醯 胺酸溶液(PA30)以8/2的重量比進行混合。在所獲得的 混合物中添加NMP/BC=1/1 (重量比)的混合溶劑,將整 體稀釋成4重量%,製成液晶配向劑。然後使用所獲得的 液晶配向劑,與實施例1同樣地製作液晶顯示元件。 [比較例5]A mixed solvent of NMP/BC=1A (weight ratio) was added to a polyglycine solution (PA2) having a concentration of 6 wt% synthesized in Synthesis Example 2, and the whole was diluted to 4% by weight to prepare a liquid crystal alignment agent. . Then, a liquid crystal display element was produced in the same manner as in Example 1 using the obtained liquid crystal alignment agent. [Example 3] A mixed solvent of NMP/BC = 1/1 (weight ratio) was added to a polyglycine solution (PA3) having a concentration of 6 wt% synthesized in Synthesis Example 3, and the whole was diluted to 4 weights. %, made into a liquid crystal alignment agent. Then, a liquid crystal display element was produced in the same manner as in Example 1 using the obtained liquid crystal alignment agent. [Example 4] A mixed solvent of NMP/BC = 1/1 (weight ratio) was added to a polyglycine solution (PA4) having a concentration of 6 wt% synthesized in Synthesis Example 4, 113 200927790, and the whole was diluted into 4% by weight, made into a liquid crystal alignment agent. Then, a liquid crystal display element was produced in the same manner as in Example 1 using the obtained liquid crystal alignment agent. [Example 5] A mixed solvent of NMP/BC = 1/1 (weight ratio) was added to a polyglycine solution (PA5) having a concentration of 6 wt% synthesized in Synthesis Example S, and the whole was diluted to 4 weights. %, made into a liquid crystal alignment agent. Then, a liquid crystal display element was produced in the same manner as in Example 1 using the obtained liquid crystal alignment agent. [Example 6] 混合 A mixed solvent of NMP/BC = 1/1 (weight ratio) was added to a polyglycine solution (PA6) having a concentration of 6 wt% synthesized in Synthesis Example 6, and the whole was diluted to 4 % by weight, made into a liquid crystal alignment agent. Then, a liquid crystal display element was produced in the same manner as in Example 1 using the obtained liquid crystal alignment agent. [Example 7] A mixed solvent of NMP/BC = 1/1 (weight ratio) was added to a polyglycine solution (PA7) having a concentration of 6 wt% synthesized in Synthesis Example 7, and the whole was diluted to 4 weights. %, made into a liquid crystal alignment agent. Then, a liquid crystal display element was produced in the same manner as in Example 1 using the obtained liquid crystal alignment agent. [Example 8] A polyglycine solution (PA2) having a concentration of 6 wt% synthesized in Synthesis Example 2 and a polyglycine solution (PA7) having a concentration of 6 wt% synthesized in Synthesis Example 7 were used. Mix 8/2 by weight. A mixed solvent of NMP/BC = 1/1 (weight ratio) was added to the obtained mixture, and the whole was diluted to 4% by weight to prepare a liquid crystal alignment agent. Then, a liquid crystal display element was produced in the same manner as in Example 1 using the obtained liquid crystal alignment agent. 114 200927790 : [Example 9] A polyglycine solution (PA13) having a concentration of 6% by weight synthesized in Synthesis Example 13 and a polyglycine solution having a concentration of 6% by weight synthesized in Synthesis Example 7 (PA7) was mixed at a weight ratio of 8/2. A mixed solvent of nmp/bc = i / i (weight ratio) was added to the obtained mixture, and the whole was diluted to 4 wt% to prepare a liquid crystal alignment agent. Then, a liquid crystal display element was produced in the same manner as in Example 1 using the obtained liquid crystal alignment agent. [Example 10] ® A polyglycine solution (PA2) having a concentration of 6 wt% synthesized in Synthesis Example 2 and a polyglycine solution (PA15) having a concentration of 6 wt% synthesized in Synthesis Example 15 Mix at a weight ratio of 8/2. A mixed solvent of NMP/BC = 1/1 (weight ratio) was added to the obtained mixture, and the whole was diluted to 4% by weight to prepare a liquid crystal alignment agent. Then, a liquid crystal display element was produced in the same manner as in Example 1 using the obtained liquid crystal alignment agent. [Example 11] A mixed solvent of NMP/BC = m (weight ratio) was added to a polyglycine solution (PA8) having a concentration of 6 wt% synthesized in Synthesis Example 8, and the whole was diluted to 4 weights. %, made into a liquid crystal alignment agent. Then, a liquid crystal display element was produced in the same manner as in Example 1 using the obtained liquid crystal alignment agent. [Example 12] A mixed solvent of NMP/BC = 1/1 (weight ratio) was added to a polyglycine solution (PA9) having a concentration of 6 wt% synthesized in Synthesis Example 9, and the whole was diluted to 4 weights. %, made into a liquid crystal alignment agent. Then, a liquid crystal display element was produced in the same manner as in Example 1 using the obtained liquid crystal alignment agent. 115 200927790, [Example 13] A mixed solvent of hNMP/BC = 1/1 (weight ratio) was added to a polyglycine solution (PA10) having a concentration of 6 wt% synthesized in Synthesis Example 10, and the whole was diluted. At 4% by weight, a liquid crystal alignment agent was prepared. Then, a liquid crystal display element was produced in the same manner as in Example 1 using the obtained liquid crystal alignment agent. [Example H] A mixed solvent of NMP/BC = 1/1 (weight ratio) was added to a polyglycine solution (PA12) having a concentration of 6 wt% synthesized in Synthesis Example 12, and the whole was diluted to 4 % by weight, made into a liquid crystal alignment agent. Then, a liquid crystal display element was produced in the same manner as in Example 1 using the obtained liquid crystal alignment agent. [Example 15] A mixed solvent of NMP/BC = 1/1 (weight ratio) was added to a polyglycine solution (PA13) having a concentration of 6 wt% synthesized in Synthesis Example 13, and the whole was diluted to 4 weights. ❶ / 〇, made of liquid crystal alignment agent. Then, a liquid crystal display element was produced in the same manner as in Example 1 using the obtained liquid crystal alignment agent. [Example 16] A mixed solvent of NMP/BC = 1/1 (weight ratio) was added to a polyglycine solution (PA14) having a concentration of 6 wt% synthesized in Synthesis Example 14, and the whole was diluted to 4 A liquid crystal display element was produced in the same manner as in Example 1 except that the liquid crystal alignment agent was used to form a liquid crystal alignment agent. [Example Π] A mixed solvent of NMP/BC = 1/1 (weight ratio) was added to a polyglycine solution (PA15) having a concentration of 6 wt% synthesized in Synthesis Example 15, and the whole was diluted to 4 weights. %, made into a liquid crystal alignment agent. Then, a liquid crystal display element was produced in the same manner as in Example 1 using the obtained liquid crystal alignment agent of 116 200927790. [Example 18] A mixed solvent of ~NMP/Bc = 1/1 (weight ratio) was added to a polyglycine solution (PA16) having a concentration of 6 wt% synthesized in Synthesis Example 16, and the whole was diluted to 4 % by weight, made into a liquid crystal alignment agent. Then, a liquid crystal display element was produced in the same manner as in Example 1 using the obtained liquid crystal alignment agent. [Example 19] A mixed solvent of NMP/BC = 1/1 (weight ratio) was added to a polyglycine solution (ΡΑΠ) having a concentration of 6 wt% synthesized in Synthesis Example 17, and the whole was diluted into 4% by weight, made into a liquid crystal alignment agent. Then, a liquid crystal display element was produced in the same manner as in Example 1 using the obtained liquid crystal alignment agent. [Example 20] A mixed solvent of NMP/BC = 1/1 (weight ratio) was added to a polyglycine solution (PA18) having a concentration of 6 wt% synthesized in Synthesis Example 18, and the whole was diluted to 4 weights. %, made into a liquid crystal alignment agent. Then, a liquid crystal display element was produced in the same manner as in Example 1 using the obtained liquid crystal alignment agent. 〇 [Example 21] A mixed solvent of hNMP/Bc = 1 / l (weight ratio) was added to a polyglycine solution (PA19) having a concentration of 6 wt% synthesized in Synthesis Example 19, and the whole was diluted to 4 % by weight, made into a liquid crystal alignment agent. Then, a liquid crystal display element was produced in the same manner as in Example 1 using the obtained liquid crystal alignment agent. [Example 22] A mixed solvent of NMP/BC = 1/1 (weight ratio) was added to a polyglycine solution (PA20) having a concentration of 6 wt% synthesized in Synthesis Example 20, 117 200927790, and the whole was diluted. 4% by weight of 'made liquid crystal alignment agent. Then, a liquid crystal display element was produced in the same manner as in Example 1 using the obtained liquid crystal alignment agent. [Example 23] A mixed solvent of NMP/BC = 1/1 (weight ratio) was added to a polyglycine solution (PA21) having a concentration of 6 wt% synthesized in Synthesis Example 21, and the whole was diluted to 4 weights. %, made into a liquid crystal alignment agent. Then, a liquid crystal display element was produced in the same manner as in Example 1 using the obtained liquid crystal alignment agent. [Example 24] The concentration synthesized in Synthesis Example 22 was 6 parts by weight. A mixed solvent of NMP/BC = 1/1 (weight ratio) was added to the polyacrylic acid solution (PA22) of hydrazine, and the whole was diluted to 4% by weight to prepare a liquid crystal alignment agent. Then, a liquid crystal display element was produced in the same manner as in Example 1 using the obtained liquid crystal alignment agent. [Example 25] A mixed solvent of NMP/BC = 1/1 (weight ratio) was added to a polyglycine solution (PA23) having a concentration of 6 wt% synthesized in Synthesis Example 23, and the whole was diluted to 4 weights. % 'made as a liquid crystal alignment agent. Then, a liquid crystal display element was produced in the same manner as in Example 1 using the obtained liquid crystal alignment agent. [Example 26] To a polyglycine solution (PA22) having a concentration of 6% by weight synthesized in Synthesis Example 22, bob of 2% by weight based on the weight of the polymer was added. Then, a mixed solvent of NMP/BC=i/i (weight ratio) was added to the obtained mixture, and the whole was diluted to 5 wt% to prepare a liquid crystal alignment agent. Then, a liquid crystal element was produced in the same manner as in Example 1 using the obtained liquid crystal alignment agent. 118 200927790 [Example 27] A mixed solvent of NMP/BC = 1/1 (weight ratio) was added to a polyglycine solution (PA11) having a concentration of 6 wt% synthesized in Synthesis Example 11, and the whole was diluted into 4% by weight, made into a liquid crystal alignment agent. Then, a liquid crystal display element was produced in the same manner as in Example 1 using the obtained liquid crystal alignment agent. [Example 28] In a polyamine solvent solution (PA19) having a concentration of 6% by weight synthesized in Synthesis Example 19, 2% by weight of © BANI-M corresponding to the weight of the polymer was added. Then, a mixed solvent of NMP/BC = (weight ratio) was added to the obtained mixture, and the whole was diluted to 5 wt% to prepare a liquid crystal alignment agent. Then, a liquid crystal display element was produced in the same manner as in Example 1 using the obtained liquid crystal alignment agent. [Example 29] HEA of 2 〇 weight ❶ / 相当于 corresponding to the weight of the polymer was added to a polyglycine solution (PA19) having a concentration of 6% by weight synthesized in Synthesis Example 19. Then, a mixed solvent of MNMP/BC = i / i (weight ratio) Ο was added to the obtained mixture, and the whole was diluted to 5 wt% to prepare a liquid crystal alignment agent. Then, a liquid crystal display element was produced in the same manner as in Example 1 using the obtained liquid crystal alignment agent. [Example 30] In a polyamine solvent solution (PA21) having a concentration of 6% by weight synthesized in Synthesis Example 21, 20 wt% of the weight of the polymer was added. PBM. Then, a mixed solvent of NMP/BC = 1/1 (weight ratio) was added to the obtained mixture, and the whole was diluted to 5 wt% to prepare a liquid crystal alignment agent. 119 200927790 Then, a liquid crystal display element was produced in the same manner as in Example 1 using the obtained liquid crystal alignment agent. [Example 31] The concentration synthesized in Synthesis Example 21 was 6 parts by weight. 20% by weight of BANI-M equivalent to the weight of the polymer was added to the polyhydrazine solution (PA21). Then, a mixed solvent of NMP/BC = 1/1 (weight ratio) was added to the obtained mixture, and the whole was diluted to 5 wt% to prepare a liquid crystal alignment agent. Then, using the obtained liquid crystal alignment agent, a liquid crystal display element was produced in the same manner as in Example 1. [Example 32] 20 wt% of PBM corresponding to the weight of the polymer, 10% by weight based on the weight of the polymer, was added to the polyhexylamine solution (PA21) having a concentration of 6 wt% synthesized in Synthesis Example 21. EHS. Then, a mixed solvent of NMP/BC = 1H (weight ratio) was added to the obtained mixture, and the whole was diluted to 5 wt% to prepare a liquid crystal alignment agent. Then, a liquid crystal display element was produced in the same manner as in Example 1 using the obtained liquid crystal alignment agent. 〇 [Example 33] 20% by weight of BANI-M, which corresponds to the weight of the polymer, was added to a polyglycine solution (PA9) having a concentration of 6% by weight synthesized in Synthesis Example 9. 10% by weight of EHS. Then, a mixed solvent of NMP/BC = 1/1 (weight ratio) was added to the obtained mixture, and the whole was diluted to 5 wt% to prepare a liquid crystal alignment agent. Then, a liquid crystal display element was produced in the same manner as in Example 1 using the obtained liquid crystal alignment agent. 120 200927790 [Example 34] Ehe in an amount of 1% by weight based on the weight of the polymer was added to a polyamine solvent solution (PA11) having a concentration of 6 wt% synthesized in Synthesis Example 11. Then, a mixed solvent of NMP/BC = 1/1 (weight ratio) was added to the obtained mixture, and the whole was diluted to 5 wt% to prepare a liquid crystal alignment agent. Then, using the obtained liquid crystal alignment agent, a liquid crystal display element was produced in the same manner as in Example 。. [Comparative Example 1] A mixed solvent of mNMP/bc = 1/1 (weight ratio) was added to a polyglycine solution (PA29) having a concentration of 6 wt% synthesized in Synthesis Example 29, and the whole was diluted to 4 % by weight, made into a liquid crystal alignment agent. Then, a liquid crystal display element was produced in the same manner as in Example i using the obtained liquid crystal alignment agent. [Comparative Example 2] A mixed solvent of MNMP/Bc = 1/1 (weight ratio) was added to a polyglycine solution (PA30) having a concentration of 6 wt% synthesized in Synthesis Example 30, and the whole was diluted to 4 weights. %, made into a liquid crystal alignment agent. Then, a liquid crystal display element was produced in the same manner as in Example 1 using the obtained liquid crystal alignment agent. [Comparative Example 3] A mixed solvent of NMP/BC = 1/1 (weight ratio) was added to a polyglycine solution (PA31) having a concentration of 6 wt% synthesized in Synthesis Example 31, and the whole was diluted to 4 weights. %, made into a liquid crystal alignment agent. Then, a liquid crystal display element was produced in the same manner as in Example 1 using the obtained liquid crystal alignment agent. [Comparative Example 4] Polyhexyl acid solution 121 c 200927790 liquid (PA29) having a concentration of 6 wt% synthesized in Synthesis Example 29 and a polyglycine solution having a concentration of 6 wt% synthesized in Synthesis Example 30 were synthesized. (PA30) was mixed at a weight ratio of 8/2. A mixed solvent of NMP/BC = 1/1 (weight ratio) was added to the obtained mixture, and the whole was diluted to 4% by weight to prepare a liquid crystal alignment agent. Then, a liquid crystal display element was produced in the same manner as in Example 1 using the obtained liquid crystal alignment agent. [Comparative Example 5]
將合成例29中所合成的濃度爲6重量%的聚醯胺酸溶 液(PA29)與合成例31中所合成的濃度爲6重量。/。的聚酿 胺酸溶液(PA31)以8/2的重量比進行混合。在所獲得的 混合物中添加NMP/BC=1/1 (重量比)的混合溶劑,將整 體稀釋成4重量%,製成液晶配向劑。然後使用所獲得的 液晶配向劑,與實施例1同樣地製作液晶顯示元件。 <3.電特性的評價> 如卜的方式 巧只化Ί?Ί a〜貝兆例、比較例j〜 比較例5中所製作的液晶顯示元件進行離子密度的測定和 長期可靠性的測定。 1) 離子密度的測定 使用TOYO Technica製造的液晶物性評價裝置0254 m離子密㈣败。測定糾設定爲:波形爲三角 z,電壓爲_,測定溫度設 】疋值越小,則可以說電特性越良好。將結果示於表3中。 2) 離子密度的保持特性的測定 122 200927790The polyamine solvent solution (PA29) having a concentration of 6% by weight synthesized in Synthesis Example 29 and the concentration synthesized in Synthesis Example 31 were 6 parts by weight. /. The polyamic acid solution (PA31) was mixed at a weight ratio of 8/2. A mixed solvent of NMP/BC = 1/1 (weight ratio) was added to the obtained mixture, and the whole was diluted to 4% by weight to prepare a liquid crystal alignment agent. Then, a liquid crystal display element was produced in the same manner as in Example 1 using the obtained liquid crystal alignment agent. <3. Evaluation of electrical characteristics> The liquid crystal display element produced in the method of Ί a 贝 〜 〜 〜 〜 、 、 、 、 、 、 、 、 、 、 离子 离子 离子 离子 离子 离子 离子 离子 离子 离子 离子 离子 离子 离子 离子 离子 离子 离子 离子Determination. 1) Measurement of ion density Using the liquid crystal physical property evaluation device manufactured by TOYO Technica, 0254 m ion-density (four) was lost. The measurement correction is set such that the waveform is a triangle z, the voltage is _, and the measurement temperature is set. The smaller the 疋 value is, the better the electrical characteristics are. The results are shown in Table 3. 2) Determination of the retention characteristics of ion density 122 200927790
下方法:將液晶顯示元件放置在溫度爲100°C的環境中, 中途隨時間取出而測定離子密度[pC]。離子密度的增加越 小(例如增加量小於1〇〇 :增加量= 500小時後的離子密度 —初期(0小時)的離子密度),則可以說離子密度的保持 特性越良好,而且可以說電特性的長期可靠性越良好。將 300小時後和500小時後的數據示於表3中。 123 200927790 >c [表3]The following method: The liquid crystal display element was placed in an environment at a temperature of 100 ° C, and the ion density [pC] was measured by taking it out over time. The smaller the increase in ion density (for example, the increase amount is less than 1 〇〇: the increase amount = the ion density after 500 hours - the ion density at the initial (0 hour)), it can be said that the ion density retention characteristic is better, and it can be said that electricity The better the long-term reliability of the characteristics. The data after 300 hours and after 500 hours are shown in Table 3. 123 200927790 >c [Table 3]
試驗例No. 液晶配向劑 離子密度(pC) 增加量 0 300小時後 500小時後 1 實施例1 18 45 50 32 2 實施例2 18 38 44 26 3 實施例3 17 34 46 29 4 實施例4 10 28 35 25 5 實施例5 11 15 16 5 6 實施例6 43 59 61 18 7 實施例7 10 11 27 17 8 實施例8 21 38 55 34 9 實施例9 26 27 35 9 10 實施例10 39 75 96 57 11 實施例11 15 16 17 2 12 實施例12 28 51 56 28 13 實施例13 34 47 62 28 14 實施例14 33 49 53 20 15 實施例15 54 57 80 26 16 實施例16 42 95 115 73 17 實施例17 23 41 84 61 18 實施例18 21 66 91 70 19 實施例19 4 28 43 39 20 實施例20 8 43 48 40 21 實施例21 35 66 72 37 22 實施例22 15 31 36 21 23 實施例23 34 60 75 41 24 實施例24 5 17 22 17 25 實施例25 3 10 10 7 26 實施例26 4 10 10 6 27 實施例27 64 85 92 28 28 實施例28 32 49 49 17 29 實施例29 40 49 52 12 30 實施例30 32 63 66 34 31 實施例31 22 44 50 28 32 實施例32 17 31 35 18 33 實施例33 3 11 19 16 34 實施例34 55 70 74 19 35 比較例1 62 209 545 483 36 比較例2 14 84 125 111 37 比較例3 66 111 202 136 38 比較例4 51 155 191 140 39 比較例5 98 312 424 326 124 200927790 如表3麻,制由含有單财包含DAC的聚 酸的液晶配向劑所獲得的液晶配向膜的液 抑制離子密度隨時間增大的效果得到了明顯改盖。 、 雖然本發明已以實施例揭露如上,然其並^以 ^發明’任何所屬技術領域中具有通常知識者,脫 Ο ==】當視後附之申請專利範圍所界二:本 無。 【主要元件符號說明】 無。 125Test No. Liquid crystal alignment agent ion density (pC) increase amount 0 300 hours after 500 hours 1 Example 1 18 45 50 32 2 Example 2 18 38 44 26 3 Example 3 17 34 46 29 4 Example 4 10 28 35 25 5 Example 5 11 15 16 5 6 Example 6 43 59 61 18 7 Example 7 10 11 27 17 8 Example 8 21 38 55 34 9 Example 9 26 27 35 9 10 Example 10 39 75 96 57 11 Example 11 15 16 17 2 12 Example 12 28 51 56 28 13 Example 13 34 47 62 28 14 Example 14 33 49 53 20 15 Example 15 54 57 80 26 16 Example 16 42 95 115 73 17 Example 17 23 41 84 61 18 Example 18 21 66 91 70 19 Example 19 4 28 43 39 20 Example 20 8 43 48 40 21 Example 21 35 66 72 37 22 Example 22 15 31 36 21 23 Example 23 34 60 75 41 24 Example 24 5 17 22 17 25 Example 25 3 10 10 7 26 Example 26 4 10 10 6 27 Example 27 64 85 92 28 28 Example 28 32 49 49 17 29 Example 29 40 49 52 12 30 Example 30 32 63 66 34 31 Example 31 22 44 50 28 32 Example 32 17 31 35 18 33 Example 33 3 11 19 16 34 Example 34 5 5 70 74 19 35 Comparative Example 1 62 209 545 483 36 Comparative Example 2 14 84 125 111 37 Comparative Example 3 66 111 202 136 38 Comparative Example 4 51 155 191 140 39 Comparative Example 5 98 312 424 326 124 200927790 As shown in Table 3 The effect of increasing the liquid suppression ion density of the liquid crystal alignment film obtained by the liquid crystal alignment agent containing the polyacid containing the DAC of the single-fat has been significantly changed. Although the present invention has been disclosed in the above embodiments by way of example, it is intended to be in the art of any of the ordinary skill in the art, and is not limited to the scope of the appended claims. [Main component symbol description] None. 125
Claims (1)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007334865 | 2007-12-26 |
Publications (2)
Publication Number | Publication Date |
---|---|
TW200927790A true TW200927790A (en) | 2009-07-01 |
TWI492966B TWI492966B (en) | 2015-07-21 |
Family
ID=40827909
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW097143519A TWI492966B (en) | 2007-12-26 | 2008-11-11 | Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display |
Country Status (4)
Country | Link |
---|---|
JP (1) | JP4985609B2 (en) |
KR (1) | KR101519865B1 (en) |
CN (1) | CN101470303B (en) |
TW (1) | TWI492966B (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI417317B (en) * | 2010-07-21 | 2013-12-01 | Daxin Materials Corp | Aromatic diamine compound, polyamic acid and polyimide prepared using the same and liquid crystal alignment agent |
TWI685543B (en) * | 2015-04-08 | 2020-02-21 | 日商Jsr股份有限公司 | Liquid crystal alignment agent, liquid crystal alignment film and its manufacturing method, liquid crystal element and its manufacturing method, compound |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5041169B2 (en) * | 2008-09-11 | 2012-10-03 | Jsr株式会社 | Liquid crystal aligning agent and liquid crystal display element |
JP5459052B2 (en) * | 2009-06-25 | 2014-04-02 | Jnc株式会社 | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element |
US20120120363A1 (en) * | 2009-07-28 | 2012-05-17 | Shoichi Ishihara | Liquid crystal display element |
JP5630139B2 (en) * | 2009-08-18 | 2014-11-26 | Jnc株式会社 | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element |
JP5556482B2 (en) * | 2009-09-15 | 2014-07-23 | Jnc株式会社 | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element |
KR20110067574A (en) | 2009-12-14 | 2011-06-22 | 삼성전자주식회사 | Liquid Crystal Display and Manufacturing Method Thereof |
JP5387428B2 (en) * | 2010-01-26 | 2014-01-15 | Jnc株式会社 | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element |
JP5569095B2 (en) * | 2010-03-29 | 2014-08-13 | Jnc株式会社 | Diamine having diphenylamine structure at two positions in the molecule, polymer obtained by reacting this diamine, liquid crystal aligning agent containing this polymer, liquid crystal aligning film formed using this liquid crystal aligning agent, and this liquid crystal aligning film Liquid crystal display device having |
JP5761180B2 (en) * | 2010-04-06 | 2015-08-12 | 日産化学工業株式会社 | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element |
KR20110124124A (en) * | 2010-05-10 | 2011-11-16 | 짓쏘 세끼유 가가꾸 가부시키가이샤 | Diamine, liquid crystal aligning agent, and liquid crystal display element |
CN103068928B (en) * | 2010-08-11 | 2015-11-25 | 日产化学工业株式会社 | Resin combination, liquid crystal aligning material and phase differential material |
JP2012155311A (en) * | 2011-01-05 | 2012-08-16 | Jnc Corp | Liquid crystal aligning agent for forming photo-aligning liquid crystal alignment layer, liquid crystal alignment layer and liquid crystal display element using the same |
WO2013015407A1 (en) * | 2011-07-27 | 2013-01-31 | 日産化学工業株式会社 | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element |
JP5962381B2 (en) * | 2011-12-27 | 2016-08-03 | Jsr株式会社 | Liquid crystal aligning agent, liquid crystal aligning film, liquid crystal display element and polymer |
JP5949070B2 (en) | 2012-04-03 | 2016-07-06 | Jsr株式会社 | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element |
CN108034435A (en) | 2012-04-24 | 2018-05-15 | 捷恩智株式会社 | Light orientation aligning agent for liquid crystal, light orientation liquid crystal orientation film, its forming method and LCD assembly |
JP6260150B2 (en) * | 2012-12-03 | 2018-01-17 | Jsr株式会社 | Liquid crystal aligning agent, liquid crystal aligning film, liquid crystal display element, retardation film, method for producing retardation film, polymer and compound |
JP5997385B2 (en) * | 2013-07-30 | 2016-09-28 | シャープ株式会社 | Manufacturing method of liquid crystal display device |
JP6315193B2 (en) * | 2013-10-03 | 2018-04-25 | Jsr株式会社 | Liquid crystal alignment agent |
WO2015111982A1 (en) * | 2014-01-27 | 2015-07-30 | 코오롱인더스트리 주식회사 | Polyimide and film using same |
KR101574016B1 (en) | 2014-01-27 | 2015-12-02 | 코오롱인더스트리 주식회사 | Polyimide and Film Thereof |
JP6492688B2 (en) | 2014-04-23 | 2019-04-03 | Jsr株式会社 | Liquid crystal aligning agent, liquid crystal aligning film, manufacturing method thereof, and liquid crystal display element |
TWI527857B (en) * | 2014-05-15 | 2016-04-01 | 奇美實業股份有限公司 | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display device |
TWI529214B (en) * | 2014-05-15 | 2016-04-11 | Chi Mei Corp | Liquid crystal aligning agent and its application |
TWI546337B (en) * | 2015-05-22 | 2016-08-21 | 奇美實業股份有限公司 | Liquid crystal alignment agent and uses thereof |
JP6627595B2 (en) | 2015-06-11 | 2020-01-08 | Jnc株式会社 | Liquid crystal alignment agent for forming liquid crystal alignment film for photo alignment, liquid crystal alignment film, and liquid crystal display device using the same |
CN110049971B (en) * | 2016-10-06 | 2023-01-13 | 日产化学株式会社 | Diamine, polymer, liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element |
KR102534902B1 (en) * | 2016-12-28 | 2023-05-19 | 닛산 가가쿠 가부시키가이샤 | Liquid crystal aligning agent, liquid crystal aligning film, and liquid crystal display element |
TWI767970B (en) * | 2016-12-28 | 2022-06-21 | 日商日產化學工業股份有限公司 | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element |
JP6925853B2 (en) * | 2017-04-26 | 2021-08-25 | 本州化学工業株式会社 | New benzoxazine resin composition and cured product thereof |
CN110041345B (en) * | 2019-05-10 | 2020-08-04 | 福建泓光半导体材料有限公司 | Resist underlayer film monomer, resist underlayer film composition and pattern forming method |
TWI717889B (en) * | 2019-11-05 | 2021-02-01 | 達興材料股份有限公司 | Alignment agent, diamine compound, alignment film and liquid crystal display device |
WO2021200291A1 (en) * | 2020-03-30 | 2021-10-07 | 日産化学株式会社 | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element |
US20240002583A1 (en) | 2020-11-04 | 2024-01-04 | Honshu Chemical Industry Co., Ltd. | Benzoxazine compound-containing composition, curable resin composition, and cured product thereof |
CN114605769B (en) * | 2022-02-12 | 2023-01-17 | 广东九彩新材料有限公司 | Polyamide color master batch colored by high-content carbon black for spinning and preparation method thereof |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4985539A (en) * | 1988-03-14 | 1991-01-15 | Himont Italia S.R.L. | Liquid-crystalline, thermotropic polymer from di-s-triazine and diamine |
TW339415B (en) | 1994-04-28 | 1998-09-01 | Chisso Corp | Processing and manufacturing method of LCD elements |
JPH09194725A (en) * | 1996-01-23 | 1997-07-29 | Japan Synthetic Rubber Co Ltd | Film-forming agent |
WO1997043774A1 (en) * | 1996-05-15 | 1997-11-20 | Hyperion Catalysis International, Inc. | Graphitic nanofibers in electrochemical capacitors |
JP2002302675A (en) * | 2001-04-06 | 2002-10-18 | Fuji Photo Film Co Ltd | Liquid crystal composition, liquid crystal device using the same, and azo compound |
US7883636B2 (en) * | 2003-08-08 | 2011-02-08 | Board Of Regents Of The Nevada System Of Higher Education, On Behalf Of The University Of Nevada, Reno | Nanostructured magnetorheological fluids and gels |
EP1799791B1 (en) * | 2004-10-13 | 2016-01-13 | Rolic AG | Photocrosslinkable materials |
JP2006131662A (en) * | 2004-11-02 | 2006-05-25 | Hitachi Cable Ltd | Polyimide resin composition and polyimide film |
-
2008
- 2008-10-09 JP JP2008263076A patent/JP4985609B2/en active Active
- 2008-11-11 TW TW097143519A patent/TWI492966B/en active
- 2008-12-16 KR KR1020080127766A patent/KR101519865B1/en not_active Expired - Fee Related
- 2008-12-24 CN CN2008101894186A patent/CN101470303B/en active Active
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI417317B (en) * | 2010-07-21 | 2013-12-01 | Daxin Materials Corp | Aromatic diamine compound, polyamic acid and polyimide prepared using the same and liquid crystal alignment agent |
TWI685543B (en) * | 2015-04-08 | 2020-02-21 | 日商Jsr股份有限公司 | Liquid crystal alignment agent, liquid crystal alignment film and its manufacturing method, liquid crystal element and its manufacturing method, compound |
Also Published As
Publication number | Publication date |
---|---|
CN101470303B (en) | 2013-01-23 |
CN101470303A (en) | 2009-07-01 |
JP4985609B2 (en) | 2012-07-25 |
JP2009175684A (en) | 2009-08-06 |
TWI492966B (en) | 2015-07-21 |
KR101519865B1 (en) | 2015-05-13 |
KR20090071395A (en) | 2009-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW200927790A (en) | Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display | |
TWI454529B (en) | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element | |
TWI458754B (en) | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display device | |
TWI596138B (en) | Method to form liquid crystal photo-alignment film, and liquid crystal display | |
TWI606081B (en) | Method of forming liquid crystal alignment film for photo-alignment, and liquid crystal displays | |
TWI592437B (en) | Liquid crystal alignment agent for forming liquid crystal alignment film for photoalignment, liquid crystal alignment film and liquid crystal display device using the same | |
TWI638856B (en) | Liquid crystal aligning agent, liquid crystal aligning film and liquid crystal display device | |
JP5556482B2 (en) | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element | |
TWI609853B (en) | Photosensitive diamine, polyamic acid or derivatives thereof, liquid crystal aligning agents, liquid crystal aligning film and liquid crystal display devices | |
TW201022331A (en) | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display device | |
TWI586709B (en) | Polyamic acid and derivatives thereof, liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display device using the same | |
TWI421280B (en) | Liquid crystal aligning agent, liquid crystal alignment layer and liquid crystal display | |
TWI573814B (en) | Liquid crystal alignment agent for forming a liquid alignment film for photoalignment, liquid crystal alignment film, and liquid crystal display element using the same | |
TW201632587A (en) | Liquid crystal aligning agent for forming liquid crystal aligning layer, liquid crystal aligning layer and liquid crystal display device using the same | |
TW201437262A (en) | Polylysine and its derivatives and its use, liquid alignment film for liquid alignment, liquid crystal display elements and tetracarboxylic dianhydride | |
TW201643205A (en) | Liquid crystal aligning agent for photoalignment, liquid crystal alignment film, and liquid crystal display device and lateral electric field liquid crystal display device using the same | |
TW200902644A (en) | Ink-jet ink | |
JP5630139B2 (en) | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element | |
TW201740165A (en) | Liquid crystal display element characterized in that even if the liquid crystal display element is exposed to strong light for a long time, the display quality will not decreased | |
CN107557023A (en) | To form the aligning agent for liquid crystal of light orientation liquid crystal orientation film, liquid crystal orientation film and use its liquid crystal display cells | |
TW201741395A (en) | Liquid crystal aligning agents for forming liquid crystal alignment films, liquid crystal alignment films and liquid crystal display devices using the same |